Section 58

EurekaMag PDF full texts Chapter 57,963


Vérollet, C.; Le Cabec, V.ér.; Maridonneau-Parini, I. 2015: HIV-1 Infection of T Lymphocytes and Macrophages Affects their Migration via Nef. Frontiers in Immunology 6: 514
Kessl, J.J.; Kutluay, S.B.; Townsend, D.; Rebensburg, S.; Slaughter, A.; Larue, R.C.; Shkriabai, N.; Bakouche, N.; Fuchs, J.R.; Bieniasz, P.D.; Kvaratskhelia, M. 2016: HIV-1 Integrase Binds the Viral RNA Genome and Is Essential during Virion Morphogenesis. Cell 166(5): 1257-1268.E12
Zhao, X.Z.; Smith, S.J.; Maskell, D.P.; Metifiot, M.; Pye, V.E.; Fesen, K.; Marchand, C.; Pommier, Y.; Cherepanov, P.; Hughes, S.H.; Burke, T.R. 2016: HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases. Acs Chemical Biology 11(4): 1074-1081
Suttiprapa, S.; Rinaldi, G.; Tsai, I.J.; Mann, V.H.; Dubrovsky, L.; Yan, H.-B.; Holroyd, N.; Huckvale, T.; Durrant, C.; Protasio, A.V.; Pushkarsky, T.; Iordanskiy, S.; Berriman, M.; Bukrinsky, M.I.; Brindley, P.J. 2016: HIV-1 Integrates Widely throughout the Genome of the Human Blood Fluke Schistosoma mansoni. Plos Pathogens 12(10): E1005931
Dangor, Z.; Kwatra, G.; Izu, A.; Adrian, P.; van Niekerk, N.; Cutland, C.L.; Adam, Y.; Velaphi, S.; Lala, S.G.; Madhi, S.A. 2015: HIV-1 Is Associated with Lower Group B Streptococcus Capsular and Surface-Protein IgG Antibody Levels and Reduced Transplacental Antibody Transfer in Pregnant Women. Journal of Infectious Diseases 212(3): 453-462
Griffin, D.O.; Goff, S.P. 2015: HIV-1 Is Restricted prior to Integration of Viral DNA in Primary Cord-Derived Human CD34+ Cells. Journal of Virology 89(15): 8096-8100
Cromer, D.; Schlub, T.E.; Smyth, R.P.; Grimm, A.J.; Chopra, A.; Mallal, S.; Davenport, M.P.; Mak, J. 2016: HIV-1 Mutation and Recombination Rates Are Different in Macrophages and T-cells. Viruses 8(4): 118
Mangino, G.; Famiglietti, M.; Capone, C.; Veroni, C.; Percario, Z.A.; Leone, S.; Fiorucci, G.; Lülf, S.; Romeo, G.; Agresti, C.; Persichini, T.; Geyer, M.; Affabris, E. 2015: HIV-1 Myristoylated Nef Treatment of Murine Microglial Cells Activates Inducible Nitric Oxide Synthase, NO2 Production and Neurotoxic Activity. Plos one 10(6): E0130189
Silva, J.G.; Martins, N.P.; Henriques, R.; Soares, H. 2016: HIV-1 Nef Impairs the Formation of Calcium Membrane Territories Controlling the Signaling Nanoarchitecture at the Immunological Synapse. Journal of Immunology 197(10): 4042-4052
Vassena, L.; Giuliani, E.; Koppensteiner, H.; Bolduan, S.; Schindler, M.; Doria, M. 2015: HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression to Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes. Journal of Virology 89(10): 5687-5700
Kumar, M.; Kaur, S.; Nazir, A.; Tripathi, R.K. 2016: HIV-1 Nef binds with human GCC185 protein and regulates mannose 6 phosphate receptor recycling. Biochemical and Biophysical Research Communications 474(1): 137-145
Sardo, L.; Iordanskiy, S.; Klase, Z.; Kashanchi, F. 2015: HIV-1 Nef blocks autophagy in human astrocytes. Cell Cycle 14(24): 3781-3782
Morley, S.C. 2015: HIV-1 Nef drives macrophages into hiding. Blood 125(10): 1512-1513
Shen, Q-Tao.; Ren, X.; Zhang, R.; Lee, I-Hyung.; Hurley, J.H. 2015: HIV-1 Nef hijacks clathrin coats by stabilizing AP-1:Arf1 polygons. Science 350(6259): Aac5137
Rossi, F.W.; Prevete, N.; Rivellese, F.; Lobasso, A.; Napolitano, F.; Granata, F.; Selleri, C.; de Paulis, A. 2016: HIV-1 Nef promotes migration and chemokine synthesis of human basophils and mast cells through the interaction with CXCR4. Clinical and Molecular Allergy: Cma 14: 15
Ren, X-Xin.; Wang, H-Bo.; Li, C.; Jiang, J-Feng.; Xiong, S-Dong.; Jin, X.; Wu, L.; Wang, J-Hua. 2016: HIV-1 Nef-associated Factor 1 Enhances Viral Production by Interacting with CRM1 to Promote Nuclear Export of Unspliced HIV-1 gag mRNA. Journal of Biological Chemistry 291(9): 4580-4588
Pereira, E.A.; daSilva, L.L.P. 2016: HIV-1 Nef: Taking Control of Protein Trafficking. Traffic 17(9): 976-996
Pawlak, E.N.; Dikeakos, J.D. 2015: HIV-1 Nef: a master manipulator of the membrane trafficking machinery mediating immune evasion. Biochimica et Biophysica Acta 1850(4): 733-741
Simonich, C.A.; Williams, K.L.; Verkerke, H.P.; Williams, J.A.; Nduati, R.; Lee, K.K.; Overbaugh, J. 2016: HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant. Cell 166(1): 77-87
Sette, P.; O'Connor, S.K.; Yerramilli, V.Siddartha.; Dussupt, V.; Nagashima, K.; Chutiraka, K.; Lingappa, J.; Scarlata, S.; Bouamr, F. 2016: HIV-1 Nucleocapsid Mimics the Membrane Adaptor Syntenin PDZ to Gain Access to ESCRTs and Promote Virus Budding. Cell Host and Microbe 19(3): 336-348
Darcissac, E.; Nacher, M.; Adriouch, L.; Berlioz-Arthaud, A.; Boukhari, R.; Couppié, P.; Djossou, F.; Donato, D.; El Guedj, M.; Lavergne, A.; Papot, E.; Pouliquen, J.-F.ço.; Tanguy, E.; Vantilcke, V.; Lacoste, V. 2016: HIV-1 Pol Gene Polymorphism and Antiretroviral Resistance Mutations in Treatment-Naive Adult Patients in French Guiana Between 2006 and 2012. Aids Research and Human Retroviruses 32(8): 801-811
Bernacchi, S.; Abd El-Wahab, E.W.; Dubois, Né.; Hijnen, M.; Smyth, R.P.; Mak, J.; Marquet, R.; Paillart, J-Christophe. 2017: HIV-1 Pr55 Gag binds genomic and spliced RNAs with different affinity and stoichiometry. Rna Biology 14(1): 90-103
Nonnemacher, M.R.; Pirrone, V.; Feng, R.; Moldover, B.; Passic, S.; Aiamkitsumrit, B.; Dampier, W.; Wojno, A.; Kilareski, E.; Blakey, B.; Ku, T.-S.J.; Shah, S.; Sullivan, N.T.; Jacobson, J.M.; Wigdahl, B. 2016: HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity. Plos one 11(4): E0150835
Benko, Z.; Elder, R.T.; Li, G.; Liang, D.; Zhao, R.Y. 2016: HIV-1 Protease in the Fission Yeast Schizosaccharomyces pombe. Plos one 11(3): E0151286
Rhee, S.-Y.; Sankaran, K.; Varghese, V.; Winters, M.A.; Hurt, C.B.; Eron, J.J.; Parkin, N.; Holmes, S.P.; Holodniy, M.; Shafer, R.W. 2016: HIV-1 Protease, Reverse Transcriptase, and Integrase Variation. Journal of Virology 90(13): 6058-6070
Kiselinova, M.; Geretti, A.M.; Malatinkova, E.; Vervisch, K.; Beloukas, A.; Messiaen, P.; Bonczkowski, P.; Trypsteen, W.; Callens, S.; Verhofstede, C.; De Spiegelaere, W.; Vandekerckhove, L. 2015: HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapine-based regimens. Journal of Antimicrobial ChemoTherapy 70(12): 3311-3316
Chen, J.; Rahman, S.A.; Nikolaitchik, O.A.; Grunwald, D.; Sardo, L.; Burdick, R.C.; Plisov, S.; Liang, E.; Tai, S.; Pathak, V.K.; Hu, W.-S. 2016: HIV-1 RNA genome dimerizes on the plasma membrane in the presence of Gag protein. Proceedings of the National Academy of Sciences of the United States of America 113(2): E201-E208
Tatarelli, P.; Taramasso, L.; Di Biagio, A.; Sticchi, L.; Nigro, N.; Barresi, R.; Viscoli, C.; Bruzzone, B. 2016: HIV-1 RNA quantification in CRF02_AG HIV-1 infection: too easy to make mistakes. New Microbiologica 39(2): 150-152
Vongrad, V.; Imig, J.; Mohammadi, P.; Kishore, S.; Jaskiewicz, L.; Hall, J.; Günthard, H.F.; Beerenwinkel, N.; Metzner, K.J. 2015: HIV-1 RNAs are not Part of the Argonaute 2 Associated RNA Interference Pathway in Macrophages. Plos one 10(7): E0132127
Harwig, A.; Das, A.T.; Berkhout, B. 2015: HIV-1 RNAs: sense and antisense, large mRNAs and small si RNAs and miRNAs. Current Opinion in HIV and Aids 10(2): 103-109
Daniels, S.M.; Sinck, L.; Ward, N.J.; Melendez-Peña, C.E.; Scarborough, R.J.; Azar, I.; Rance, E.; Daher, Aïcha.; Pang, K-Ming.; Rossi, J.J.; Gatignol, A. 2015: HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs. Rna Biology 12(2): 123-135
Ajamian, L.; Abel, K.; Rao, S.; Vyboh, K.; García-de-Gracia, F.; Soto-Rifo, R.; Kulozik, A.E.; Gehring, N.H.; Mouland, A.J. 2015: HIV-1 Recruits UPF1 but Excludes UPF2 to Promote Nucleocytoplasmic Export of the Genomic RNA. Biomolecules 5(4): 2808-2839
Vallejo, A. 2015: HIV-1 Reservoir Association with Immune Activation. Ebiomedicine 2(9): 1020-1021
Andrés, C.; Plana, M.; Guardo, A.C.; Alvarez-Fernández, C.; Climent, N.; Gallart, T.; León, A.; Clotet, B.; Autran, B.; Chomont, N.; Gatell, J.M.; Sánchez-Palomino, S.; García, F. 2015: HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses. Journal of Virology 89(18): 9189-9199
Barton, K.; Winckelmann, A.; Palmer, S. 2016: HIV-1 Reservoirs During Suppressive Therapy. Trends in Microbiology 24(5): 345-355
Zhou, J.; Price, A.J.; Halambage, U.D.; James, L.C.; Aiken, C. 2015: HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry. Journal of Virology 89(17): 9068-9079
Li, A.; Li, J.; Johnson, K.A. 2016: HIV-1 Reverse Transcriptase Polymerase and RNase H (Ribonuclease H) Active Sites Work Simultaneously and Independently. Journal of Biological Chemistry 291(51): 26566-26585
Hollenbaugh, J.A.; Kim, B. 2016: HIV-1 Reverse Transcriptase-Based Assay to Determine Cellular dNTP Concentrations. Methods in Molecular Biology 1354: 61-70
Lamers, S.L.; Barbier, A.E.; Ratmann, O.; Fraser, C.; Rose, R.; Laeyendecker, O.; Grabowski, M.K. 2016: HIV-1 Sequence Data Coverage in Central East Africa from 1959 to 2013. AIDS research and human retroviruses 32(9): 904-908
Henrick, B.M.; Yao, X.-D.; Rosenthal, K.L. 2015: HIV-1 Structural Proteins Serve as PAMPs for TLR2 Heterodimers Significantly Increasing Infection and Innate Immune Activation. Frontiers in Immunology 6: 426
Jongwe, T.I.; Chapman, R.; Douglass, N.; Chetty, S.; Chege, G.; Williamson, A.-L. 2016: HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice. Plos one 11(7): E0159141
Günthard, H.F.; Scherrer, A.U. 2016: HIV-1 Subtype C, Tenofovir, and the Relationship with Treatment Failure and Drug Resistance. Journal of Infectious Diseases 214(9): 1289-1291
Sheward, D.J.; Ntale, R.; Garrett, N.J.; Woodman, Z.L.; Abdool Karim, S.S.; Williamson, C. 2015: HIV-1 Superinfection Resembles Primary Infection. Journal of Infectious Diseases 212(6): 904-908
Fan, Y.; He, J.J. 2016: HIV-1 Tat Induces Unfolded Protein Response and Endoplasmic Reticulum Stress in Astrocytes and Causes Neurotoxicity through Glial Fibrillary Acidic Protein (GFAP) Activation and Aggregation. Journal of Biological Chemistry 291(43): 22819-22829
Wheeler, N.A.; Fuss, B.; Knapp, P.E.; Zou, S. 2016: HIV-1 Tat Inhibits Autotaxin Lysophospholipase D Activity and Modulates Oligodendrocyte Differentiation. Asn Neuro 8(5)
Fan, Y.; He, J.J. 2016: HIV-1 Tat Promotes Lysosomal Exocytosis in Astrocytes and Contributes to Astrocyte-mediated Tat Neurotoxicity. Journal of Biological Chemistry 291(43): 22830-22840
Planès, R.ém.; Ben Haij, N.; Leghmari, K.; Serrero, M.; BenMohamed, L.; Bahraoui, E. 2016: HIV-1 Tat Protein Activates both the MyD88 and TRIF Pathways to Induce Tumor Necrosis Factor Alpha and Interleukin-10 in Human Monocytes. Journal of Virology 90(13): 5886-5898
Zhou, Y.; Zhang, K.; Yin, X.; Nie, Q.; Ma, Y. 2016: HIV-1 Tat Protein Enhances Expression and Function of Breast Cancer Resistance Protein. Aids Research and Human Retroviruses 32(1): 1-3
Ben Haij, N.; Planès, Rémi.; Leghmari, K.; Serrero, M.; Delobel, P.; Izopet, J.; BenMohamed, L.; Bahraoui, E. 2015: HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway. Plos one 10(6): E0129425
Remoli, A.L.; Marsili, G.; Perrotti, E.; Acchioni, C.; Sgarbanti, M.; Borsetti, A.; Hiscott, J.; Battistini, A. 2016: HIV-1 Tat Recruits HDM2 E3 Ligase to Target IRF-1 for Ubiquitination and Proteasomal Degradation. Mbio 7(5)
Chen, Y.; Huang, W.; Jiang, W.; Wu, X.; Ye, B.; Zhou, X. 2016: HIV-1 Tat Regulates Occludin and Aβ Transfer Receptor Expression in Brain Endothelial Cells via Rho/ROCK Signaling Pathway. Oxidative Medicine and Cellular Longevity 2016: 4196572
Fields, J.; Dumaop, W.; Eleuteri, S.; Elueteri, S.; Campos, S.; Serger, E.; Trejo, M.; Kosberg, K.; Adame, A.; Spencer, B.; Rockenstein, E.; He, J.J.; Masliah, E. 2015: HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 35(5): 1921-1938
De Simone, F.I.; Darbinian, N.; Amini, S.; Muniswamy, M.; White, M.K.; Elrod, J.W.; Datta, P.K.; Langford, D.; Khalili, K. 2016: HIV-1 Tat and Cocaine Impair Survival of Cultured Primary Neuronal Cells via a Mitochondrial Pathway. Journal of Neuroimmune Pharmacology: the Official Journal of the Society on Neuroimmune Pharmacology 11(2): 358-368
Bertrand, S.J.; Hu, C.; Aksenova, M.V.; Mactutus, C.F.; Booze, R.M. 2015: HIV-1 Tat and cocaine mediated synaptopathy in cortical and midbrain neurons is prevented by the isoflavone Equol. Frontiers in Microbiology 6: 894
Fatin, M.F.; Ruslinda, A.R.; Md Arshad, M.K.; Tee, K.K.; Ayub, R.M.; Hashim, U.; Kamarulzaman, A.; Gopinath, S.C.B. 2016: HIV-1 Tat biosensor: Current development and trends for early detection strategies. Biosensors and Bioelectronics 78: 358-366
Marks, W.D.; Paris, J.J.; Schier, C.J.; Denton, M.D.; Fitting, S.; McQuiston, A.R.; Knapp, P.E.; Hauser, K.F. 2016: HIV-1 Tat causes cognitive deficits and selective loss of parvalbumin, somatostatin, and neuronal nitric oxide synthase expressing hippocampal CA1 interneuron subpopulations. Journal of Neurovirology 22(6): 747-762
Ensoli, F.; Cafaro, A.; Casabianca, A.; Tripiciano, A.; Bellino, S.; Longo, O.; Francavilla, V.; Picconi, O.; Sgadari, C.; Moretti, S.; Cossut, M.R.P.; Arancio, A.; Orlandi, C.; Sernicola, L.; Maggiorella, M.T.; Paniccia, G.; Mussini, C.; Lazzarin, A.; Sighinolfi, L.; Palamara, G.; Gori, A.; Angarano, G.; Di Pietro, M.; Galli, M.; Mercurio, V.S.; Castelli, F.; Di Perri, G.; Monini, P.; Magnani, M.; Garaci, E.; Ensoli, B. 2015: HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase Ii exploratory clinical trial. Retrovirology 12: 33
Luzzi, A.; Morettini, F.; Gazaneo, S.; Mundo, L.; Onnis, A.; Mannucci, S.; Rogena, E.A.; Bellan, C.; Leoncini, L.; De Falco, G. 2014: HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas. Infectious Agents and Cancer 9: 41
McLaughlin, J.P.; Ganno, M.L.; Eans, S.O.; Mizrachi, E.; Paris, J.J. 2014: HIV-1 Tat protein exposure potentiates ethanol reward and reinstates extinguished ethanol-conditioned place preference. Current HIV Research 12(6): 415-423
Bruno, A.P.; De Simone, F.I.; Iorio, V.; De Marco, M.; Khalili, K.; Sariyer, I.K.; Capunzo, M.; Nori, S.L.; Rosati, A. 2014: HIV-1 Tat protein induces glial cell autophagy through enhancement of BAG3 protein levels. Cell Cycle 13(23): 3640-3644
Cafaro, A.; Piccaro, G.; Altavilla, G.; Gigantino, V.; Matarese, G.; Olivieri, E.; Ferrantelli, F.; Ensoli, B.; Palma, C. 2016: HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology. Bmc Infectious Diseases 16(1): 442
Wei, J.; Zhang, Y.; Knapp, P.E.; Zhao, T. 2016: HIV-1 Tat regulates the expression of the dcw operon and stimulates the proliferation of bacteria. Microbial Pathogenesis 90: 34-40
Krogh, K.A.; Green, M.V.; Thayer, S.A. 2014: HIV-1 Tat-induced changes in synaptically-driven network activity adapt during prolonged exposure. Current HIV Research 12(6): 406-414
Rahimian, P.; He, J.J. 2016: HIV-1 Tat-shortened neurite outgrowth through regulation of microRNA-132 and its target gene expression. Journal of Neuroinflammation 13(1): 247
Li, L.; Sun, G.; Zhong, P.; Han, J.; Li, T.; Jia, D.; Liu, Y.; Sun, C.; Wang, Z.; Li, H.; Wang, X.; Li, J. 2016: HIV-1 Thai B strain has spread out of former plasma donors into general population through sexual contact in Henan, China. Journal of Medical Virology 88(4): 614-621
Marzel, A.; Shilaih, M.; Yang, W.-L.; Böni, J.ür.; Yerly, S.; Klimkait, T.; Aubert, V.; Braun, D.L.; Calmy, A.; Furrer, H.; Cavassini, M.; Battegay, M.; Vernazza, P.L.; Bernasconi, E.; Günthard, H.F.; Kouyos, R.D.; Aubert, V.; Battegay, M.; Bernasconi, E.; Böni, J.; Bucher, H.C.; Burton-Jeangros, C.; Calmy, A.; Cavassini, M.; Dollenmaier, G.; Egger, M.; Elzi, L.; Fehr, J.; Fellay, J.; Furrer, H.; Fux, C.A.; Gorgievski, M.; Günthard, H.F.; Haerry, D.; Hasse, B.; Hirsch, H.H.; Hoffmann, M.; Hösli, I.; Kahlert, C.; Kaiser, L.; Keiser, O.; Klimkait, T.; Kouyos, R.D.; Kovari, H.; Ledergerber, B.; Martinetti, G.; de Tejada, B.M.; Metzner, K.; Müller, N.; Nadal, D.; Nicca, D.; Pantaleo, G.; Rauch, A.; Regenass, S.; Rickenbach, M.; Rudin, C. 2016: HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of new Infections in the Swiss HIV Cohort Study. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 62(1): 115-122
Sayan, M.; Sargin, F.; Inan, D.; Sevgi, D.Y.; Celikbas, A.K.; Yasar, K.; Kaptan, F.; Kutlu, S.; Fisgin, N.T.; Inci, A.; Ceran, N.; Karaoglan, I.; Cagatay, A.; Celen, M.K.; Koruk, S.T.; Ceylan, B.; Yildirmak, T.; Akalın, H.; Korten, V.; Willke, A. 2016: HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey. Aids Research and Human Retroviruses 32(1): 26-31
Swaminathan, S.; Sui, H.; Adelsberger, J.W.; Chen, Q.; Sneller, M.; Migueles, S.A.; Kottilil, S.; Ober, A.; Jones, S.; Rehm, C.A.; Lane, H.C.; Imamichi, T. 2014: HIV-1 Treated Patients with Undetectable Viral Loads have Lower Levels of Innate Immune Responses via Cytosolic DNA Sensing Systems Compared with Healthy Uninfected Controls. Journal of Aids and Clinical Research 5(6)
Tang, Z.; Lan, G.; Chen, Y.Qing.; Zhu, Q.; Yang, X.; Shen, Z.; Chen, Y.; Zhang, H.; Kan, W.; Xing, H.; Ruan, Y.; Shao, Y. 2015: HIV-1 Treatment-as-Prevention: A Cohort Study Analysis of Serodiscordant Couples in Rural Southwest China. Medicine 94(24): E902
Nascimento-Brito, S.; Paulo Zukurov, J.; Maricato, J.T.; Volpini, A.C.; Salim, A.C.M.; Araújo, F.áv.M.G.; Coimbra, R.S.; Oliveira, G.C.; Antoneli, F.; Janini, L.M.ár.R. 2015: HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA. Plos one 10(9): E0139037
Williams, W.B.; Liao, H-Xin.; Moody, M.Anthony.; Kepler, T.B.; Alam, S.Munir.; Gao, F.; Wiehe, K.; Trama, A.M.; Jones, K.; Zhang, R.; Song, H.; Marshall, D.J.; Whitesides, J.F.; Sawatzki, K.; Hua, A.; Liu, P.; Tay, M.Z.; Seaton, K.E.; Shen, X.; Foulger, A.; Lloyd, K.E.; Parks, R.; Pollara, J.; Ferrari, G.; Yu, J-Sung.; Vandergrift, N.; Montefiori, D.C.; Sobieszczyk, M.E.; Hammer, S.; Karuna, S.; Gilbert, P.; Grove, D.; Grunenberg, N.; McElrath, M.Juliana.; Mascola, J.R.; Koup, R.A.; Corey, L.; Nabel, G.J.; Morgan, C.; Churchyard, G.; Maenza, J.; Keefer, M.; 2015: HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies. Science 349(6249): Aab1253
Sanders, R.W.; van Gils, M.J.; Derking, R.; Sok, D.; Ketas, T.J.; Burger, J.A.; Ozorowski, G.; Cupo, A.; Simonich, C.; Goo, L.; Arendt, H.; Kim, H.J.; Lee, J.Hyun.; Pugach, P.; Williams, M.; Debnath, G.; Moldt, B.; van Breemen, Mëlle.J.; Isik, Gözde.; Medina-Ramírez, M.; Back, J.Willem.; Koff, W.C.; Julien, J-Philippe.; Rakasz, E.G.; Seaman, M.S.; Guttman, M.; Lee, K.K.; Klasse, P.Johan.; LaBranche, C.; Schief, W.R.; Wilson, I.A.; Overbaugh, J.; Burton, D.R.; Ward, A.B.; Montefiori, D.C.; Dean, H.; Moore, J.P. 2015: HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers. Science 349(6244): Aac4223
Zschoche, J.H.; Nesbit, S.; Murtaza, U.; Sowell, A.; Waldfogel, J.M.; Arwood, N.; Rush, J.; McNamara, L.; Swarthout, M.; Nesbit, T.; Ortmann, M. 2018: Development and implementation of procedures for outpatient naloxone prescribing at a large academic medical center. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 75(22): 1812-1820
Alvarez, P.; Fernández McPhee, C.; Prieto, L.; Martín, L.; Obiang, J.; Avedillo, P.; Vargas, A.; Rojo, P.; Benito, Aín.; Ramos, Jé.Tomás.; Holguín, África. 2016: HIV-1 Variants and Drug Resistance in Pregnant Women from Bata (Equatorial Guinea): 2012-2013. PloS one 11(10): e0165333
Zinyama-Gutsire, R.B.L.; Christiansen, M.; Hedley, P.L.; Rusakaniko, S.; Hagen, C.; Stray-Pedersen, B.; Buzdugan, R.; Cowan, F.; Chasela, C. 2016: HIV-1 Vertical Transmission in Zimbabwe in 622 Mother and Infant Pairs: Rethinking the Contribution of Mannose Binding Lectin Deficiency in Africa. Omics: a Journal of Integrative Biology 20(7): 433-441
Calcagno, A.; Motta, I.; Ghisetti, V.; Lo Re, S.; Allice, T.; Marinaro, L.; Milia, M.G.; Tettoni, M.C.; Trentini, L.; Orofino, G.; Salassa, B.; Di Perri, G.; Bonora, S. 2015: HIV-1 very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients. Aids Research and Human Retroviruses 31(10): 999-1008
Mamik, M.K.; Hui, E.; Branton, W.G.; McKenzie, B.A.; Chisholm, J.; Cohen, E.A.; Power, C. 2017: HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated Neuroinflammation. Journal of Neuroimmune Pharmacology: the Official Journal of the Society on Neuroimmune Pharmacology 12(2): 233-248
Bui, J.K.; Mellors, J.W.; Cillo, A.R. 2016: HIV-1 Virion Production from Single Inducible Proviruses following T-Cell Activation Ex Vivo. Journal of Virology 90(3): 1673-1676
Chutiwitoonchai, N.; Siarot, L.; Takeda, E.; Shioda, T.; Ueda, M.; Aida, Y. 2016: HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release. Plos one 11(9): E0163100
Yan, Q.; Shen, C.; Qin, J.; Li, W.; Hu, M.; Lu, H.; Qin, D.; Zhu, J.; Gao, S-Jiang.; Lu, C. 2016: HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling. Journal of Virology 90(19): 8739-8753
Romani, B.; Shaykh Baygloo, N.; Aghasadeghi, M.R.; Allahbakhshi, E. 2015: HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest. Journal of Biological Chemistry 290(28): 17380-17389
Romani, B.; Baygloo, N.S.; Hamidi-Fard, M.; Aghasadeghi, M.R.; Allahbakhshi, E. 2016: HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class i HDACs to Overcome Latent Infection of Macrophages. Journal of Biological Chemistry 291(6): 2696-2711
Lahouassa, H.; Blondot, M.-L.; Chauveau, L.; Chougui, G.; Morel, M.; Leduc, M.; Guillonneau, F.ço.; Ramirez, B.C.; Schwartz, O.; Margottin-Goguet, F. 2016: HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages. Proceedings of the National Academy of Sciences of the United States of America 113(19): 5311-5316
Zhang, X.; Zhou, T.; Frabutt, D.A.; Zheng, Y-Hui. 2016: HIV-1 Vpr increases Env expression by preventing Env from endoplasmic reticulum-associated protein degradation (ERAD). Virology 496: 194-202
Yan, Y.; Huang, F.; Yuan, T.; Sun, B.; Yang, R. 2016: HIV-1 Vpr increases HCV replication through VprBP in cell culture. Virus Research 223: 153-160
Liang, Z.; Liu, R.; Lin, Y.; Liang, C.; Tan, J.; Qiao, W. 2015: HIV-1 Vpr protein activates the NF-κB pathway to promote G2/M cell cycle arrest. Virologica Sinica 30(6): 441-448
Liu, X.; Guo, H.; Wang, H.; Markham, R.; Wei, W.; Yu, X.-F. 2015: HIV-1 Vpr suppresses the cytomegalovirus promoter in a CRL4(DCAF1) E3 ligase independent manner. Biochemical and Biophysical Research Communications 459(2): 214-219
Trinité, B.; Chan, C.N.; Lee, C.S.; Levy, D.N. 2016: HIV-1 Vpr- and Reverse Transcription-Induced Apoptosis in Resting Peripheral Blood CD4 T Cells and Protection by Common Gamma-Chain Cytokines. Journal of Virology 90(2): 904-916
Pujol, Fçois.M.; Laketa, V.; Schmidt, F.; Mukenhirn, M.; Müller, B.; Boulant, S.; Grimm, D.; Keppler, O.T.; Fackler, O.T. 2016: HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites. Journal of Virology 90(15): 6709-6723
Apps, R.; Del Prete, G.Q.; Chatterjee, P.; Lara, A.; Brumme, Z.L.; Brockman, M.A.; Neil, S.; Pickering, S.; Schneider, D.K.; Piechocka-Trocha, A.; Walker, B.D.; Thomas, R.; Shaw, G.M.; Hahn, B.H.; Keele, B.F.; Lifson, J.D.; Carrington, M. 2016: HIV-1 Vpu Mediates HLA-C Downregulation. Cell Host and Microbe 19(5): 686-695
Ramirez, P.W.; DePaula-Silva, A.B.; Szaniawski, M.; Barker, E.; Bosque, A.; Planelles, V. 2015: HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins. Retrovirology 12: 65
Carlson, J.M.; Le, A.Q.; Shahid, A.; Brumme, Z.L. 2015: HIV-1 adaptation to HLA: a window into virus-host immune interactions. Trends in Microbiology 23(4): 212-224
Garg, H.; Lee, R.T.C.; Maurer-Stroh, S.; Joshi, A. 2016: HIV-1 adaptation to low levels of CCR5 results in V3 and V2 loop changes that increase envelope pathogenicity, CCR5 affinity and decrease susceptibility to Maraviroc. Virology 493: 86-99
Hrecka, K.; Hao, C.; Shun, M.-C.; Kaur, S.; Swanson, S.K.; Florens, L.; Washburn, M.P.; Skowronski, J. 2016: HIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins. Proceedings of the National Academy of Sciences of the United States of America 113(27): E3921-E3930
Rawson, J.M.O.; Landman, S.R.; Reilly, C.S.; Mansky, L.M. 2015: HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation. Retrovirology 12: 60
Cardno, T.S.; Shimaki, Y.; Sleebs, B.E.; Lackovic, K.; Parisot, J.P.; Moss, R.M.; Crowe-McAuliffe, C.; Mathew, S.F.; Edgar, C.D.; Kleffmann, T.; Tate, W.P. 2015: HIV-1 and Human PEG10 Frameshift Elements Are Functionally Distinct and Distinguished by Novel Small Molecule Modulators. Plos one 10(10): E0139036
Pocock, G.M.; Becker, J.T.; Swanson, C.M.; Ahlquist, P.; Sherer, N.M. 2016: HIV-1 and M-PMV RNA Nuclear Export Elements Program Viral Genomes for Distinct Cytoplasmic Trafficking Behaviors. Plos Pathogens 12(4): E1005565
Imran, M.; Manzoor, S.; Saalim, M.; Resham, S.; Ashraf, J.; Javed, A.; Waqar, A.B. 2016: HIV-1 and hijacking of the host immune system: the current scenario. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 124(10): 817-831
Férir, G.; Gordts, S.C.; Schols, D. 2014: HIV-1 and its resistance to peptidic carbohydrate-binding agents (CBAs): an overview. Molecules 19(12): 21085-21112
Diedrich, C.R.; O'Hern, J.; Wilkinson, R.J. 2016: HIV-1 and the Mycobacterium tuberculosis granuloma: a systematic review and meta-analysis. Tuberculosis 98: 62-76
Stake, M.; Singh, D.; Singh, G.; Marcela Hernandez, J.; Kaddis Maldonado, R.; Parent, L.J.; Boris-Lawrie, K. 2015: HIV-1 and two avian retroviral 5' untranslated regions bind orthologous human and chicken RNA binding proteins. Virology 486: 307-320
Steegen, K.; Bronze, M.; Papathanasopoulos, M.A.; van Zyl, G.; Goedhals, D.; Variava, E.; MacLeod, W.; Sanne, I.; Stevens, W.S.; Carmona, S. 2017: HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa. Journal of Antimicrobial ChemoTherapy 72(1): 210-219
García-Gallego, S.; Díaz, L.; Jiménez, Jé.Luis.; Gómez, R.; de la Mata, F.Javier.; Muñoz-Fernández, M.Ángeles. 2015: HIV-1 antiviral behavior of anionic PPI metallo-dendrimers with EDA core. European journal of medicinal chemistry 98: 139-148
Johnson, E.L.; Chakraborty, R. 2016: HIV-1 at the placenta: immune correlates of protection and infection. Current Opinion in Infectious Diseases 29(3): 248-255
Jardine, J.G.; Kulp, D.W.; Havenar-Daughton, C.; Sarkar, A.; Briney, B.; Sok, D.; Sesterhenn, F.; Ereño-Orbea, J.; Kalyuzhniy, O.; Deresa, I.; Hu, X.; Spencer, S.; Jones, M.; Georgeson, E.; Adachi, Y.; Kubitz, M.; deCamp, A.C.; Julien, J.-P.; Wilson, I.A.; Burton, D.R.; Crotty, S.; Schief, W.R. 2016: HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen. Science 351(6280): 1458-1463
Chen, N.-Y.; Zhou, L.; Gane, P.J.; Opp, S.; Ball, N.J.; Nicastro, G.; Zufferey, M.; Buffone, C.; Luban, J.; Selwood, D.; Diaz-Griffero, F.; Taylor, I.; Fassati, A. 2016: HIV-1 capsid is involved in post-nuclear entry steps. Retrovirology 13: 28
Cosnefroy, O.él.; Murray, P.J.; Bishop, K.N. 2016: HIV-1 capsid uncoating initiates after the first strand transfer of reverse transcription. Retrovirology 13(1): 58
Deshpande, S.; Patil, S.; Kumar, R.; Hermanus, T.; Murugavel, K.G.; Srikrishnan, A.K.; Solomon, S.; Morris, L.; Bhattacharya, J. 2016: HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms. Retrovirology 13(1): 60
Foster, C.; Kaye, S.; Smith, C.; Mackie, N.E. 2015: HIV-1 co-receptor tropism and disease progression in children and young adults with perinatally acquired HIV-1 infection. the HICCUP Study. Journal of Virus Eradication 1(3): 173-178
Mehla, R.; Chauhan, A. 2015: HIV-1 differentially modulates autophagy in neurons and astrocytes. Journal of Neuroimmunology 285: 106-118
Msimanga, P.W.; Vardas, E.; Engelbrecht, S. 2015: HIV-1 diversity in an antiretroviral treatment naïve cohort from Bushbuckridge, Mpumalanga Province, South Africa. Virology Journal 12: 24
Qin, C.; Zhang, P.; Zhu, W.; Hao, F.; Gu, A.; Fen, P.; Zhu, X.; Du, H. 2016: HIV-1 diversity in infected individuals in Suzhou and Suqian, China. Springerplus 5(1): 886
Bártolo, I.ês.; Zakovic, S.; Martin, F.; Palladino, C.; Carvalho, P.íc.; Camacho, R.; Thamm, S.; Clemente, S.; Taveira, N. 2014: HIV-1 diversity, transmission dynamics and primary drug resistance in Angola. Plos one 9(12): E113626
Vérollet, C.; Souriant, S.; Raynaud-Messina, B.; Maridonneau-Parini, I. 2015: HIV-1 drives the migration of macrophages. Medecine Sciences: M/S 31(8-9): 730-733
Wynn, J.E.; Santos, W.L. 2015: HIV-1 drug discovery: targeting folded RNA structures with branched peptides. Organic and Biomolecular Chemistry 13(21): 5848-5858
Clutter, D.S.; Jordan, M.R.; Bertagnolio, S.; Shafer, R.W. 2016: HIV-1 drug resistance and resistance testing. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 46: 292-307
El Bouzidi, K.; White, E.; Mbisa, J.L.; Sabin, C.A.; Phillips, A.N.; Mackie, N.; Pozniak, A.L.; Tostevin, A.; Pillay, D.; Dunn, D.T.; Aitken, C.; Asboe, D.; Pozniak, A.; Cane, P.; Chadwick, D.; Churchill, D.; Clark, D.; Collins, S.; Delpech, V.; Douthwaite, S.; Dunn, D.; Fearnhill, E.; Porter, K.; Tostevin, A.; White, E.; Fraser, C.; Geretti, A.M.; Hale, A.; Hué, S.ép.; Kaye, S.; Kellam, P.; Lazarus, L.; Leigh-Brown, A.; Mbisa, T.; Mackie, N.; Moses, S.; Orkin, C.; Nastouli, E.; Pillay, D.; Phillips, A.; Sabin, C.; Smit, E.; Templeton, K.; Tilston, P.; Williams, I.; Zhang, H.; Dunn, D.; Fairbrother, K.; Fearnhill, E.; Porter, K.; Tostevin, A.; White, E.; Greatorex, J.; O'Shea, S.; Mullen, J.; Smit, E.; Mbisa, T.; Cox, A.; Tandy, R.; 2016: HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK. Journal of Antimicrobial ChemoTherapy 71(12): 3487-3494
Musumeci, G.; Magnani, G.; Bon, I.; Longo, S.; Bertoldi, A.; Degli Antoni, A.M.; Rossi, M.R.; Ruggeri, A.; Sambri, V.; Semprini, S.; Sighinolfi, L.; Ursitti, M.A.; Zerbini, A.; Colangeli, V.; Calza, L.; Finarelli, A.C.; Massimiliani, E.; Re, M.C. 2016: HIV-1 early and late diagnosis in the Emilia Romagna Region (Italy): a three year study. New Microbiologica 39(4): 241-246
Sliepen, K.; Sanders, R.W. 2016: HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies. Expert Review of Vaccines 15(3): 349-365
Librelotto, C.S.; Gräf, T.; Simon, D.; de Almeida, S.E.M.; Lunge, V.R. 2015: HIV-1 epidemiology and circulating subtypes in the countryside of South Brazil. Revista da Sociedade Brasileira de Medicina Tropical 48(3): 249-257
Van den Kerkhof, T.L.G.M.; de Taeye, S.W.; Boeser-Nunnink, B.D.; Burton, D.R.; Kootstra, N.A.; Schuitemaker, H.; Sanders, R.W.; van Gils, M.J. 2016: HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds. Retrovirology 13(1): 48
Lynch, R.M.; Wong, P.; Tran, L.; O'Dell, S.; Nason, M.C.; Li, Y.; Wu, X.; Mascola, J.R. 2015: HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies. Journal of Virology 89(8): 4201-4213
Liu, C.; Ma, X.; Liu, B.; Chen, C.; Zhang, H. 2015: HIV-1 functional cure: will the dream come true?. Bmc Medicine 13: 284
Tedbury, P.R.; Freed, E.O. 2015: HIV-1 gag: an emerging target for antiretroviral therapy. Current Topics in Microbiology and Immunology 389: 171-201
Billings, E.; Sanders-Buell, E.; Bose, M.; Kijak, G.H.; Bradfield, A.; Crossler, J.; Arroyo, M.A.; Maboko, L.; Hoffmann, O.; Geis, S.; Birx, D.L.; Kim, J.H.; Michael, N.L.; Robb, M.L.; Hoelscher, M.; Tovanabutra, S. 2017: HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania. Aids Research and Human Retroviruses 33(4): 373-381
Lu, X.; Zhao, C.; Wang, W.; Nie, C.; Zhang, Y.; Zhao, H.; Chen, S.; Cui, Z. 2016: HIV-1 genetic diversity and its distribution characteristics among newly diagnosed HIV-1 individuals in Hebei province, China. Aids Research and Therapy 13: 3
Van Laethem, K.; Theys, K.; Vandamme, A.-M. 2015: HIV-1 genotypic drug resistance testing: digging deep, reaching wide?. Current Opinion in Virology 14: 16-23
Qian, Y.-W.; Li, C.; Jiang, A.-P.; Ge, S.; Gu, P.; Fan, X.; Li, T.-S.; Jin, X.; Wang, J.-H.; Wang, Z.-L. 2016: HIV-1 gp120 Glycoprotein Interacting with Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN) Down-Regulates Tight Junction Proteins to Disrupt the Blood Retinal Barrier and Increase its Permeability. Journal of Biological Chemistry 291(44): 22977-22987
Samikkannu, T.; Ranjith, D.; Rao, K.V.K.; Atluri, V.S.R.; Pimentel, E.; El-Hage, N.; Nair, M.P.N. 2015: HIV-1 gp120 and morphine induced oxidative stress: role in cell cycle regulation. Frontiers in Microbiology 6: 614
Acharya, P.; Lusvarghi, S.; Bewley, C.A.; Kwong, P.D. 2015: HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth. Expert Opinion on Therapeutic Targets 19(6): 765-783
Coutu, M.; Finzi, A.és. 2015: HIV-1 gp120 dimers decrease the overall affinity of gp120 preparations for CD4-induced ligands. Journal of Virological Methods 215-216: 37-44
Morini, S.; Musumeci, G.; Bon, I.; Miserocchi, A.; Alviano, F.; Longo, S.; Bertoldi, A.; Velati, C.V.; Gibellini, D.; Re, M.C. 2016: HIV-1 gp120 impairs the differentiation and survival of cord blood CD34+ HPCs induced to the erythroid lineage. New Microbiologica 39(1): 13-23
Masotti, A.; Donninelli, G.; Da Sacco, L.; Varano, B.; Del Cornò, M.; Gessani, S. 2015: HIV-1 gp120 influences the expression of micro RNAs in human monocyte-derived dendritic cells via STAT3 activation. Bmc Genomics 16: 480
Del Cornò, M.; Cappon, A.; Donninelli, G.; Varano, B.; Marra, F.; Gessani, S. 2016: HIV-1 gp120 signaling through TLR4 modulates innate immune activation in human macrophages and the biology of hepatic stellate cells. Journal of Leukocyte Biology 100(3): 599-606
Shah, A.; Kumar, A. 2016: HIV-1 gp120-Mediated Mitochondrial Dysfunction and HIV-Associated Neurological Disorders. Neurotoxicity Research 30(2): 135-137
Ru, W.; Tang, S.-J. 2016: HIV-1 gp120Bal down-Regulates Phosphorylated NMDA Receptor Subunit 1 in Cortical Neurons via Activation of Glutamate and Chemokine Receptors. Journal of Neuroimmune Pharmacology: the Official Journal of the Society on Neuroimmune Pharmacology 11(1): 182-191
Wang, Y.; Kapoor, P.; Parks, R.; Silva-Sanchez, A.; Alam, S.M.; Verkoczy, L.; Liao, H.-X.; Zhuang, Y.; Burrows, P.; Levinson, M.; Elgavish, A.; Cui, X.; Haynes, B.F.; Schroeder, H. 2016: HIV-1 gp140 epitope recognition is influenced by immunoglobulin DH gene segment sequence. Immunogenetics 68(2): 145-155
Villabona-Arenas, C.Julian.; Domyeum, J.; Mouacha, F.; Butel, C.; Delaporte, E.; Peeters, M.; Mpoudi-Ngole, E.; Aghokeng, A.Fobang. 2015: HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 36: 210-216
Alessandri-Gradt, E.; Morgand, M.; Delaugerre, C.; Peytavin, G.; Sellier, P.; Simon, F.ço.; Plantier, J.-C. 2015: HIV-1 group O resistance pathway with raltegravir is similar to HIV-1 group M. Aids 29(10): 1271-1273
Pino, M.; Erkizia, I.; Benet, S.; Erikson, E.; Fernández-Figueras, M.T.; Guerrero, D.; Dalmau, J.; Ouchi, D.; Rausell, A.; Ciuffi, A.; Keppler, O.T.; Telenti, A.; Kräusslich, H.-G.; Martinez-Picado, J.; Izquierdo-Useros, N. 2015: HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells. Retrovirology 12: 37
Hassan, J.; Browne, K.; De Gascun, C. 2016: HIV-1 in Monocytes and Macrophages: An Overlooked Reservoir?. Viral Immunology 29(9): 532-533
Lima, K.O.d.; Salustiano, D.M.; Cavalcanti, A.M.S.; Leal, Él.d.S.; Lacerda, H.ís.R. 2015: HIV-1 incidence among people seeking voluntary counseling and testing centers, including pregnant women, in Pernambuco State, Northeast Brazil. Cadernos de Saude Publica 31(6): 1327-1331
Vemula, S.V.; Veerasamy, R.; Ragupathy, V.; Biswas, S.; Devadas, K.; Hewlett, I. 2015: HIV-1 induced nuclear factor I-B (NF-IB) expression negatively regulates HIV-1 replication through interaction with the long terminal repeat region. Viruses 7(2): 543-558
Pastori, D.; Esposito, A.; Carnevale, R.; Bartimoccia, S.; Novo, M.; Fantauzzi, A.; Di Campli, F.; Pignatelli, P.; Violi, F.; Mezzaroma, I. 2015: HIV-1 induces in vivo platelet activation by enhancing platelet NOX2 activity. Journal of Infection 70(6): 651-658
Lima, Y.Andressa.Ramos.; Reis, Mônica.Nogueira.Guarda.; Cardoso, L.Paula.Vaz.; Stefani, M.Martins.Araújo. 2016: HIV-1 infection and pregnancy in young women in Brazil: socioeconomic and drug resistance profiles in a cross-sectional study. Bmj Open 6(7): E010837
Kleinman, C.L.; Doria, M.; Orecchini, E.; Giuliani, E.; Galardi, S.; De Jay, N.; Michienzi, A. 2014: HIV-1 infection causes a down-regulation of genes involved in ribosome biogenesis. Plos one 9(12): E113908
Fernández McPhee, C.; Álvarez, P.; Prieto, L.; Obiang, J.; Avedillo, P.; Vargas, A.; Rojo, P.; Abad, C.; Ramos, J.é T.ás.; Holguín, A. 2015: HIV-1 infection using dried blood spots can be confirmed by Bio-Rad Geenius™ HIV 1/2 confirmatory assay. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 63: 66-69
Nishijima, T.; Nagata, N.; Watanabe, K.; Sekine, K.; Tanaka, S.; Kishida, Y.; Aoki, T.; Hamada, Y.; Yazaki, H.; Teruya, K.; Gatanaga, H.; Kikuchi, Y.; Igari, T.; Akiyama, J.; Mizokami, M.; Fujimoto, K.; Uemura, N.; Oka, S. 2015: HIV-1 infection, but not syphilis or HBV infection, is a strong risk factor for anorectal condyloma in Asian population: a prospective colonoscopy screening study. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 37: 70-76
Mazzuca, P.; Caruso, A.; Caccuri, F. 2016: HIV-1 infection, microenvironment and endothelial cell dysfunction. New Microbiologica 39(3): 163-173
Armenia, D.; Fabeni, L.; Alteri, C.; Di Pinto, D.; Di Carlo, D.; Bertoli, A.; Gori, C.; Carta, S.; Fedele, V.; Forbici, F.; D'Arrigo, R.; Svicher, V.; Berno, G.; Pizzi, D.; Nicastri, E.; Sarmati, L.; Pinnetti, C.; Ammassari, A.; D'Offizi, G.; Latini, A.; Andreoni, M.; Antinori, A.; Ceccherini-Silberstein, F.; Perno, C.F.; Santoro, M.M. 2015: HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia. Journal of Antimicrobial ChemoTherapy 70(6): 1865-1873
Christ, F.; Debyser, Z. 2015: HIV-1 integrase inhibition: looking at cofactor interactions. Future Medicinal Chemistry 7(18): 2407-2410
Feng, L.; Larue, R.C.; Slaughter, A.; Kessl, J.J.; Kvaratskhelia, M. 2015: HIV-1 integrase multimerization as a therapeutic target. Current Topics in Microbiology and Immunology 389: 93-119
Demeulemeester, J.; Vets, S.; Schrijvers, R.; Madlala, P.; De Maeyer, M.; De Rijck, J.; Ndung'u, T.; Debyser, Z.; Gijsbers, R. 2014: HIV-1 integrase variants retarget viral integration and are associated with disease progression in a chronic infection cohort. Cell Host and Microbe 16(5): 651-662
Cohn, L.B.; Silva, I.T.; Oliveira, T.Y.; Rosales, R.A.; Parrish, E.H.; Learn, G.H.; Hahn, B.H.; Czartoski, J.L.; McElrath, M.J.; Lehmann, C.; Klein, F.; Caskey, M.; Walker, B.D.; Siliciano, J.D.; Siliciano, R.F.; Jankovic, M.; Nussenzweig, M.C. 2015: HIV-1 integration landscape during latent and active infection. Cell 160(3): 420-432
Gui, T.; Lu, X.; Li, H.; Li, T.; Liu, Y.; Bao, Z.; Li, L.; Li, J. 2016: HIV-1 is spreading out of former high-risk population through heterosexual transmission in Hebei, China. Current HIV Research 14(2): 148-153
Dutartre, H.él.èn. 2016: HIV-1 is stored by follicular dendritic cells in lymph nodes even under antiviral treatments. Medecine Sciences: M/S 32(10): 803-805
Politch, J.A.; Mayer, K.H.; Anderson, D.J. 2016: HIV-1 is undetectable in preejaculatory secretions from HIV-1-infected men on suppressive HAART. Aids 30(12): 1899-1903
Chan, C.N.; Trinité, B.; Lee, C.S.; Mahajan, S.; Anand, A.; Wodarz, D.; Sabbaj, S.; Bansal, A.; Goepfert, P.A.; Levy, D.N. 2016: HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells. Retrovirology 13: 1
Ganser, L.R.; Al-Hashimi, H.M. 2016: HIV-1 leader RNA dimeric interface revealed by NMR. Proceedings of the National Academy of Sciences of the United States of America 113(47): 13263-13265
Mellberg, T.; Krabbe, J.; Gisslén, M.; Svennerholm, B. 2016: HIV-1 low copy viral sequencing-A prototype assay. Infectious Diseases 48(6): 472-476
Ko, L.-J.; Yu, F.-H.; Huang, K.-J.; Wang, C.-T. 2015: HIV-1 matrix domain removal ameliorates virus assembly and processing defects incurred by positive nucleocapsid charge elimination. Febs Open Bio 5: 283-291
O'Neil, L.; Andenoro, K.; Pagano, I.; Carroll, L.; Langer, L.; Dell, Z.; Perera, D.; Treece, B.W.; Heinrich, F.; Lösche, M.; Nagle, J.F.; Tristram-Nagle, S. 2016: HIV-1 matrix-31 membrane binding peptide interacts differently with membranes containing PS vs. PI(4,5)P2. Biochimica et Biophysica Acta 1858(12): 3071-3081
Carter, C.C.; Wagner, G.A.; Hightower, G.K.; Caballero, G.; Phung, P.; Richman, D.D.; Pond, S.L.K.; Smith, D.M. 2015: HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing. Virology 474: 34-40
Musich, T.; O'Connell, O.; Gonzalez-Perez, M.P.; Derdeyn, C.A.; Peters, P.J.; Clapham, P.R. 2015: HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages. Retrovirology 12: 25
Chamontin, Célia.; Rassam, P.; Ferrer, M.; Racine, P-Jean.; Neyret, A.; Lainé, Sébastien.; Milhiet, P-Emmanuel.; Mougel, Mène. 2015: HIV-1 nucleocapsid and ESCRT-component Tsg101 interplay prevents HIV from turning into a DNA-containing virus. Nucleic acids research 43(1): 336-347
Yu, K.L.; Lee, S.H.; Lee, E.S.; You, J.C. 2016: HIV-1 nucleocapsid protein localizes efficiently to the nucleus and nucleolus. Virology 492: 204-212
Benmarzouk-Hidalgo, O.J.; Torres-Cornejo, A.; Gutierrez-Valencia, A.; Viciana, P.; López-Cortés, L.F. 2017: HIV-1 p24 and CD4+ T cell count during boosted protease-inhibitor monotherapy in HIV-infected patients. Enfermedades Infecciosas y Microbiologia Clinica 35(3): 174-178
Wang, Y.; Liang, Y.; Feng, Y.; Wang, B.; Li, Y.; Wu, Z.; Zhang, J.; Baloch, Z.; Zhang, A.-M.; Liu, L.; Qin, W.; Xia, X. 2015: HIV-1 prevalence and subtype/recombinant distribution among travelers entering China from Vietnam at the HeKou port in the Yunnan province, China, between 2003 and 2012. Journal of Medical Virology 87(9): 1500-1509
Morén, C.; González-Casacuberta, I.; Álvarez-Fernández, C.; Bañó, M.; Catalán-Garcia, M.; Guitart-Mampel, M.; Juárez-Flores, D.L.; Tobías, E.; Milisenda, J.é; Cardellach, F.; Gatell, J.M.; Sánchez-Palomino, S.; Garrabou, G.òr. 2017: HIV-1 promonocytic and lymphoid cell lines: an in vitro model of in vivo mitochondrial and apoptotic lesion. Journal of Cellular and Molecular Medicine 21(2): 402-409
Lelièvre, J.-D.; Lévy, Y. 2016: HIV-1 prophylactic vaccines: state of the art. Journal of Virus Eradication 2(1): 5-11
Wagner, R.N.; Reed, J.C.; Chanda, S.K. 2015: HIV-1 protease cleaves the serine-threonine kinases RIPK1 and RIPK2. Retrovirology 12: 74
Budambula, V.; Musumba, F.O.; Webale, M.K.; Kahiga, T.M.; Ongecha-Owuor, F.; Kiarie, J.N.; Sowayi, G.A.; Ahmed, A.A.; Ouma, C.; Were, T. 2015: HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users. Aids Research and Therapy 12: 27
Laco, G.S. 2015: HIV-1 protease substrate-groove: Role in substrate recognition and inhibitor resistance. Biochimie 118: 90-103
Panagiotakopoulos, L.; Kelly, S.; Neigh, G.N. 2015: HIV-1 proteins accelerate HPA axis habituation in female rats. Physiology and Behavior 150: 8-15
Fitting, S.; Booze, R.M.; Mactutus, C.F. 2015: HIV-1 proteins, Tat and gp120, target the developing dopamine system. Current HIV Research 13(1): 21-42
Gohda, J.; Ma, Y.; Huang, Y.; Zhang, Y.; Gu, L.; Han, Y.; Li, T.; Gao, B.; Gao, G.F.; Inoue, J.-I.; Iwamoto, A.; Ishida, T. 2015: HIV-1 replicates in human osteoclasts and enhances their differentiation in vitro. Retrovirology 12: 12
Guerrero, S.; Batisse, J.; Libre, C.; Bernacchi, S.; Marquet, R.; Paillart, J-Christophe. 2015: HIV-1 replication and the cellular eukaryotic translation apparatus. Viruses 7(1): 199-218
Williamson, C.; Swanstrom, R. 2015: HIV-1 replication capacity: Setting the pace of disease. Proceedings of the National Academy of Sciences of the United States of America 112(12): 3591-3592
Donath, M.; Wolf, T.; Stürmer, M.; Herrmann, E.; Bickel, M.; Khaykin, P.; Göpel, S.; Gute, P.; Haberl, A.; de Leuw, P.; Schüttfort, G.; Berger, A.; Stephan, C. 2016: HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy. Medical Microbiology and Immunology 205(6): 575-583
Vérollet, C.; Souriant, S.; Bonnaud, E.; Jolicoeur, P.; Raynaud-Messina, B.; Kinnaer, C.; Fourquaux, I.; Imle, A.; Benichou, S.; Fackler, O.T.; Poincloux, R.; Maridonneau-Parini, I. 2015: HIV-1 reprograms the migration of macrophages. Blood 125(10): 1611-1622
Wainberg, M.A.; Han, Y-Shan. 2015: HIV-1 resistance to dolutegravir: update and new insights. Journal of Virus Eradication 1(1): 13-16
Magnus, C.; Reh, L.; Trkola, A. 2016: HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolution. Virus Research 218: 57-70
Daudé, C.; Décimo, D.; Trabaud, M.-A.; André, P.; Ohlmann, T.éo.; de Breyne, S. 2016: HIV-1 sequences isolated from patients promote expression of shorter isoforms of the Gag polyprotein. Archives of Virology 161(12): 3495-3507
Cohen, K.W.; Dugast, A.-S.; Alter, G.; McElrath, M.J.; Stamatatos, L. 2015: HIV-1 single-stranded RNA induces CXCL13 secretion in human monocytes via TLR7 activation and plasmacytoid dendritic cell-derived type i IFN. Journal of Immunology 194(6): 2769-2775
Mueller, N.; Berkhout, B.; Das, A.T. 2015: HIV-1 splicing is controlled by local RNA structure and binding of splicing regulatory proteins at the major 5' splice site. Journal of General Virology 96(Part 7): 1906-1917
Frange, P.; Assoumou, L.; Descamps, D.; Chéret, A.; Goujard, Cécile.; Tran, L.; Gousset, M.; Avettand-Fenoël, V.; Bocket, L.; Fafi-Kremer, S.; Guinard, J.; Morand-Joubert, L.; Nicot, F.; Plantier, J-Christophe.; Rogez, S.; Wirden, M.; Rouzioux, C.; Meyer, L.; Chaix, M-Laure.; Abel, S.; Abraham, B.; Allegre, T.; Antoniotti, A.; Armero, R.; Audhuy, B.; Aumaitre, H.; Beaucaire, G.; Beck-Wirth, G.; Berger, J.L.; Bernard, L.; Beuscart, C.; Bodard, L.; Bouchaud, O.; Boué, F.; Cabane, J-P.; Cabie, A.; Champagne, H.; Cheneau, C.; Chennebault, J-M.; Cheret, A.; Christian, B.; Compagnucci, A.; Daneluzzi, V.; Debab, Y.; Dellamonica, P.; Delfraissy, 2015: HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies. Journal of Antimicrobial ChemoTherapy 70(7): 2084-2089
Li, Y.; Gu, L.; Han, Y.; Xie, J.; Wang, H.; Lv, W.; Song, X.; Li, Y.; Iwamoto, A.; Ishida, T.; Li, T. 2015: HIV-1 subtype B/B' and baseline drug resistance mutation are associated with virologic failure: a multicenter cohort study in China. Journal of Acquired Immune Deficiency Syndromes 68(3): 289-297
Junqueira, D.M.; Almeida, S.E.d.M. 2016: HIV-1 subtype B: Traces of a pandemic. Virology 495: 173-184
Davanos, N.; Panos, G.; Gogos, C.A.; Mouzaki, A. 2015: HIV-1 subtype characteristics of infected persons living in southwestern Greece. Hiv/Aids 7: 277-283
Germer, J.J.; Wu, P.; Soderberg, J.D.; Mandrekar, J.N.; Yao, J.D. 2015: HIV-1 subtype diversity among clinical specimens submitted for routine antiviral drug resistance testing in the United States. Diagnostic Microbiology and Infectious Disease 83(3): 257-260
Zhang, J.; Yang, J.; Pan, X.; Guo, Z.; Ding, X.; Xu, Y.; Huang, J.; Xia, Y. 2015: HIV-1 subtype diversity and transmission clusters among men having sex with men who recently got HIV-l infection, in Zhejiang province. Zhonghua Liu Xing Bing Xue Za Zhi 36(1): 61-66
Samikkannu, T.; Atluri, V.S.R.; Arias, A.Y.; Rao, K.V.K.; Mulet, C.T.; Jayant, R.D.; Nair, M.P.N. 2014: HIV-1 subtypes B and C Tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders. Current HIV Research 12(6): 397-405
Köksal, M.O.; Beka, H.; Lübke, N.; Verheyen, J.; Eraksoy, H.; Cagatay, A.; Kaiser, R.; Akgül, B.; Agacfidan, A. 2015: HIV-1 subtypes and drug resistance profiles in a cohort of heterosexual patients in Istanbul, Turkey. Medical Microbiology and Immunology 204(4): 551-555
Sugden, S.; Ghazawi, F.; MacPherson, P. 2016: HIV-1 tat protein recruits CIS to the cytoplasmic tail of CD127 to induce receptor ubiquitination and proteasomal degradation. Virology 498: 192-200
Schoofs, T.; Klein, F.; Braunschweig, M.; Kreider, E.F.; Feldmann, A.; Nogueira, L.; Oliveira, T.; Lorenzi, J.C.C.; Parrish, E.H.; Learn, G.H.; West, A.P.; Bjorkman, P.J.; Schlesinger, S.J.; Seaman, M.S.; Czartoski, J.; McElrath, M.J.; Pfeifer, N.; Hahn, B.H.; Caskey, M.; Nussenzweig, M.C. 2016: HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1. Science 352(6288): 997-1001
Leth, S.; Nymann, R.; Jørgensen, S.; Olesen, R.; Rasmussen, T.A.; Østergaard, L.; Denton, P.W.; Tolstrup, M.; Søgaard, O.S. 2016: HIV-1 transcriptional activity during frequent longitudinal sampling in aviremic patients on antiretroviral therapy. Aids 30(5): 713-721
Turrini, F.; Marelli, S.; Kajaste-Rudnitski, A.; Lusic, M.; Van Lint, C.; Das, A.T.; Harwig, A.; Berkhout, B.; Vicenzi, E. 2015: HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter. Retrovirology 12: 104
Zhu, J.; Yuan, Y.; Midde, N.M.; Gomez, A.M.; Sun, W.-L.; Quizon, P.M.; Zhan, C.-G. 2016: HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum. Journal of Neurovirology 22(3): 282-292
Villeneuve, L.M.; Purnell, P.R.; Stauch, K.L.; Callen, S.E.; Buch, S.J.; Fox, H.S. 2016: HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution. Journal of Neurovirology 22(5): 564-574
Esbjörnsson, J.; Mild, M.; Audelin, A.; Fonager, J.; Skar, H.; Bruun Jørgensen, L.; Liitsola, K.; Björkman, P.; Bratt, G.ör.; Gisslén, M.; Sönnerborg, A.; Nielsen, C.; Medstrand, P.; Albert, J. 2016: HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic Countries. Virus Evolution 2(1): Vew010
Moura, M.E.S.; da Guarda Reis, M.ôn.N.; Lima, Y.A.R.; Eulálio, K.D.; Cardoso, L.P.V.; Stefani, M.M.A.új. 2015: HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil. Journal of Medical Virology 87(5): 798-806
Jiao, Y.; Li, S.; Li, Z.; Zhang, Z.; Zhao, J.; Li, L.; Wang, L.; Yin, Q.; Wang, Y.; Zeng, Z.; Shao, Y.; Ma, L. 2014: HIV-1 transmitted drug resistance-associated mutations and mutation co-variation in HIV-1 treatment-naïve MSM from 2011 to 2013 in Beijing, China. Bmc Infectious Diseases 14: 689
Lai, R.P.J.; Meintjes, G.; Wilkinson, R.J. 2016: HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome. Seminars in Immunopathology 38(2): 185-198
Mann, J.K.; Ndung'u, T. 2015: HIV-1 vaccine immunogen design strategies. Virology Journal 12: 3
Liu, Q.; Li, Y.; Luo, Z.; Yang, G.; Liu, Y.; Liu, Y.; Sun, M.; Dai, J.; Li, Q.; Qin, C.; Shao, Y. 2015: HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection. Aids 29(6): 649-658
Alvarez, P.; Martín, L.; Prieto, L.; Obiang, J.; Vargas, A.; Avedillo, P.; Rojo, P.; Fernández McPhee, C.; Benito, A.ín.; Ramos, J.é T.ás.; Holguín, Áf. 2015: HIV-1 variability and viral load technique could lead to false positive HIV-1 detection and to erroneous viral quantification in infected specimens. Journal of Infection 71(3): 368-376
Borel, S.; Robert-Hebmann, V.ér.; Alfaisal, J.; Jain, A.; Faure, M.; Espert, L.; Chaloin, L.; Paillart, J.-C.; Johansen, T.; Biard-Piechaczyk, M. 2015: HIV-1 viral infectivity factor interacts with microtubule-associated protein light chain 3 and inhibits autophagy. Aids 29(3): 275-286
Frange, P.; Faye, A.; Avettand-Fenoël, Véronique.; Bellaton, E.; Descamps, D.; Angin, M.; David, A.; Caillat-Zucman, S.; Peytavin, G.; Dollfus, C.; Le Chenadec, J.; Warszawski, J.; Rouzioux, C.; Sáez-Cirión, A. 2016: HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report. Lancet. HIV 3(1): E49-E54
Borgmann, K.; Ghorpade, A. 2015: HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads. Frontiers in Microbiology 6: 1143
Symeonides, M.; Murooka, T.T.; Bellfy, L.N.; Roy, N.H.; Mempel, T.R.; Thali, M. 2015: HIV-1-Induced Small T Cell Syncytia Can Transfer Virus Particles to Target Cells through Transient Contacts. Viruses 7(12): 6590-6603
Gomez, A.M.; Ouellet, M.; Deshiere, A.; Breton, Y.; Tremblay, M.J. 2016: HIV-1-Mediated BAFF Secretion in Macrophages Does not Require Endosomal TLRs, Type-i IFN, and Nef, but Depends on the Cellular Phenotype Status. Journal of Immunology 196(9): 3806-3817
Lund, J.M.; Broliden, K.; Pyra, M.N.; Thomas, K.K.; Donnell, D.; Irungu, E.; Muwonge, T.R.; Mugo, N.; Manohar, M.; Jansson, M.; Mackelprang, R.; Marzinke, M.A.; Baeten, J.M.; Lingappa, J.R. 2016: HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis. Journal of Virology 90(21): 9855-9861
Imaz, A.; Martinez-Picado, J.; Niubó, J.; Kashuba, A.D.M.; Ferrer, E.; Ouchi, D.; Sykes, C.; Rozas, N.; Acerete, L.; Curto, J.; Vila, A.; Podzamczer, D. 2016: HIV-1-RNA Decay and Dolutegravir Concentrations in Semen of Patients Starting a first Antiretroviral Regimen. Journal of Infectious Diseases 214(10): 1512-1519
Gantner, P.; Assoumou, L.; Leruez-Ville, M.; David, L.; Suzan-Monti, M.; Costagliola, D.; Rouzioux, C.; Ghosn, J.; Ghosn, J.; Suzan-Monti, M.; Costagliola, D.; Leruez-Ville, M.; Rouzioux, C.; Spire, B.; Tréluyer, J.-M.; Mascard, L.; Landman, R.; Zucman, D.; Ponscarme, D.; Rami, A.; Sellier, P.; Viard, J.-P.; Delobelle, A.; Beaudoux, C.él.; Point, G.; Marchand, L.; Couffin-Cadiergues, S. 2016: HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimens. Journal of Antimicrobial ChemoTherapy 71(11): 3202-3205
Ntusi, N.; O'Dwyer, E.; Dorrell, L.; Wainwright, E.; Piechnik, S.; Clutton, G.; Hancock, G.; Ferreira, V.; Cox, P.; Badri, M.; Karamitsos, T.; Emmanuel, S.; Clarke, K.; Neubauer, S.; Holloway, C. 2016: HIV-1-Related Cardiovascular Disease Is Associated with Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema. CIRCULATION. Cardiovascular Imaging 9(3): E004430
Gach, J.S.; Gorlani, A.; Dotsey, E.Y.; Becerra, J.C.; Anderson, C.T.M.; Berzins, B.; Felgner, P.L.; Forthal, D.N.; Deeks, S.G.; Wilkin, T.J.; Casazza, J.P.; Koup, R.A.; Katlama, C.; Autran, B.; Murphy, R.L.; Achenbach, C.J. 2016: HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects. Plos one 11(8): E0160341
Du, V.Y.; Bansal, A.; Carlson, J.; Salazar-Gonzalez, J.F.; Salazar, M.G.; Ladell, K.; Gras, S.; Josephs, T.M.; Heath, S.L.; Price, D.A.; Rossjohn, J.; Hunter, E.; Goepfert, P.A. 2016: HIV-1-Specific CD8 T Cells Exhibit Limited Cross-Reactivity during Acute Infection. Journal of Immunology 196(8): 3276-3286
Ali, A.; Kitchen, S.G.; Chen, I.S.Y.; Ng, H.L.; Zack, J.A.; Yang, O.O. 2016: HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies. Journal of Virology 90(15): 6999-7006
Kadri, F.; Pacifici, M.; Wilk, A.; Parker-Struckhoff, A.; Del Valle, L.; Hauser, K.F.; Knapp, P.E.; Parsons, C.; Jeansonne, D.; Lassak, A.; Peruzzi, F. 2015: HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase. Journal of Biological Chemistry 290(52): 30931-30946
Giraldo, D.M.; Hernandez, J.C.; Urcuqui-Inchima, S. 2016: HIV-1-derived single-stranded RNA acts as activator of human neutrophils. Immunologic Research 64(5-6): 1185-1194
Hernandez, J.C.; St Laurent, G.; Urcuqui-Inchima, S. 2016: HIV-1-exposed seronegative individuals show alteration in TLR expression and pro-inflammatory cytokine production ex vivo: An innate immune quiescence status?. Immunologic Research 64(1): 280-290
Cardone, M.; Ikeda, K.N.; Varano, B.; Gessani, S.; Conti, L. 2015: HIV-1-induced impairment of dendritic cell cross talk with γδ T lymphocytes. Journal of Virology 89(9): 4798-4808
Giraldo, D.M.; Hernandez, J.C.; Velilla, P.; Urcuqui-Inchima, S. 2016: HIV-1-neutrophil interactions trigger neutrophil activation and Toll-like receptor expression. Immunologic Research 64(1): 93-103
Gomez, A.M.; Ouellet, M.; Tremblay, M.J. 2015: HIV-1-triggered release of type i IFN by plasmacytoid dendritic cells induces BAFF production in monocytes. Journal of Immunology 194(5): 2300-2308
López-Dupla, M.; Maymó-Masip, E.; Martínez, E.; Domingo, P.; Leal, M.; Peraire, J.; Viladés, C.; Veloso, S.; Arnedo, M.; Ferrando-Martínez, S.; Beltrán-Debón, R.úl.; Alba, V.ón.; Gatell, J.M.; Vendrell, J.; Vidal, F.; Chacón, M.R. 2015: HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels. Plos one 10(12): E0144789
Wei, W.; Yu, X.-F. 2015: HIV-1/HIV-2 versus SAMHD1 restriction: a tale of two viruses. Cell Host and Microbe 17(1): 8-9
Yamaguchi, J.; Brennan, C.A.; Alessandri-Gradt, E.; Plantier, J.-C.; Cloherty, G.A.; Berg, M.G. 2017: HIV-2 Surveillance with Next-Generation Sequencing Reveals Mutations in a Cytotoxic Lymphocyte-Restricted Epitope Involved in Long-Term Nonprogression. Aids Research and Human Retroviruses 33(4): 347-352
Bertine, M.él.; Visseaux, B.; Storto, A.; Collin, G.; Matheron, S.; Descamps, D.; Charpentier, C. 2016: HIV-2 Vif Diversity Among Defective and Nondefective Sequences. Journal of Acquired Immune Deficiency Syndromes 72(1): E9
Chauveau, L.; Puigdomenech, I.; Ayinde, D.; Roesch, F.; Porrot, F.ço.; Bruni, D.; Visseaux, B.; Descamps, D.; Schwartz, O. 2015: HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells. Retrovirology 12: 2
Pratt, R.J. 1988: HIV-2:The Implications. Nursing Standard: 1987) 2(38): 8-9
Charpentier, C.; Camacho, R.; Ruelle, J.; Eberle, J.; Gürtler, L.; Pironti, A.; Stürmer, M.; Brun-Vézinet, Fçoise.; Kaiser, R.; Descamps, D.; Obermeier, M. 2015: HIV-2EU-Supporting Standardized HIV-2 Drug-Resistance Interpretation in Europe: An Update. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 61(8): 1346-1347
Carrasco, M.A.; Esser, M.B.; Sparks, A.; Kaufman, M.R. 2016: HIV-Alcohol Risk Reduction Interventions in Sub-Saharan Africa: A Systematic Review of the Literature and Recommendations for a Way Forward. Aids and Behavior 20(3): 484-503
Chang, G.Y. 2017: HIV-Associated CNS Vasculopathy in the Modern Era. Journal of Clinical Neurology 13(1): 103-104
Phillips, N.; Amos, T.; Kuo, C.; Hoare, J.; Ipser, J.; Thomas, K.G.F.; Stein, D.J. 2016: HIV-Associated Cognitive Impairment in Perinatally Infected Children: a Meta-analysis. Pediatrics 138(5)
Tenforde, M.W.; Wake, R.; Leeme, T.; Jarvis, J.N. 2016: HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited Settings. Current Clinical Microbiology Reports 3: 92-102
Demirkaya, N.; Wit, F.W.N.M.; van Den Berg, T.J.T.P.; Kooij, K.W.; Prins, M.; Schlingemann, R.O.; Abramoff, M.D.; Reiss, P.; Verbraak, F.D.; Reiss, P.; Wit, F.W.N.M.; van der Valk, M.; Schouten, J.; Kooij, K.W.; van Zoest, R.A.; Elsenga, B.C.; Prins, M.; Martens, M.; Moll, S.; Berkel, J.; Totté, M.; Visser, G.R.; Kovalev, S.; Zaheri, S.; Hillebregt, M.M.J.; Ruijs, Y.M.C.; Benschop, D.P.; Reiss, P.; Kootstra, N.A.; Harskamp-Holwerda, A.; Maurer, I.; Ruiz, M.M.M.; Girigorie, A.F.; van Leeuwen, E.; Janssen, F.R.; Heidenrijk, M.; Zikkenheiner, W.; Boumans, L.; Wezel, M.; Jansen-Kok, C.S.M.; Geerlings, S.E.; Godfried, M.H.; Goorhuis, A.; Hovius, J.W.R.; van der Meer, J.T.M.; Nellen, F.J.B.; van der Poll, T.; Prins, J.M.; Reiss, P.; van der Valk 2016: HIV-Associated Neuroretinal Disorder in Patients with Well-Suppressed HIV-Infection: a Comparative Cohort Study. Investigative Ophthalmology and Visual Science 57(3): 1388-1397
Chandran, R.; Feller, L.; Lemmer, J.; Khammissa, R.A.G. 2016: HIV-Associated Oral Mucosal Melanin Hyperpigmentation: a Clinical Study in a South African Population Sample. Aids Research and Treatment 2016: 8389214
Montales, M.T.; Chaudhury, A.; Beebe, A.; Patil, S.; Patil, N. 2015: HIV-Associated TB Syndemic: a Growing Clinical Challenge Worldwide. Frontiers in Public Health 3: 281
Tseng, J.; Maurer, T.; Mutizwa, M.M. 2017: HIV-Associated Toxic Epidermal Necrolysis at San Francisco General Hospital. Journal of the International Association of Providers of Aids Care 16(1): 37-41
Armitage, A.E.; Moran, E. 2016: HIV-Associated Tuberculosis: Does the Iron-Regulatory Hormone Hepcidin Connect Anemia with Poor Prognosis?. Journal of Infectious Diseases 213(1): 3-5
Al-Mozaini, M.A.; Mansour, M.K.; Al-Hokail, A.A.; Mohmed, M.A.; Daham, M.A.B.; Al-Abdely, H.M.; Frayha, H.H.; Al-Rabiah, F.A.; Alhajjar, S.H.; Keshavjee, S.; Adra, C.N.; Alrajhi, A.A. 2014: HIV-Care Outcome in Saudi Arabia; a Longitudinal Cohort. Journal of Aids and Clinical Research 5(11)
Nilsson, C.; Hejdeman, B.; Godoy-Ramirez, K.; Tecleab, T.; Scarlatti, G.; Bråve, A.; Earl, P.L.; Stout, R.R.; Robb, M.L.; Shattock, R.J.; Biberfeld, G.; Sandström, E.; Wahren, B. 2015: HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: a Phase i Randomized Trial. Plos one 10(6): E0131748
Eade, C.R.; Diaz, C.; Chen, S.; Cole, A.L.; Cole, A.M. 2015: HIV-Enhancing Factors Are Secreted by Reproductive Epithelia upon Inoculation with Bacterial Vaginosis-Associated Bacteria. Protein and Peptide Letters 22(8): 672-680
Nduati, E.W.; Nkumama, I.N.; Gambo, F.K.; Muema, D.M.; Knight, M.G.; Hassan, A.S.; Jahangir, M.N.; Etyang, T.J.; Berkley, J.A.; Urban, B.C. 2016: HIV-Exposed Uninfected Infants Show Robust Memory B-Cell Responses in Spite of a Delayed Accumulation of Memory B Cells: an Observational Study in the First 2 Years of Life. Clinical and vaccine immunology: CVI 23(7): 576-585
Evans, C.; Humphrey, J.H.; Ntozini, R.; Prendergast, A.J. 2016: HIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era. Frontiers in Immunology 7: 190
Nkuize, M.; De Wit, S.ép.; Muls, V.; Delforge, M.; Miendje Deyi, V.ér.Y.; Cadière, G.B.; Buset, M. 2015: HIV-Helicobacter pylori Co-Infection: Antibiotic Resistance, Prevalence, and Risk Factors. Plos one 10(12): E0145119
Haynes, B.F.; Shaw, G.M.; Korber, B.; Kelsoe, G.; Sodroski, J.; Hahn, B.H.; Borrow, P.; McMichael, A.J. 2016: HIV-Host Interactions: Implications for Vaccine Design. Cell Host and Microbe 19(3): 292-303
Abdel-Hameed, E.A.; Ji, H.; Shata, M.T. 2016: HIV-Induced Epigenetic Alterations in Host Cells. Advances in Experimental Medicine and Biology 879: 27-38
Khaitan, A.; Kilberg, M.; Kravietz, A.; Ilmet, T.; Tastan, C.; Mwamzuka, M.; Marshed, F.; Liu, M.; Ahmed, A.; Borkowsky, W.; Unutmaz, D. 2016: HIV-Infected Children have Lower Frequencies of CD8+ Mucosal-Associated Invariant T (MAIT) Cells that Correlate with Innate, Th17 and Th22 Cell Subsets. Plos one 11(8): E0161786
Coulon, P.-G.ég.; Richetta, C.ém.; Rouers, A.él.; Blanchet, F.P.; Urrutia, A.; Guerbois, M.; Piguet, V.; Theodorou, I.; Bet, A.; Schwartz, O.; Tangy, F.éd.ér.; Graff-Dubois, S.ép.; Cardinaud, S.; Moris, A. 2016: HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells. Journal of Immunology 197(2): 517-532
Rozin, I.; Sayles, H.; Anderson, M.J.; Furl, R.; Stimpson, J.P.; Swindells, S.; Bares, S.H. 2015: HIV-Infected Patient Knowledge, Attitudes, and Beliefs Regarding the Affordable Care Act. Aids Research and Human Retroviruses 31(6): 581-586
Colineau, L.; Rouers, A.; Yamamoto, T.; Xu, Y.; Urrutia, A.; Pham, H.-P.; Cardinaud, S.; Samri, A.; Dorgham, K.; Coulon, P.-G.ég.; Cheynier, R.ém.; Hosmalin, A.; Oksenhendler, E.; Six, A.; Kelleher, A.D.; Zaunders, J.; Koup, R.A.; Autran, B.; Moris, A.; Graff-Dubois, S.ép. 2015: HIV-Infected Spleens Present Altered Follicular Helper T Cell (Tfh) Subsets and Skewed B Cell Maturation. Plos one 10(10): E0140978
Matthews, L.T.; Ribaudo, H.B.; Kaida, A.; Bennett, K.; Musinguzi, N.; Siedner, M.J.; Kabakyenga, J.; Hunt, P.W.; Martin, J.N.; Boum, Y.; Haberer, J.E.; Bangsberg, D.R. 2016: HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods. Journal of Acquired Immune Deficiency Syndromes 71(4): 399-406
Njom Nlend, A.E.; Nguwoh, P.S.; Ngounouh, C.T.; Tchidjou, H.K.; Pieme, C.A.; Otélé, J.M.; Penlap, V.ér.; Colizzi, V.; Moyou, R.S.; Fokam, J. 2016: HIV-Infected or -Exposed Children Exhibit Lower Immunogenicity to Hepatitis B Vaccine in Yaoundé, Cameroon: An Appeal for Revised Policies in Tropical Settings?. Plos one 11(9): E0161714
Lee, J.-H.; Schierer, S.; Blume, K.; Dindorf, J.; Wittki, S.; Xiang, W.; Ostalecki, C.; Koliha, N.; Wild, S.; Schuler, G.; Fackler, O.T.; Saksela, K.; Harrer, T.; Baur, A.S. 2016: HIV-Nef and ADAM17-Containing Plasma Extracellular Vesicles Induce and Correlate with Immune Pathogenesis in Chronic HIV Infection. Ebiomedicine 6: 103-113
Mitchell, J.W.; Sophus, A.I.; Petroll, A.E. 2016: HIV-Negative Partnered Men's Willingness to use Non-Occupational Post-Exposure Prophylaxis and Associated Factors in a U.S. Sample of HIV-Negative and HIV-Discordant Male Couples. Lgbt Health 3(2): 146-152
Mitchell, J.W.; Stephenson, R. 2015: HIV-Negative Partnered Men's Willingness to use Pre-Exposure Prophylaxis and Associated Factors Among an Internet Sample of U.S. HIV-Negative and HIV-Discordant Male Couples. Lgbt Health 2(1): 35-40
Mitten, M.J. 1994: HIV-Positive Athletes. Physician and Sportsmedicine 22(10): 63-68
Hathorn, E.; Smit, E.; Elsharkawy, A.M.; Bramhall, S.R.; Bufton, S.A.; Allan, S.; Mutimer, D. 2016: HIV-Positive-to-HIV-Positive Liver Transplantation. New England Journal of Medicine 375(18): 1807-1809
Gilbert, J.M.; Fitch, K.V.; Grinspoon, S.K. 2015: HIV-Related Cardiovascular Disease, Statins, and the REPRIEVE Trial. Topics in Antiviral Medicine 23(4): 146-149
Linn, K.; Fay, A.; Meddles, K.; Isbell, S.; Lin, P.N.; Thair, C.; Heaps, J.; Paul, R.; Mar, S.S. 2015: HIV-Related Cognitive Impairment of Orphans in Myanmar with Vertically Transmitted HIV Taking Antiretroviral Therapy. Pediatric Neurology 53(6): 485-490.E1
Serke, M.; Serke, S.; Geiseler, B.; Weiss, R.; Huhn, D. 1991: HIV-Related Lymphoblastic Lymphoma. Leukemia and Lymphoma 4(2): 131-135
Meintjes, G.; Kerkhoff, A.D.; Burton, R.; Schutz, C.; Boulle, A.; Van Wyk, G.; Blumenthal, L.; Nicol, M.P.; Lawn, S.D. 2015: HIV-Related Medical Admissions to a South African District Hospital Remain Frequent Despite Effective Antiretroviral Therapy Scale-Up. Medicine 94(50): E2269
Clark, H.; Surendera Babu, A.; Harris, S.; Hardnett, F. 2015: HIV-Related Mortality Among Adults (≥ 18 years) of Various Hispanic or Latino Subgroups--United States, 2006-2010. Journal of racial and ethnic health disparities 2(1): 53-61
Feinstein, M.J.; Mitter, S.S.; Yadlapati, A.; Achenbach, C.J.; Palella, F.J.; Gonzalez, P.E.; Meyers, S.; Collins, J.D.; Shah, S.J.; Lloyd-Jones, D.M. 2016: HIV-Related Myocardial Vulnerability to Infarction and Coronary Artery Disease. Journal of the American College of Cardiology 68(18): 2026-2027
Masur, H. 2015: HIV-Related Opportunistic Infections Are Still Relevant in 2015. Topics in Antiviral Medicine 23(3): 116-119
Thapa, S.; Thapa, D.K.; Buve, A.; Hannes, K.; Nepal, C.; Mathei, C. 2017: HIV-Related Risk Behaviors Among Labor Migrants, their Wives and the General Population in Nepal. Journal of Community Health 42(2): 260-268
Kann, L.; Olsen, E.O'Malley.; Kinchen, S.; Morris, E.; Wolitski, R.J. 2016: HIV-Related Risk Behaviors Among Male High School Students Who Had Sexual Contact with Males - 17 Large Urban School Districts, United States, 2009-2013. MMWR. Morbidity and mortality weekly report 65(5): 106-109
Stringer, K.L.; Turan, B.; McCormick, L.; Durojaiye, M.; Nyblade, L.; Kempf, M.-C.; Lichtenstein, B.; Turan, J.M. 2016: HIV-Related Stigma Among Healthcare Providers in the Deep South. Aids and Behavior 20(1): 115-125
Dolwick Grieb, S.M.; Shah, H.; Flores-Miller, A.; Zelaya, C.; Page, K.R. 2017: HIV-Related Stigma Among Spanish-speaking Latinos in an Emerging Immigrant Receiving City. Journal of immigrant and minority health 19(4): 868-875
Logie, C.H.; Newman, P.A.; Weaver, J.; Roungkraphon, S.; Tepjan, S. 2016: HIV-Related Stigma and HIV Prevention Uptake Among Young Men Who Have Sex with Men and Transgender Women in Thailand. Aids Patient Care and Stds 30(2): 92-100
Bennett, D.S.; Hersh, J.; Herres, J.; Foster, J. 2016: HIV-Related Stigma, Shame, and Avoidant Coping: Risk Factors for Internalizing Symptoms Among Youth Living with HIV?. Child Psychiatry and Human Development 47(4): 657-664
Kalichman, S.C.; Kalichman, M.O. 2016: HIV-Related Stress and Life Chaos Mediate the Association Between Poverty and Medication Adherence Among People Living with HIV/AIDS. Journal of Clinical Psychology in Medical Settings 23(4): 420-430
Abdulkader, R.Suliankatchi.; Goswami, K.; Rai, S.K.; Misra, P.; Kant, S. 2015: HIV-Risk Behavior Among the Male Migrant Factory Workers in a North Indian City. Indian Journal of Community Medicine: Official Publication of Indian Association of Preventive and Social Medicine 40(2): 108-115
Ballester-Arnal, R.; Gil-Llario, M.ía.D.; Castro-Calvo, J.ús.; Giménez-García, C. 2016: HIV-Risk Index: Development and Validation of a Brief Risk Index for Hispanic Young people. Aids and Behavior 20(8): 1796-1807
Donenberg, G.R.; Emerson, E.; Mackesy-Amiti, M.E.; Udell, W. 2015: HIV-Risk Reduction with Juvenile Offenders on Probation. Journal of Child and Family Studies 24(6): 1672-1684
Norman, L.R.; Loue, S. 2015: HIV-Risk Related Attitudes and Behaviors Among Older Impoverished Women Living in Puerto Rico. Journal of Immigrant and Minority Health 17(6): 1791-1802
Gallerano, D.; Cabauatan, C.R.; Sibanda, E.N.; Valenta, R. 2015: HIV-Specific Antibody Responses in HIV-Infected Patients: from a Monoclonal to a Polyclonal View. International Archives of Allergy and Immunology 167(4): 223-241
Jensen, S.S.; Fomsgaard, A.; Borggren, M.; Tingstedt, J.L.; Gerstoft, J.; Kronborg, G.; Rasmussen, L.D.; Pedersen, C.; Karlsson, I. 2015: HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART). Plos one 10(12): E0145249
Jensen, S.S.; Tingstedt, J.L.; Larsen, T.K.; Brandt, L.; Gerstoft, J.; Kronborg, G.; Pedersen, C.; Fomsgaard, A.; Karlsson, I. 2016: HIV-Specific CD8+ T Cell-Mediated Viral Suppression Correlates with the Expression of CD57. Journal of Acquired Immune Deficiency Syndromes 71(1): 8-16
Daniel, O.J.; Adejumo, O.A.; Gidado, M.; Abdur-Razzaq, H.A.; Jaiyesimi, E.O. 2015: HIV-TB co-infection in children: associated factors and access to HIV services in Lagos, Nigeria. Public Health Action 5(3): 165-169
Ahmed, A.; Rakshit, S.; Vyakarnam, A. 2016: HIV-TB co-infection: mechanisms that drive reactivation of Mycobacterium tuberculosis in HIV infection. Oral Diseases 22(Suppl 1): 53-60
Suarez, G.V.; Angerami, M.ía.T.; Vecchione, M.ía.B.; Laufer, N.; Turk, G.; Ruiz, M.J.; Mesch, V.; Fabre, B.; Maidana, P.; Ameri, D.; Cahn, P.; Sued, O.; Salomón, H.; Bottasso, O.A.; Quiroga, M.ía.F. 2015: HIV-TB coinfection impairs CD8(+) T-cell differentiation and function while dehydroepiandrosterone improves cytotoxic antitubercular immune responses. European Journal of Immunology 45(9): 2529-2541
Mastrantonio, R.; Cervelli, M.; Pietropaoli, S.; Mariottini, P.; Colasanti, M.; Persichini, T. 2016: HIV-Tat Induces the Nrf2/ARE Pathway through NMDA Receptor-Elicited Spermine Oxidase Activation in Human Neuroblastoma Cells. Plos one 11(2): E0149802
Zeitler, M.; Steringer, J.P.; Müller, H-Michael.; Mayer, M.P.; Nickel, W. 2015: HIV-Tat Protein Forms Phosphoinositide-dependent Membrane Pores Implicated in Unconventional Protein Secretion. Journal of Biological Chemistry 290(36): 21976-21984
Ensoli, B.; Nchabeleng, M.; Ensoli, F.; Tripiciano, A.; Bellino, S.; Picconi, O.; Sgadari, C.; Longo, O.; Tavoschi, L.; Joffe, D.; Cafaro, A.; Francavilla, V.; Moretti, S.; Pavone Cossut, M.Rosaria.; Collacchi, B.; Arancio, A.; Paniccia, G.; Casabianca, A.; Magnani, M.; Buttò, S.; Levendal, E.; Ndimande, J.Velaphi.; Asia, B.; Pillay, Y.; Garaci, E.; Monini, P. 2016: HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial. Retrovirology 13(1): 34
Es-Salah-Lamoureux, Z.; Jouni, M.; Malak, O.A.; Belbachir, N.; Al Sayed, Z.R.; Gandon-Renard, M.; Lamirault, G.; Gauthier, C.; Baró, I.; Charpentier, F.; Zibara, K.; Lemarchand, P.; Beaumelle, B.; Gaborit, N.; Loussouarn, G. 2016: HIV-Tat induces a decrease in IKr and IKsvia reduction in phosphatidylinositol-(4,5)-bisphosphate availability. Journal of Molecular and Cellular Cardiology 99: 1-13
Rountree, M.A.; Chen, L.; Bagwell, M. 2016: HIV-Testing Rates and Testing Locations Among Women who have Experienced Intimate Partner Violence: Data from the Centers for Disease Control Behavioral Risk Factor Surveillance System, 2006. Violence Against Women 22(4): 399-414
Harper, K.N. 2017: HIV-altered gut microbiome may be driving disease progression. Aids 31(2): N1
Mbugua, K.K.; Holmes, M.J.; Cotton, M.F.; Ratai, E.-M.; Little, F.; Hess, A.T.; Dobbels, E.; Van der Kouwe, A.J.W.; Laughton, B.; Meintjes, E.M. 2016: HIV-associated CD4+/CD8+ depletion in infancy is associated with neurometabolic reductions in the basal ganglia at age 5 years despite early antiretroviral therapy. Aids 30(9): 1353-1362
Etherton, M.R.; Lyons, J.L.; Ard, K.L. 2015: HIV-associated Neurocognitive Disorders and Antiretroviral Therapy: Current Concepts and Controversies. Current Infectious Disease Reports 17(6): 485
Gootenberg, D.B.; Paer, J.M.; Luevano, J.-M.; Kwon, D.S. 2017: HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation. Current Opinion in Infectious Diseases 30(1): 31-43
Bellazreg, F.; Knani, L.; Ben Abdelkarim, S.; Hattab, Z.; Hachfi, W.; Ben Hadj Hamida, F.; Letaief, A. 2016: HIV-associated conjunctivo-palpebral Kaposi's sarcoma: A case report. Journal Francais d'Ophtalmologie 39(4): e93-e95
Ogasawara, N.; Takano, K.-I.; Kobayashi, H.; Kikuchi, K.; Matsumiya, H.; Yoshioka, I.; Himi, T. 2017: HIV-associated cystic lesions of the parotid gland. Auris Nasus Larynx 44(1): 126-130
Santoso, L.F.; Erkkinen, E.E.; Deb, A.; Adon, C. 2016: HIV-associated dementia in the Dominican Republic: a consequence of stigma, domestic abuse and limited health literacy. BMJ Case Reports
Putot, A.; Perrin, S.; Jolivet, A.; Vantilcke, V. 2015: HIV-associated disseminated histoplasmosis in western French Guiana, 2002-2012. Mycoses 58(3): 160-166
Reddy, R.; Gogia, A.; Kumar, L.; Sharma, A.; Bakhshi, S.; Sharma, M.C.; Mallick, S.; Sahoo, R. 2016: HIV-associated hematologic malignancies: Experience from a Tertiary Cancer Center in India. Indian Journal of Medical and Paediatric Oncology: Official Journal of Indian Society of Medical and Paediatric Oncology 37(3): 141-145
Pillay, B.; Ramdial, P.K.; Naidoo, D.P. 2015: HIV-associated large-vessel vasculopathy: a review of the current and emerging clinicopathological spectrum in vascular surgical practice. Cardiovascular Journal of Africa 26(2): 70-81
Gadiraju, R.; Bommireddipalli, S.; Rangray, R.; DePuey, E.G. 2009: HIV-associated lymphocytic interstitial pneumonitis causes diffuse sestamibi lung uptake in myocardial perfusion imaging. Radiology Case Reports 4(4): 352
Carroll, V.; Garzino-Demo, A. 2015: HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape. Pathogens and Disease 73(7)
Riedel, D.J.; Rositch, A.F.; Redfield, R.R.; Blattner, W.A. 2016: HIV-associated lymphoma sub-type distribution, immunophenotypes and survival in an urban clinic population. Leukemia and Lymphoma 57(2): 306-312
Singh, E.; Naidu, G.; Davies, M.-A.; Bohlius, J. 2017: HIV-associated malignancies in children. Current Opinion in HIV and Aids 12(1): 77-83
Chinula, L.; Moses, A.; Gopal, S. 2017: HIV-associated malignancies in sub-Saharan Africa: progress, challenges, and opportunities. Current Opinion in HIV and Aids 12(1): 89-95
Hu, Z.; Luo, Z.; Wan, Z.; Wu, H.; Li, W.; Zhang, T.; Jiang, W. 2015: HIV-associated memory B cell perturbations. Vaccine 33(22): 2524-2529
Bowen, L.N.; Tyagi, R.; Li, W.; Alfahad, T.; Smith, B.; Wright, M.; Singer, E.J.; Nath, A. 2016: HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy. Neurology 87(17): 1756-1762
Voigt, R.M.; Keshavarzian, A.; Losurdo, J.; Swanson, G.; Siewe, B.; Forsyth, C.B.; French, A.L.; Demarais, P.; Engen, P.; Raeisi, S.; Mutlu, E.; Landay, A.L. 2015: HIV-associated mucosal gene expression: region-specific alterations. Aids 29(5): 537-546
Suzuki, K.; Saito, K.; Tanaka, Y. 2014: HIV-associated nephropathy with amoebic enteritis: a case report and literature review. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 51(6): 576-580
Clifford, D.B. 2017: HIV-associated neurocognitive disorder. Current Opinion in Infectious Diseases 30(1): 117-122
Wagner, G.A.; Chaillon, A.; Liu, S.; Franklin, D.R.; Caballero, G.; Kosakovsky Pond, S.L.; Vaida, F.; Heaton, R.K.; Letendre, S.L.; Grant, I.; Richman, D.D.; Smith, D.M. 2016: HIV-associated neurocognitive disorder is associated with HIV-1 dual infection. Aids 30(17): 2591-2597
Sanmarti, M.; Ibáñez, L.; Huertas, S.; Badenes, D.; Dalmau, D.; Slevin, M.; Krupinski, J.; Popa-Wagner, A.; Jaen, A. 2014: HIV-associated neurocognitive disorders. Journal of Molecular Psychiatry 2(1): 2
Harding, K.E.; Robertson, N.P. 2015: HIV-associated neurocognitive disorders. Journal of Neurology 262(6): 1596-1598
Marra, C.M. 2015: HIV-associated neurocognitive disorders and central nervous system drug penetration: what next?. Antiviral Therapy 20(4): 365-367
Simoes, E.; Justino, J.D. 2015: HIV-associated neurocognitive disorders: a review for NPs. Nurse Practitioner 40(7): 1-7
Rumbaugh, J.A.; Tyor, W. 2015: HIV-associated neurocognitive disorders: Five new things. Neurology. Clinical Practice 5(3): 224-231
Levy, I. 2015: HIV-associated neurocognitive disorders: still a hot topic?. Israel Medical Association Journal: Imaj 17(1): 52-53
Tedaldi, E.M.; Minniti, N.L.; Fischer, T. 2015: HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities. Biomed Research International 2015: 641913
Strehlau, R.; Kuhn, L.; Abrams, E.J.; Coovadia, A. 2016: HIV-associated neurodevelopmental delay: prevalence, predictors and persistence in relation to antiretroviral therapy initiation and viral suppression. Child: Care Health and Development 42(6): 881-889
Krishnan, A.; Zaia, J.A. 2014: HIV-associated non-Hodgkin lymphoma: viral origins and therapeutic options. HEMATOLOGY. American Society of Hematology. Education Program 1: 584-589
Katz, H.; Rose, C.; Rivera, N.T.; Bray, N. 2015: HIV-associated primary effusion lymphoma presenting as a paracardial mass. BMJ Case Reports
Bohac, G.C.; Dezube, B.J.; Cooley, T.P.; Aboulafia, D.; Pantanowitz, L. 2016: HIV-associated prostate cancer. Journal of Clinical Oncology 26(15_Suppl): 16089-16089
Correale, M.; Palmiotti, G.A.; Lo Storto, M.M.; Montrone, D.; Foschino Barbaro, M.P.; Di Biase, M.; Lacedonia, D. 2015: HIV-associated pulmonary arterial hypertension: from bedside to the future. European Journal of Clinical Investigation 45(5): 515-528
Wearne, N.; Okpechi, I.G. 2016: HIV-associated renal disease - an overview. Clinical Nephrology 86(13): 41-47
Ebrahim, S.; Singh, B.; Ramklass, S.S. 2014: HIV-associated salivary gland enlargement: a clinical review. Sadj: Journal of the South African Dental Association 69(9): 400-403
Luey, C.; Milne, D.; Briggs, S.; Thomas, M.; Handy, R.; Nisbet, M. 2015: HIV-associated tuberculosis in Auckland. New Zealand Medical Journal 128(1416): 36-43
Dargazanli, C.; Menjot de Champfleur, N.; Corlobé, A.; Bonafé, A.; Labauge, P.; Thouvenot, E.; Arquizan, C. 2016: HIV-associated vasculopathy: Potential pitfall for IV thrombolysis and indication for vessel wall imaging. Journal of Neuroradiology 43(6): 415-417
Astermark, J.; Johnsson, H.; Stigendal, L.; Lethagen, S.; Berntorp, E. 1997: HIV-disease progression in Swedish haemophiliacs and the influence of replacement therapy. Haemophilia: the Official Journal of the World Federation of Hemophilia 3(4): 277-282
Zash, R.; Souda, S.; Leidner, J.; Ribaudo, H.; Binda, K.; Moyo, S.; Powis, K.M.; Petlo, C.; Mmalane, M.; Makhema, J.; Essex, M.; Lockman, S.; Shapiro, R. 2016: HIV-exposed children account for more than half of 24-month mortality in Botswana. Bmc Pediatrics 16: 103
Evans, C.; Jones, C.E.; Prendergast, A.J. 2016: HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. LANCET. Infectious Diseases 16(6): E92
Anígilájé, E.A.; Dabit, O.J.; Olutola, A.; Ageda, B.; Aderibigbe, S.A. 2015: HIV-free survival according to the early infant-feeding practices; a retrospective study in an anti-retroviral therapy programme in Makurdi, Nigeria. Bmc Infectious Diseases 15: 132
Chikhungu, L.C.; Bispo, S.; Rollins, N.; Siegfried, N.; Newell, M.-L. 2016: HIV-free survival at 12-24 months in breastfed infants of HIV-infected women on antiretroviral treatment. Tropical Medicine and International Health: Tm and Ih 21(7): 820-828
Palma, J.; Abood, M.E.; Benamar, K. 2015: HIV-gp120 and physical dependence to buprenorphine. Drug and Alcohol Dependence 150: 175-178
Hayward, P. 2015: HIV-hepatitis C co-infection. LANCET. Infectious Diseases 15(4): 382
Bull, L.; Rayment, M. 2016: HIV-indicator-condition-driven HIV testing: clinically effective but still rarely implemented. Clinical Medicine 16(2): 175-179
Yang, L.; Poles, M.A.; Fisch, G.S.; Ma, Y.; Nossa, C.; Phelan, J.A.; Pei, Z. 2016: HIV-induced immunosuppression is associated with colonization of the proximal gut by environmental bacteria. Aids 30(1): 19-29
Shete, A.; Suryawanshi, P.; Godbole, S.; Pawar, J.; Paranjape, R.; Thakar, M. 2016: HIV-infected CD4+ T Cells use T-bet-dependent Pathway for Production of IL-10 Upon Antigen Recognition. Scandinavian Journal of Immunology 83(4): 288-296
Ismail, S.M.; Eisa, A.A.; Ibrahim, F. 2016: HIV-infected people in Sudan Moving Toward Chronic Poverty: Possible Interventions. Journal of the Association of Nurses in Aids Care: Janac 27(1): 30-43
Blackstock, O.J.; Shah, P.A.; Haughton, L.J.; Horvath, K.J.; Cunningham, C.O. 2015: HIV-infected Women's Perspectives on the use of the Internet for Social Support: a Potential Role for Online Group-based Interventions. Journal of the Association of Nurses in Aids Care: Janac 26(4): 411-419
Palmer, A. 2011: HIV-infected adolescents have multiple risk factors for mental illness. HIV Clinician 23(3): 1-4
Harper, K.N. 2015: HIV-infected adults experience accentuated but not accelerated ageing. Aids 29(9): N3
Maldarelli, F. 2015: HIV-infected cells are frequently clonally expanded after prolonged antiretroviral therapy: implications for HIV persistence. Journal of Virus Eradication 1(4): 237-244
Vagenas, P.; Zelenev, A.; Altice, F.L.; Di Paola, A.; Jordan, A.O.; Teixeira, P.A.; Frew, P.M.; Spaulding, A.C.; Springer, S.A. 2016: HIV-infected men who have sex with men, before and after release from jail: the impact of age and race, results from a multi-site study. Aids Care 28(1): 22-31
Zenón, F.; Cantres-Rosario, Y.; Adiga, R.; Gonzalez, M.; Rodriguez-Franco, E.; Langford, D.; Melendez, L.M. 2015: HIV-infected microglia mediate cathepsin B-induced neurotoxicity. Journal of Neurovirology 21(5): 544-558
Shannon, M.T. 2015: HIV-infected mothers' experiences during their infants' HIV testing. Research in Nursing and Health 38(2): 142-151
Kumar, A.M.V.; Singarajipura, A.; Naik, B.; Guddemane, D.K.; Patel, Y.; Shastri, S.; Kumar, S.; Deshmukh, R.; Rewari, B.B.; Harries, A.D. 2017: HIV-infected presumptive tuberculosis patients without tuberculosis: how many are eligible for antiretroviral therapy in Karnataka, India?. Journal of Epidemiology and Global Health 7(1): 11-19
Petoumenos, K.; Law, M. 2015: HIV-infection and comorbidities: a complex mix. LANCET. HIV 2(7): E265-E266
Jallow, A.; Ljunggren, G.; Wändell, P.; Wahlström, L.; Carlsson, A.C. 2017: HIV-infection and psychiatric illnesses - A double edged sword that threatens the vision of a contained epidemic: The Greater Stockholm HIV Cohort Study. Journal of Infection 74(1): 22-28
Baptista, M.J.; Garcia, O.; Morgades, M.; Gonzalez-Barca, E.; Miralles, P.; Lopez-Guillermo, A.; Abella, E.; Moreno, M.; Sancho, J.-M.; Feliu, E.; Ribera, J.-M.; Navarro, J.-T. 2015: HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era. Aids 29(7): 811-818
Seybold, U. 2015: HIV-infection: Early therapy is beneficial. Deutsche Medizinische Wochenschrift 140(18): 1338
Bringmann, G.; Steinert, C.; Feineis, D.; Mudogo, V.; Betzin, J.; Scheller, C. 2016: HIV-inhibitory michellamine-type dimeric naphthylisoquinoline alkaloids from the Central African liana Ancistrocladus congolensis. Phytochemistry 128: 71-81
Morita, Y.; Emoto, M.; Serizawa, K.; Rai, S.; Hirase, C.; Kanai, Y.; Ohyama, Y.; Shiga, T.; Tanaka, H.; Miyatake, J.; Tatsumi, Y.; Ashida, T.; Kimura, M.; Ito, M.; Matsumura, I. 2015: HIV-negative Primary Bone Marrow Hodgkin Lymphoma Manifesting with a High Fever Associated with Hemophagocytosis as the Initial Symptom: A Case Report and Review of the Previous Literature. Internal Medicine 54(11): 1393-1396
Mitchell, J.W.; Lee, J-Young.; Woodyatt, C.; Bauermeister, Jé.; Sullivan, P.; Stephenson, R. 2016: HIV-negative male couples' attitudes about pre-exposure prophylaxis (PrEP) and using PrEP with a sexual agreement. Aids Care 28(8): 994-999
Mitchell, J.W.; Sullivan, P.S. 2015: HIV-negative partnered men's attitudes toward using an in-home rapid HIV test and associated factors among a sample of US HIV-Negative and HIV-discordant male couples. Sexually Transmitted Diseases 42(3): 123-128
Stuard, W.L.; Squiers, K.; Suss, A.; Schrader, E.; Triantafyllou, D.; Brenner, A.; North, C.S. 2019: Development and Implementation of Psychiatric Services in a Student-Operated Clinic. Community Mental Health Journal 55(4): 553-560
Raimondo, M.; Facco, G.; Regine, V.; Pupella, S.; Grazzini, G.; Suligoi, B. 2016: HIV-positive blood donors unaware of their sexual at-risk behaviours before donation in Italy. Vox Sanguinis 110(2): 134-142
Mehdiyar, M.; Andersson, R.; Hjelm, K.; Povlsen, L. 2016: HIV-positive migrants' encounters with the Swedish health care system. Global Health Action 9: 31753
Anonymous 1991: HIV-positive patients claim discrimination. Nursing Standard: 1987) 6(1): 16
Katirayi, L.; Namadingo, H.; Phiri, M.; Bobrow, E.A.; Ahimbisibwe, A.; Berhan, A.Y.; Buono, N.; Moland, K.M.; Tylleskär, T. 2016: HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study. Journal of the International Aids Society 19(1): 20919
Spangler, S.A.; Onono, M.; Bukusi, E.A.; Cohen, C.R.; Turan, J.M. 2014: HIV-positive status disclosure and use of essential PMTCT and maternal health services in rural Kenya. Journal of Acquired Immune Deficiency Syndromes 67(Suppl 4): S235-S242
Abdool Karim, Q.; Dellar, R.C.; Bearnot, B.; Werner, L.; Frohlich, J.A.; Kharsany, A.B.M.; Abdool Karim, S.S. 2015: HIV-positive status disclosure in patients in care in rural South Africa: implications for scaling up treatment and prevention interventions. Aids and Behavior 19(2): 322-329
Canaud, G.; Avettand-Fenoel, V.; Legendre, C. 2015: HIV-positive-to-HIV-positive kidney transplantation. New England Journal of Medicine 372(21
Fulco, P.P. 2015: HIV-positive-to-HIV-positive kidney transplantation. New England Journal of Medicine 372(21): 2069-2070
Bogale, G.W.; Boer, H.; Seydel, E.R. 2009: HIV-prevention knowledge among illiterate and low-literate women in rural Amhara, Ethiopia. African Journal of Aids Research: Ajar 8(3): 349-357
Maksimovic-Ivanic, D.; Fagone, P.; McCubrey, J.; Bendtzen, K.; Mijatovic, S.; Nicoletti, F. 2017: HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?. International Journal of Cancer 140(8): 1713-1726
Papanastasopoulos, P.; Annan, B.; Dalla Pria, A.; Bower, M. 2016: HIV-related Kaposi's Sarcoma with Musculoskeletal Involvement in the Modern Antiretroviral Era. Anticancer Research 36(7): 3465-3469
Chen, J-Peng.; Han, M-Ming.; Liao, Z-Jun.; Dai, Z-Zhen.; Liu, L.; Chen, H.; Wen, X-Yan.; Hu, S.; Que, P.; Wen, W.; Peng, B. 2015: HIV-related behaviors, social support and health-related quality of life among men who have sex with men and women (MSMW): a cross-sectional study in Chongqing, China. Plos one 10(2): E0118651
Mohd Nasarruddin, A.; Wan Mohammad, W.Mohd.Zahiruddin.; Nik Hussain, N.Hazlina.; Ali, S.Hawa.; Zubir, H.Mat. 2015: HIV-related characteristics among female partners of injecting drug users in Kelantan, Malaysia: a descriptive study. Aids Care 27(3): 301-306
Van Egeraat, L.; Hanass-Hancock, J.; Myezwa, H. 2015: HIV-related disabilities: an extra burden to HIV and AIDS healthcare workers?. African Journal of Aids Research: Ajar 14(3): 285-294
Rios, A. 2014: HIV-related hematological malignancies: a concise review. Clinical Lymphoma Myeloma and Leukemia 14 Suppl: S96-103
Gandhi, R.T. 2012: HIV-related immune activation and non-AIDS-related complications: story unfolds. Journal Watch. Aids Clinical Care 24(1): 6-7
Hinduan, Z.R.; Suherman, H.; Pinxten, W.J.Lucas.; Alisjahbana, B.; Hospers, H.J. 2013: HIV-related knowledge and attitudes among Indonesian prison officers. International Journal of Prisoner Health 9(2): 92-102
Gledović, Z.; Rakočević, B.ži.; Mugoša, B.; Grgurević, A. 2015: HIV-related knowledge, attitudes and practice among health care workers in Montenegro. Collegium Antropologicum 39(1): 81-85
Chimoyi, L.; Tshuma, N.; Muloongo, K.; Setswe, G.; Sarfo, B.; Nyasulu, P.S. 2015: HIV-related knowledge, perceptions, attitudes, and utilisation of HIV counselling and testing: a venue-based intercept commuter population survey in the inner city of Johannesburg, South Africa. Global Health Action 8: 26950
Perry, M.E.; Kalenga, K.; Watkins, L.F.; Mukaya, J.E.; Powis, K.M.; Bennett, K.; Mmalane, M.; Makhema, J.; Shapiro, R.L. 2017: HIV-related mortality at a district hospital in Botswana. International Journal of Std and Aids 28(3): 277-283
Scheim, A.I.; Bauer, G.R.; Travers, R. 2017: HIV-Related Sexual Risk Among Transgender Men who Are Gay, Bisexual, or have Sex with Men. Journal of Acquired Immune Deficiency Syndromes 74(4): E89-E96
Vincent, W.; Fang, X.; Calabrese, S.K.; Heckman, T.G.; Sikkema, K.J.; Hansen, N.B. 2017: HIV-related shame and health-related quality of life among older, HIV-positive adults. Journal of Behavioral Medicine 40(3): 434-444
Mihan, R.; Kerr, J.; Maticka-Tyndale, E.; Gbadebo, K.; Omorodion, F.; Pierre-Pierre, V.; Travers, R. 2016: HIV-related stigma among African, Caribbean, and Black youth in Windsor, Ontario. Aids Care 28(6): 758-763
Mundt, S.; Briggs, S. 2016: HIV-related stigma and discrimination in the New Zealand healthcare setting: a mixed-methods study. Sexual Health 13(6): 582-588
Rydström, L-Lott.; Wiklander, M.; Navér, L.; Ygge, B-Marie.; Eriksson, L.E. 2016: HIV-related stigma and health-related quality of life among children living with HIV in Sweden. Aids Care 28(5): 665-671
Olley, B.O.; Ogunde, M.J.; Oso, P.O.; Ishola, A. 2016: HIV-related stigma and self-disclosure: the mediating and moderating role of anticipated discrimination among people living with HIV/AIDS in Akure Nigeria. Aids Care 28(6): 726-730
Hargreaves, J.R.; Stangl, A.; Bond, V.; Hoddinott, G.; Krishnaratne, S.; Mathema, H.; Moyo, M.; Viljoen, L.; Brady, L.; Sievwright, K.; Horn, L.; Sabapathy, K.; Ayles, H.; Beyers, N.; Bock, P.; Fidler, S.; Griffith, S.; Seeley, J.; Hayes, R. 2016: HIV-related stigma and universal testing and treatment for HIV prevention and care: design of an implementation science evaluation nested in the HPTN 071 (PopART) cluster-randomized trial in Zambia and South Africa. Health Policy and Planning 31(10): 1342-1354
Pannetier, J.; Lelièvre, E.; Le Cœur, S. 2016: HIV-related stigma experiences: Understanding gender disparities in Thailand. Aids Care 28(2): 170-178
Radcliffe, S.; Neaigus, A.; Bernard, M.Antoinette.; Shepard, C. 2015: HIV-related stigma in a New York City sample of adults in outpatient care for HIV infection: a short report. Aids Care 27(9): 1156-1161
Ion, A.; Wagner, A.C.; Greene, S.; Loutfy, M.R. 2017: HIV-related stigma in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada. Aids Care 29(2): 137-144
Kamen, C.; Arganbright, J.; Kienitz, E.; Weller, M.; Khaylis, A.; Shenkman, T.; Smith, S.; Koopman, C.; Gore-Felton, C. 2015: HIV-related stigma: implications for symptoms of anxiety and depression among Malawian women. African Journal of Aids Research: Ajar 14(1): 67-73
Mabileau, G.; Schwarzinger, M.; Flores, J.; Patrat, C.; Luton, D.; Epelboin, S.; Mandelbrot, L.; Matheron, S.; Yazdanpanah, Y. 2015: HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?. American Journal of Obstetrics and Gynecology 213(3): 341.E1
Laar, A.K.; Taylor, A.E.; Akasoe, B.A. 2015: HIV-seropositivity is not important in childbearing decision-making among HIV-positive Ghanaian women receiving antiretroviral therapy. Aids Care 27(7): 870-875
Scheid, J.F. 2015: HIV-specific B cell response in patients with broadly neutralizing serum activity. Science 350(6265): 1175
Williams, K.L.; Cortez, V.; Dingens, A.S.; Gach, J.S.; Rainwater, S.; Weis, J.F.; Chen, X.; Spearman, P.; Forthal, D.N.; Overbaugh, J. 2015: HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma from HIV-infected humans. Ebiomedicine 2(10): 1464-1477
Jones, R.B.; Walker, B.D. 2016: HIV-specific CD8⁺ T cells and HIV eradication. Journal of Clinical Investigation 126(2): 455-463
Berman, J.W.; Carvallo, L.; Buckner, C.M.; Luers, A.ée.; Prevedel, L.; Bennett, M.V.; Eugenin, E.A. 2016: HIV-tat alters Connexin43 expression and trafficking in human astrocytes: role in NeuroAIDS. Journal of Neuroinflammation 13(1): 54
Parriault, M.-C.; van Melle, A.; Basurko, C.él.; Gaubert-Marechal, E.; Macena, R.H.M.; Rogier, S.ép.; Kerr, L.R.F.S.; Nacher, M. 2015: HIV-testing among female sex workers on the border between Brazil and French Guiana: the need for targeted interventions. Cadernos de Saude Publica 31(8): 1615-1622
Li, X.; Wu, G.; Lu, R.; Feng, L.; Fan, W.; Xiao, Y.; Sun, Z.; Zhang, H.; Xing, H.; Shao, Y.; Ruan, Y. 2014: HIV-testing behavior and associated factors among MSM in Chongqing, China: results of 2 consecutive cross-sectional surveys from 2009 to 2010. Medicine 93(27): E124
Ofek, G.; Diskin, R. 2014: HIV. Expanding the breadth of an HIV-1 vaccine. Science 346(6215): 1290-1291
Mascola, J.R. 2015: HIV. the modern era of HIV-1 vaccine development. Science 349(6244): 139-140
Zou, H.; Dai, X.; Meng, X.; Wang, H.; Jiang, C.; Wang, Y.; Zhang, L.; Gao, Y.; Tang, S.; Xu, T.; Sun, W.; Wen, Y. 2014: HIV/AIDS - Related Knowledge, Attitudes, and Sexual Practices among Migrant Wives in Rural Anhui Province, China. Journal of Aids and Clinical Research 5(7): 319
Bekalu, M.Awoke.; Eggermont, S.; Viswanath, K.Vish. 2017: HIV/AIDS Communication Inequalities and Associated Cognitive and Affective Outcomes: A Call for a Socioecological Approach to AIDS Communication in Sub-Saharan Africa. Health Communication 32(6): 685-694
Masquillier, C.; Wouters, E.; Mortelmans, D.; van Wyk, B.; Hausler, H.; Van Damme, W. 2016: HIV/AIDS Competent Households: Interaction between a Health-Enabling Environment and Community-Based Treatment Adherence Support for people Living with HIV/AIDS in South Africa. Plos one 11(3): E0151379
Catumbela, E.Castro.Cassoco.; Santos, C.; Freitas, A.; Costa, C.; Sarmento, Aónio.; Costa Pereira, A. 2016: HIV/AIDS Indicators for Clinical Care Quality Assessment: Relevance and Utility Assessed by Health Professionals. Acta Medica Portuguesa 29(6): 389-400
Mahat, G.; Scoloveno, M.A.; Scoloveno, R. 2016: HIV/AIDS Knowledge, Self-Efficacy for Limiting Sexual Risk Behavior and Parental Monitoring. Journal of Pediatric Nursing 31(1): E63-E69
Pandve, H.T.; Giri, P.A. 2015: HIV/AIDS Prevention and Control in India: Achievements and Future Challenges. North American Journal of Medical Sciences 7(12): 575-576
Dahlui, M.; Azahar, N.; Bulgiba, A.; Zaki, R.; Oche, O.M.; Adekunjo, F.O.; Chinna, K. 2015: HIV/AIDS Related Stigma and Discrimination against PLWHA in Nigerian Population. Plos one 10(12): E0143749
Johnson, M.E.; Kondo, K.K.; Brems, C.; Eldridge, G.D. 2015: HIV/AIDS Research in Correctional Settings: A Difficult Task Made Even Harder?. Journal of Correctional Health Care: the Official Journal of the National Commission on Correctional Health Care 21(2): 101-111
Kumar, A. 2016: HIV/AIDS Risk and Prevention Issues Among Inuit Living in Nunavut Territory of Canada. In Vivo 30(6): 905-916
Koku, E.F.; Rajab-Gyagenda, W.M.; Korto, M.D.; Morrison, S.D.; Beyene, Y.; Mbajah, J.; Ashton, C. 2016: HIV/AIDS among African Immigrants in the U.S.: The Need for Disaggregating HIV Surveillance Data by Country of Birth. Journal of health care for the poor and underserved 27(3): 1316-1329
Serbessa, M.K.; Mariam, D.H.; Kassa, A.; Alwan, F.; Kloos, H. 2016: HIV/AIDS among pastoralists and refugees in north-east Africa: a neglected problem. African Journal of Aids Research: Ajar 15(1): 45-54
Khoza-Shangase, K. 2010: HIV/AIDS and auditory function in adults: the need for intensified research in the developing world. African Journal of Aids Research: Ajar 9(1): 1-9
Magadi, M.A.; Magadi, W.A. 2017: HIV/AIDS and contraceptive use: factors associated with contraceptive use among sexually active HIV-positive women in Kenya. Contraception 95(3): 312-321
Maynard-Tucker, G. 2009: HIV/AIDS and family planning services integration: review of prospects for a comprehensive approach in sub-Saharan Africa. African Journal of Aids Research: Ajar 8(4): 465-472
Julesz, M.át.é 2016: HIV/AIDS and law in Hungary. Orvosi Hetilap 157(47): 1884-1890
Finkelstein, J.L.; Gala, P.; Rochford, R.; Glesby, M.J.; Mehta, S. 2015: HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settings. Journal of the International Aids Society 18: 19033
Breuer, E.; Myer, L.; Struthers, H.; Joska, J.A. 2011: HIV/AIDS and mental health research in sub-Saharan Africa: a systematic review. African Journal of Aids Research: Ajar 10(2): 101-122
Cunha, B.M.; Mota, L.M.H.; Pileggi, G.S.; Safe, I.P.; Lacerda, M.V.G. 2015: HIV/AIDS and rheumatoid arthritis. Autoimmunity Reviews 14(5): 396-400
Mubangizi, J.C. 2004: HIV/AIDS and the South African Bill of Rights, with specific reference to the approach and role of the courts. African Journal of Aids Research: Ajar 3(2): 113-119
Hamid Albujeer, A.N.; Shamshiri, A.R.; Taher, A. 2015: HIV/AIDS awareness among Iraqi medical and dental students. Journal of International Society of Preventive and Community Dentistry 5(5): 372-376
Jin, X.; Xiong, R.; Mao, Y. 2015: HIV/AIDS cases detection in medical institutions from 2008 to 2013 in China. Zhonghua Liu Xing Bing Xue Za Zhi 36(4): 323-326
Dapaah, J.Mensah.; Senah, K.A. 2016: HIV/AIDS clients, privacy and confidentiality; the case of two health centres in the Ashanti Region of Ghana. Bmc Medical Ethics 17(1): 41
Oliveira, R.d.S.M.d.; Benzaken, A.S.; Saraceni, V.; Sabidó, M. 2015: HIV/AIDS epidemic in the State of Amazonas: characteristics and trends from 2001 to 2012. Revista da Sociedade Brasileira de Medicina Tropical 48(Suppl 1): 70-78
Nathanson, N. 2016: HIV/AIDS epidemic: the whole truth. Science 351(6269): 133
Barnes, C.M.; Miller, J.A.; Bostock, S. 2017: Helping employees sleep well: Effects of cognitive behavioral therapy for insomnia on work outcomes. Journal of Applied Psychology 102(1): 104-113
Hess, R.F.; Mbavu, M. 2010: HIV/AIDS fatalism, beliefs and prevention indicators in Gabon:comparisons between Gabonese and Malians. African Journal of Aids Research: Ajar 9(2): 125-133
McKay, R.A. 2014: HIV/AIDS histories: community service organizations and the direct-action AIDS movement in documentary film. Bulletin of the History of Medicine 88(4): 734-737
Steinbrook, R. 2016: HIV/AIDS in 2016 and Beyond. JAMA 316(11): 1139-1140
Ahluwalia, G. 2014: HIV/AIDS in India - indigenous evidence through operational research. Indian Journal of Medical Research 140(4): 475-476
Paranjape, R.S.; Challacombe, S.J. 2016: HIV/AIDS in India: an overview of the Indian epidemic. Oral Diseases 22(Suppl 1): 10-14
Ammar, D.; Cordova, A. 2014: HIV/AIDS in Lebanese prisons: challenges and proposed actions. International Journal of Prisoner Health 10(3): 147-154
Mwale, B. 2002: HIV/AIDS in Malawi. Malawi Medical Journal: the Journal of Medical Association of Malawi 14(2): 2-3
Loening-Voysey, H. 2002: HIV/AIDS in South Africa: caring for vulnerable children. African Journal of Aids Research: Ajar 1(2): 103-110
Bradshaw, D.; Msemburi, W.; Dorrington, R.; Pillay-van Wyk, V.; Laubscher, R.; Groenewald, P. 2016: HIV/AIDS in South Africa: how many people died from the disease between 1997 and 2010?. Aids 30(5): 771-778
Drame, F.M.; Foley, E.E. 2015: HIV/AIDS in mid-sized cities in Senegal: from individual to place-based vulnerability. Social Science and Medicine 133: 296-303
Mothi, S.N.; Lala, M.M.; Tappuni, A.R. 2016: HIV/AIDS in women and children in India. Oral Diseases 22(Suppl 1): 19-24
De Andrade, V.; Baloyi, B. 2010: HIV/AIDS knowledge among adolescent sign-language users in South Africa. African Journal of Aids Research: Ajar 9(3): 307-313
Gurmu, E.; Etana, D. 2015: HIV/AIDS knowledge and stigma among women of reproductive age in Ethiopia. African Journal of Aids Research: Ajar 14(3): 191-199
Roshchina, A.A.; Ponomareva, E.Y.; Rebrov, A.P. 2015: HIV/AIDS masks in a therapist's practice. Terapevticheskii Arkhiv 87(4): 41-46
Lubinga, E.; Schulze, M.; Jansen, C.; Maes, A. 2010: HIV/AIDS messages as a spur for conversation among young South Africans?. African Journal of Aids Research: Ajar 9(2): 175-185
OA Sowande; Talabi, A.; Olowookere, S.; Adejuyigbe; Owotade, F. 2015: HIV/AIDS pandemic and current practice among Paediatric Surgeons in Nigeria. African Journal of Medicine and Medical Sciences 44(4): 297-302
Posse, M.; Baltussen, R. 2013: HIV/AIDS patient satisfaction with a food assistance programme in Sofala province, Mozambique. African Journal of Aids Research: Ajar 12(4): 203-210
Verdugo, F.; Pinto, F.; Charpentier, P.; Von Mühlenbrock, C.; Soto, A.és.; Dabanch, J.; Fica, A. 2015: HIV/AIDS patients in a Critical Care Unit: the experience of a general hospital in a developing country. Revista Chilena de Infectologia: Organo Oficial de la Sociedad Chilena de Infectologia 32(3): 294-303
Khodayari-Zarnaq, R.; Ravaghi, H.; Mohammad Mosaddeghrad, A.; Sedaghat, A.; Mohraz, M. 2016: HIV/AIDS policy agenda setting in Iran. Medical Journal of the Islamic Republic of Iran 30: 392
Stefaniak, J. 2015: HIV/AIDS presenting with stroke-like features caused by cerebral Nocardia abscesses: a case report. Bmc Neurology 15: 183
Mor, Z.; Eisenberg, J.R.; Grotto, I.; Tishler-Aurkin, D. 2015: HIV/AIDS prevalence in Israeli prisons: Is there a need for universal screening?. Journal of Public Health Policy 36(4): 484-490
Muula, A.S. 2002: HIV/AIDS prevention efforts in Malawi. Malawi Medical Journal: the Journal of Medical Association of Malawi 14(2): 26-27
Qureshi, M.A.; Khan, S.; Zahid, M.; Ali, Z. 2015: HIV/AIDS registration in Pakistan. LANCET. Infectious Diseases 15(6): 635-636
Berhanemeskel, E.; Beedemariam, G.; Fenta, T.Gedif. 2016: HIV/AIDS related commodities supply chain management in public health facilities of Addis Ababa, Ethiopia: a cross-sectional survey. Journal of Pharmaceutical Policy and Practice 9: 11
Ning, S.; Xue, Z.; Wei, J.; Mu, S.; Xu, Y.; Jia, S.; Qiu, C.; Xu, J. 2015: HIV/AIDS related mortality in southern Shanxi province and its risk factors. Zhonghua Liu Xing Bing Xue Za Zhi 36(3): 245-249
Kondo, K.K.; Johnson, M.E.; Ironside, E.F.; Brems, C.; Eldridge, G.D. 2014: HIV/AIDS research in correctional settings: perspectives on training needs from researchers and IRB members. Aids Education and Prevention: Official Publication of the International Society for Aids Education 26(6): 565-576
Garett, R.; Smith, J.; Chiu, J.; Young, S.D. 2016: HIV/AIDS stigma among a sample of primarily African-American and Latino men who have sex with men social media users. AIDS care 28(6): 731-735
Koodibetse, K.G. 2015: HIV/AIDS stigma and discrimination in South Africa--still a problem. South African Medical Journal 105(9): 703
Stein, J. 2003: HIV/AIDS stigma: the latest dirty secret. African Journal of Aids Research: Ajar 2(2): 95-101
Chin'ombe, N.; Ruhanya, V. 2015: HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies. Pan African Medical Journal 20: 386
Altaf Chowdhury, S.Asif.; Smith, J.; Trowsdale, S.; Leather, S. 2016: HIV/AIDS, health and wellbeing study among International Transport Workers' Federation (ITF) seafarer affiliates. International Maritime Health 67(1): 42-50
Dawson, H. 2013: HIV/AIDS, the erosion of social capital and the collapse of rural livelihoods in the Nkomazi district of South Africa. African Journal of Aids Research: Ajar 12(4): 185-194
Maduro, A.P.; Gonçalves, L.; Inácio, J.; Faria, N.C.G.; Martins, M.L.; Teles, F.R.R. 2015: HIV/AIDS-Associated Cryptococcosis in Portugal Spanning the Pre- to Post-HAART Era: A Retrospective Assessment at the Genotypic Level Based on URA5-RFLP. Current Microbiology 71(4): 449-457
Patel, N.; Naidoo, P.; Mosiane, P.; Jann-Kruger, C. 2016: HIV/AIDS-associated Kaposi's sarcoma of the gastrointestinal tract: a pictorial spectrum. South African Medical Journal 106(10): 986-987
Wang, C-Wen.; Chan, C.L.W.; Ho, R.T.H. 2015: HIV/AIDS-related deaths in China, 2000-2012. AIDS care 27(7): 849-854
Chen, B.; Zhu, Y.; Guo, R.; Ding, S.; Zhang, Z.; Cai, H.; Zhu, H.; Wen, Y. 2016: HIV/AIDS-related knowledge awareness and risk behaviors among injection drug users in Maanshan, China: a cross-sectional study. Bmc Public Health 16: 97
Kabbash, I.Ali.; Abo Ali, E.A.; Elgendy, M.Mahmoud.; Abdrabo, M.Mohamed.; Salem, H.Mohamed.; Gouda, M.Ramadan.; Elbasiony, Y.Saleh.; Elboshy, N.; Hamed, M. 2018: HIV/AIDS-related stigma and discrimination among health care workers at Tanta University Hospitals, Egypt. Environmental Science and Pollution Research International 25(31): 30755-30762
Namuleme, R.K. 2015: HIV/AIDS-related stigma and information behaviour: an ethnographic study in the UK. Health Information and Libraries Journal 32(1): 61-66
Velloza, J.; Watt, M.H.; Choi, K.W.; Abler, L.; Kalichman, S.C.; Skinner, D.; Pieterse, D.; Sikkema, K.J. 2015: HIV/AIDS-related stigma in South African alcohol-serving venues and its potential impact on HIV disclosure, testing and treatment-seeking behaviours. Global Public Health 10(9): 1092-1106
Cohen, J. 2015: HIV/AIDS. Child fights HIV to a draw. Science 349(6246): 355
Wilson, D.; Lavelle, S. 2016: HIV/AIDS/STD in Africa. Aids Care 4(4): 438-443
Awasthi, K.R.; Adefemi, K.; Tamrakar, M. 2015: HIV/AIDS: A Persistent Health Issue for Women and Children in Mid and Far Western Nepal. Kathmandu University Medical Journal 13(49): 88-93
Walker, L.; Gilbert, L. 2002: HIV/AIDS: South African women at risk. African Journal of Aids Research: Ajar 1(1): 75-85
Gillett, G. 2016: HIV/AIDS: The Challenging Journey. American Journal of Bioethics: Ajob 16(10): 27-28
Zucker, K.J. 2015: HIV/AIDS: international behavioral research. Archives of Sexual Behavior 44(2): 265
Gökengin, D.; Doroudi, F.; Tohme, J.; Collins, B.; Madani, N. 2016: HIV/AIDS: trends in the Middle East and North Africa region. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 44: 66-73
Ruiz-Artacho, P.; Téllez-Molina, M.J.; Vergas-García, J.; Altali-Alhames, K.; Estrada-Pérez, V.; Fernández-Cruz-Pérez, A. 2013: HIV/HBV coinfection: Serological control and therapeutic strategies. Revista Clinica Espanola 213(6): 285-290
Rice, D.P.; Faragon, J.J.; Banks, S.; Chirch, L.M. 2016: HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals. Journal of Clinical and Translational Hepatology 4(3): 234-240
Gross, C.; Akoth, E.; Price, A.; Kattakuzhy, S.; Silk, R.; Rosenthal, E. 2016: HIV/HCV Co-infection: Overcoming Barriers to Treatment. Journal of the Association of Nurses in Aids Care: Janac 27(4): 524-529
Hsu, C.-S.; Kao, J.-H. 2016: HIV/HCV Coinfection in Taiwan. Aids Reviews 18(4): 193-197
Demir, M.ün.; Phiri, S.; Kaiser, R.; Chaweza, T.; Neuhann, F.; Tweya, H.; Fätkenheuer, G.; Steffen, H.-M. 2016: HIV/Hepatitis C Virus Co-infection among Adults Beginning Antiretroviral Therapy, Malawi. Emerging Infectious Diseases 22(11): 2018-2020
Wu, J.; Wu, H.; Li, P.; Lu, C. 2016: HIV/STIs risks between migrant MSM and local MSM: a cross-sectional comparison study in China. PeerJ 4: e2169
Manhart, L.E.; Epstein, M.; Bailey, J.A.; Hill, K.G.; Haggerty, K.P.; Catalano, R.F. 2016: HIV/Sexually Transmitted Infection Prevention Messaging: Targeting Root Causes of Sexual Risk Behavior. Sexually Transmitted Diseases 43(2): 71-77
Pai-Dhungat, J.V.; Parikh, F. 2015: HIV/TB--An Unholy Alliance. Journal of the Association of Physicians of India 63(3): 126
Peraire, J.; López-Dupla, M.; Alba, V.; Beltrán-Debón, R.; Martinez, E.; Domingo, P.; Asensi, V.; Leal, M.; Viladés, C.; Inza, M.-I.; Escoté, X.; Arnedo, M.; Mateo, G.; Valle-Garay, E.; Ferrando-Martinez, S.; Veloso, S.; Vendrell, J.; Gatell, J.M.; Vidal, F. 2015: HIV/antiretroviral therapy-related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasma. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 21(7): 711.E1-8
Rahimian, P.; He, J.J. 2017: HIV/neuroAIDS biomarkers. Progress in Neurobiology 157: 117-132
Soares, R.; Rocha, G.ça.; Meliço-Silvestre, A.ón.; Gonçalves, T. 2016: HIV1-viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies. Reviews in Medical Virology 26(5): 314-329
Kirchner, J.T. 2015: HIV: 3 cases that hid in plain sight. Journal of Family Practice 64(1): 20-26
Nau, J-yves. 2015: HIV: France authorizes and fully reimburses Truvada prophylaxis. Revue Medicale Suisse 11(497): 2302-2303
De la Fuente, S.; de Mendoza, C. 2016: HIV: Test and Treat, Please!. Aids Reviews 18(3): 166-167
Vlach, J.; Saad, J.S. 2014: HIV: a vicTIM. Trends in Microbiology 22(11): 603-604
Warriner, J.; Croston, M. 2016: HIV: an integrated approach. Nursing Standard: 31(5): 29
Drompt, L. 2015: HIV: new cases have decreased by 10 %. Revue Medicale Suisse 11(476): 1214-1215
Anonymous 2015: HIV: the question is not when to treat, but how to treat. Lancet 386(10002): 1420
Feng, T.; Gan, J.; Qin, A.; Huang, X.; Wu, N.; Hu, H.; Yao, H. 2016: HIV‑1 downregulates the expression and phosphorylation of receptor tyrosine kinase by targeting the NF‑κB pathway. Molecular Medicine Reports 14(3): 1947-1952
Barnhart-Dailey, M.C.; Trivedi, P.; Stukenberg, P.T.; Foltz, D.R. 2017: HJURP interaction with the condensin Ii complex during G1 promotes CENP-A deposition. Molecular Biology of the Cell 28(1): 54-64
Tachiwana, H.; Müller, S.; Blümer, J.; Klare, K.; Musacchio, A.; Almouzni, G.èv. 2015: HJURP involvement in de novo CenH3(CENP-A) and CENP-C recruitment. Cell Reports 11(1): 22-32
Perpelescu, M.; Hori, T.; Toyoda, A.; Misu, S.; Monma, N.; Ikeo, K.; Obuse, C.; Fujiyama, A.; Fukagawa, T. 2015: HJURP is involved in the expansion of centromeric chromatin. Molecular Biology of the Cell 26(15): 2742-2754
Wu, Q.; Wang, H.; An, P.; Tao, Y.; Deng, J.; Zhang, Z.; Shen, Y.; Chen, C.; Min, J.; Wang, F. 2015: HJV and HFE Play Distinct Roles in Regulating Hepcidin. Antioxidants and Redox Signaling 22(15): 1325-1336
Tawk, C.S.; Ghattas, I.R.; Smith, C.A. 2015: HK022 Nun Requires Arginine-Rich Motif Residues Distinct from λ N. Journal of Bacteriology 197(22): 3573-3582
Zhao, K.-W.; Murray, E.J.B.; Murray, S.S. 2017: HK2 Proximal Tubule Epithelial Cells Synthesize and Secrete Plasma Proteins Predominantly Through the Apical Surface. Journal of Cellular Biochemistry 118(4): 924-933
Huang, X.; Liu, M.; Sun, H.; Wang, F.; Xie, X.; Chen, X.; Su, J.; He, Y.; Dai, Y.; Wu, H.; Shen, L. 2015: HK2 is a radiation resistant and independent negative prognostic factor for patients with locally advanced cervical squamous cell carcinoma. International Journal of Clinical and Experimental Pathology 8(4): 4054-4063
Tan, V.P.; Miyamoto, S. 2015: HK2/hexokinase-II integrates glycolysis and autophagy to confer cellular protection. Autophagy 11(6): 963-964
Ludvik, A.E.; Pusec, C.M.; Priyadarshini, M.; Angueira, A.R.; Guo, C.; Lo, A.; Hershenhouse, K.S.; Yang, G.-Y.; Ding, X.; Reddy, T.E.; Lowe, W.L.; Layden, B.T. 2016: HKDC1 Is a Novel Hexokinase Involved in Whole-Body Glucose use. Endocrinology 157(9): 3452-3461
Bors, P.A.; Kemner, A.; Fulton, J.; Stachecki, J.; Brennan, L.K. 2015: HKHC Community Dashboard: design, development, and function of a Web-based performance monitoring system. Journal of Public Health Management and Practice: Jphmp 21 Suppl. 3: S36-S44
Wong, K.K.; Fracasso, P.M.; Bukowski, R.M.; Munster, P.N.; Lynch, T.; Abbas, R.; Quinn, S.E.; Zacharchuk, C.; Burris, H. 2016: HKI-272, an irreversible pan erbB receptor tyrosine kinase inhibitor: Preliminary phase 1 results in patients with solid tumors. Journal of Clinical Oncology 24(18_Suppl): 3018-3018
Hamamoto, S.; Horie, T.; Hauser, F.; Deinlein, U.; Schroeder, J.I.; Uozumi, N. 2015: HKT transporters mediate salt stress resistance in plants: from structure and function to the field. Current Opinion in Biotechnology 32: 113-120
Yépez, R.; Illescas, J.F.; Gijón, P.; Sánchez-Sánchez, M.; González-Zamora, E.; Santillan, R.; Álvarez, J.R.; Ibarra, I.A.; Aguilar-Pliego, J. 2016: HKUST-1 as a Heterogeneous Catalyst for the Synthesis of Vanillin. Journal of Visualized Experiments: Jove 2016(113)
Kim, J.; Kim, C.-S.; Jo, K.; Cho, Y.-S.; Kim, H.-G.; Lee, G.-H.; Lee, Y.M.; Sohn, E.; Kim, J.S. 2015: HL-217, a new topical anti-angiogenic agent, inhibits retinal vascular leakage and pathogenic subretinal neovascularization in Vldlr⁻/⁻ mice. Biochemical and Biophysical Research Communications 456(1): 53-58
Ju, K.D.; Kim, H.J.; Tsogbadrakh, B.; Lee, J.; Ryu, H.; Cho, E.J.; Hwang, Y.-H.; Kim, K.; Yang, J.; Ahn, C.; Oh, K.-H. 2016: HL156A, a novel AMP-activated protein kinase activator, is protective against peritoneal fibrosis in an in vivo and in vitro model of peritoneal fibrosis. American Journal of Physiology. Renal Physiology 310(5): F342-F350
Row, H.; Jeong, J.; Cho, S.; Kim, S.; Kim, K. 2016: HL271, a novel chemical compound derived from metformin, differs from metformin in its effects on the circadian clock and metabolism. Biochemical and Biophysical Research Communications 469(3): 783-789
Adnan, M.; Peterkin, D.; McLaughlin, A.; Hill, N. 2015: HL7 Middleware Framework for Laboratory Notifications for Notifiable Diseases. Studies in Health Technology and Informatics 214: 1-7
Barrett, L. 2015: Building trust is key to HIE success. Health Management Technology 36(2): 26
Amarapurkar, D.N.; Somani, V.S.; Shah, A.S.; Kankonkar, S.R. 2015: HLA - DQ genotyping in celiac disease in western India. Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 36(3): 174-178
Martín, P.; Krsnik, I.; Navarro, B.; Provencio, M.; García, J.F.; Bellas, C.; Vilches, C.; Gomez-Lozano, N. 2015: HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02. Plos one 10(8): E0135512
Park, H.J.; Kim, Y.J.; Kim, D.H.; Kim, J.; Park, K.H.; Park, J.W.; Lee, J.H. 2016: HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs. Yonsei Medical Journal 57(1): 118-126
Atasoy, M.; Anadolu-Braise, R.; Pirim, I.; Dogan, H.; Ikbal, M.üt. 2009: HLA Antigen Profile Differences in Patients with SCC (Squamous Cell Carcinoma) In-Situ /Actinic Keratosis and Invasive SCC: Is there a Genetic Succeptibility for Invasive SCC Development?. Eurasian Journal of Medicine 41(3): 162-164
Vase, M.Ølholm.; Maksten, E.Futtrup.; Strandhave, C.; Søndergaard, E.; Bendix, K.; Hamilton-Dutoit, S.; Andersen, C.; Møller, M.Boe.; Sørensen, Søren.Schwartz.; Kampmann, J.; Eiskjær, H.; Iversen, M.; Weinreich, I.Duus.; Møller, B.; Jespersen, B.; d'Amore, F. 2015: HLA Associations and Risk of Posttransplant Lymphoproliferative Disorder in a Danish Population-Based Cohort. Transplantation Direct 1(7): E25
Angeles-Han, S.T.; McCracken, C.; Yeh, S.; Jang, S.Ryeong.; Jenkins, K.; Cope, S.; Bohnsack, J.; Hersh, A.; Thompson, S.D.; Prahalad, S. 2015: HLA Associations in a Cohort of Children With Juvenile Idiopathic Arthritis With and Without Uveitis. Investigative Ophthalmology and Visual Science 56(10): 6043-6048
Srivastava, R.; Phatak, S.; Yadav, A.; Bajpai, P.; Aggarwal, A. 2016: HLA B27 typing in 511 children with juvenile idiopathic arthritis from India. Rheumatology International 36(10): 1407-1411
Keynan, Y.; Rueda, Z.V.; Bresler, K.; Becker, M.; Kasper, K. 2015: HLA B51 is associated with faster AIDS progression among newly diagnosed HIV-infected individuals in Manitoba, Canada. International Journal of Immunogenetics 42(5): 336-340
Rutkowski, K.; Taylor, C.; Wagner, A. 2017: HLA B62 as a possible risk factor for drug reaction with eosinophilia and systemic symptoms to piperacillin/tazobactam. Journal of Allergy and Clinical Immunology. in Practice 5(3): 829-830
Gandhi, R.T.; Bosch, R.J.; Rangsin, R.; Chuenchitra, T.; Sirisopana, N.; Kim, J.H.; Robb, M.L.; Vejbaesya, S.; Paris, R.M.; Nelson, K.E. 2016: HLA Class i Alleles Associated with Mortality in Thai Military Recruits with HIV-1 CRF01_AE Infection. Aids Research and Human Retroviruses 32(1): 44-49
Karabekian, Z.; Ding, H.; Stybayeva, G.; Ivanova, I.; Muselimyan, N.; Haque, A.; Toma, I.; Posnack, N.G.; Revzin, A.; Leitenberg, D.; Laflamme, M.A.; Sarvazyan, N. 2015: HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications. Tissue engineering. Part A 21(19-20): 2559-2571
Vejbaesya, S.; Thongpradit, R.; Kalayanarooj, S.; Luangtrakool, K.; Luangtrakool, P.; Gibbons, R.V.; Srinak, D.; Ngammthaworn, S.; Apisawes, K.; Yoon, I-Kyu.; Thomas, S.J.; Jarman, R.G.; Srikiakthachorn, A.; Green, S.; Chandanayingyong, D.; Park, S.; Friedman, J.; Rothman, A.L.; Stephens, H.A.F. 2015: HLA Class I Supertype Associations With Clinical Outcome of Secondary Dengue Virus Infections in Ethnic Thais. Journal of Infectious Diseases 212(6): 939-947
Hajjej, A.; Almawi, W.Y.; Hattab, L.; El-Gaaied, A.; Hmida, S. 2015: HLA Class i and Class Ii Alleles and Haplotypes Confirm the Berber Origin of the Present day Tunisian Population. Plos one 10(8): E0136909
Rodriguez-Reyna, T.S.; Mercado-Velázquez, P.; Yu, N.; Alosco, S.; Ohashi, M.; Lebedeva, T.; Cruz-Lagunas, A.; Núñez-Álvarez, C.; Cabiedes-Contreras, J.; Vargas-Alarcón, G.; Granados, J.; Zúñiga, J.; Yunis, E. 2015: HLA Class i and Ii Blocks Are Associated to Susceptibility, Clinical Subtypes and Autoantibodies in Mexican Systemic Sclerosis (SSc) Patients. Plos one 10(5): E0126727
Lion, J.; Taflin, C.; Cross, A.R.; Robledo-Sarmiento, M.; Mariotto, E.; Savenay, A.; Carmagnat, M.; Suberbielle, C.; Charron, D.; Haziot, A.; Glotz, D.; Mooney, N. 2016: HLA Class Ii Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 16(5): 1408-1420
Luo, M.; Embree, J.; Ramdahin, S.; Bielawny, T.; Laycock, T.; Tuff, J.; Haber, D.; Plummer, M.; Plummer, F.A. 2015: HLA Class Ii Antigens and their Interactive Effect on Perinatal Mother-To-Child HIV-1 Transmission. Plos one 10(5): E0126068
Barkia Beradhi, S.; Flesch, B.K.; Hansen, M.P.; Matheis, N.; Kahaly, G.J. 2016: HLA Class Ii Differentiates Between Thyroid and Polyglandular Autoimmunity. Hormone and Metabolic Research 48(4): 232-237
Bhallil, O.; Ibrahimi, A.; Ouadghiri, S.; Ouzeddoun, N.; Benseffaj, N.; Bayahia, R.; Essakalli, M. 2017: HLA Class II with Lupus Nephritis in Moroccan Patients. Immunological Investigations 46(1): 1-9
Djurisic, S.; Hviid, T.V.F. 2014: HLA Class Ib Molecules and Immune Cells in Pregnancy and Preeclampsia. Frontiers in Immunology 5: 652
Erdmann, N.; Du, V.Y.; Carlson, J.; Schaefer, M.; Jureka, A.; Sterrett, S.; Yue, L.; Dilernia, D.; Lakhi, S.; Tang, J.; Sidney, J.; Gilmour, J.; Allen, S.; Hunter, E.; Heath, S.; Bansal, A.; Goepfert, P.A. 2015: HLA Class-Ii Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses. Plos Pathogens 11(8): E1005111
Shepherd, B.L.; Ferrand, R.; Munyati, S.; Folkard, S.; Boyd, K.; Bandason, T.; Jallow, S.; Rowland-Jones, S.L.; Yindom, L.-M. 2015: HLA Correlates of Long-Term Survival in Vertically Infected HIV-1-Positive Adolescents in Harare, Zimbabwe. Aids Research and Human Retroviruses 31(5): 504-507
Dhib-Jalbut, S.; Valenzuela, R.M.; Ito, K.; Kaufman, M.; Ann Picone, M.; Buyske, S. 2013: HLA DR and DQ alleles and haplotypes associated with clinical response to glatiramer acetate in multiple sclerosis. Multiple Sclerosis and Related Disorders 2(4): 340-348
Kaur, N.; Minz, R.W.; Anand, S.; Saikia, B.; Aggarwal, R.; Das, A.; Thapa, B.R.; Chawla, Y.K. 2014: HLA DRB1 Alleles Discriminate the Manifestation of Autoimmune Hepatitis as Type 1 or Type 2 in North Indian Population. Journal of Clinical and Experimental Hepatology 4(1): 14-18
Rivera-Pirela, S.E.; Echeverría, M.; Salcedo, P.; Márquez, G.; Carrillo, Z.; Parra, Y.; Cipriani, A.María.; Núñez, Jé.R.; Álvarez de Mon, M. 2016: HLA DRB1*, DQB1*, DPA1*, and DPB1* and their association with the pathogenesis of leukemia in the population of Venezuela. Revista Alergia Mexico 63(3): 237-251
Lagha, A.; Messadi, A.; Boussaidi, S.; Kochbati, S.; Tazeghdenti, A.; Ghazouani, E.; Almawi, W.Y.; Yacoubi-Loueslati, B. 2016: HLA DRB1/DQB1 alleles and DRB1-DQB1 haplotypes and the risk of rheumatoid arthritis in Tunisians: a population-based case-control study. Hla 88(3): 100-109
Luo, S.; Lin, J.; Xie, Z.; Xiang, Y.; Zheng, P.; Huang, G.; Li, X.; Liao, Y.; Hagopian, W.A.; Wang, C.-Y.; Zhou, Z. 2016: HLA Genetic Discrepancy Between Latent Autoimmune Diabetes in Adults and Type 1 Diabetes: LADA China Study No. 6. Journal of Clinical Endocrinology and Metabolism 101(4): 1693-1700
Mühlau, M.; Andlauer, T.F.M.; Hemmer, B. 2016: HLA Genetic Risk Burden in Multiple Sclerosis. JAMA Neurology 73(12): 1500-1501
Lucan, C.; Pop, L.-A.; Florian, A.; Pileczki, V.; Petrushev, B.; Dima, D.; Frinc, I.; Berindan-Neagoe, I.; Irimie, A.; Berce, C.; Florian, I.-S.; Bojan, A.; Tomuleasa, C. 2016: HLA Genotyping using Next Generation Sequencing. Romanian Journal of Internal Medicine 54(2): 98-104
Fasano, M.E.; Dametto, E.; D'Alfonso, S. 2015: HLA Genotyping: Methods for the Identification of the HLA-DQ2,-DQ8 Heterodimers Implicated in Celiac Disease (CD) Susceptibility. Methods in Molecular Biology 1326: 79-92
Bacigalupo, A.; Sica, S. 2016: HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide. Advances in Hematology 2016: 7802967
Osoegawa, K.; Mack, S.J.; Udell, J.; Noonan, D.A.; Ozanne, S.; Trachtenberg, E.; Prestegaard, M. 2016: HLA Haplotype Validator for quality assessments of HLA typing. Human Immunology 77(3): 273-282
Sippert, E.íl.Ân.; de Oliveira e Silva, C.év.; Ayo, C.M.; Marques, S.B.D.; Visentainer, J.E.L.; Sell, A.M. 2015: HLA Haplotypes and Genotypes Frequencies in Brazilian Chronic Periodontitis Patients. Mediators of Inflammation 2015: 481656
Dāvidsone, Z.; Eglīte, J.ļe.; Lazareva, A.; Dzelzīte, S.īt.; Šantere, R.; Bērziņa, D.; Staņēviča, V. 2016: HLA Ii class alleles in juvenile idiopathic arthritis patients with and without temporomandibular joint arthritis. Pediatric Rheumatology Online Journal 14(1): 24
Meys, R.; Purdie, K.J.; de Koning, M.N.C.; Quint, K.D.; Little, A.-M.; Baker, F.; Francis, N.; Asboe, D.; Hawkins, D.; Marsh, S.G.E.; Harwood, C.A.; Gotch, F.M.; Bunker, C.B. 2016: HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment. Journal of Infectious Diseases 213(11): 1717-1724
Heaney, A.P.; Sumerel, B.; Rajalingam, R.; Bergsneider, M.; Yong, W.H.; Liau, L.M. 2015: HLA Markers DQ8 and DR53 Are Associated With Lymphocytic Hypophysitis and May Aid in Differential Diagnosis. Journal of Clinical Endocrinology and Metabolism 100(11): 4092-4097
Milner, J.; Melcher, M.L.; Lee, B.; Veale, J.; Ronin, M.; D'Alessandro, T.; Hil, G.; Fry, P.C.; Shannon, P.W. 2016: HLA Matching Trumps Donor Age: Donor-Recipient Pairing Characteristics that Impact Long-Term Success in Living Donor Kidney Transplantation in the Era of Paired Kidney Exchange. Transplantation Direct 2(7): E85
Walton, D.C.; Hiho, S.J.; Cantwell, L.S.; Diviney, M.B.; Wright, S.T.; Snell, G.I.; Paraskeva, M.A.; Westall, G.P. 2016: HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 16(9): 2695-2703
Cecka, J.M. 2016: HLA Matching for Renal Transplantation: the Last Word?. Transplantation 100(5): 975-976
Verneris, M.R.; Lee, S.J.; Ahn, K.Woo.; Wang, H-Lin.; Battiwalla, M.; Inamoto, Y.; Fernandez-Vina, M.A.; Gajewski, J.; Pidala, J.; Munker, R.; Aljurf, M.; Saber, W.; Spellman, S.; Koreth, J. 2015: HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 21(10): 1783-1789
Mjoen, G.; Reisaeter, A.V.; Dahle, D.O. 2016: HLA Mismatch and Allograft Survival. Transplantation 100(9): E52
Galleze, A.; Raache, R.; Amroun, H.; Cherif, N.; Fadli, M.; Meçabih, F.; Mecheti, B.; Belhani, M.; Bensenouci, A.; Abbadi, M.C.; Attal, N. 2015: HLA Polymorphism in Algerian Children with Lymphomas. Journal of Pediatric Hematology/Oncology 37(8): E458-E461
Rao, X.; Hoof, I.; van Baarle, D.; Keşmir, C.; Textor, J. 2015: HLA Preferences for Conserved Epitopes: A Potential Mechanism for Hepatitis C Clearance. Frontiers in Immunology 6: 552
Singla, S.; Kumar, P.; Singh, P.; Kaur, G.; Rohtagi, A.; Choudhury, M. 2016: HLA Profile of Celiac Disease among First-Degree Relatives from a Tertiary Care Center in North India. Indian Journal of Pediatrics 83(11): 1248-1252
Gómez-Díaz, R.A.; Nishimura-Meguro, E.; Garrido-Magaña, E.; Lizárraga-Paulin, L.; Aguilar-Herrera, B.E.; Bekker-Méndez, C.; Medina-Santillán, R.; Barquera, R.; Mondragón-González, R.; Wacher, N.H. 2016: HLA Risk Haplotype: Insulin Deficiency in Pediatric Type 1 Diabetes. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 68(3): 128-136
Mayor, N.P.; Robinson, J.; McWhinnie, A.J.M.; Ranade, S.; Eng, K.; Midwinter, W.; Bultitude, W.P.; Chin, C.-S.; Bowman, B.; Marks, P.; Braund, H.; Madrigal, J.A.; Latham, K.; Marsh, S.G.E. 2015: HLA Typing for the Next Generation. Plos one 10(5): E0127153
Kongmaroeng, C.; Romphruk, A.; Puapairoj, C.; Leelayuwat, C.; Kulski, J.K.; Inoko, H.; Dunn, D.S.; Romphruk, A.V. 2015: HLA alleles and haplotypes in Burmese (Myanmarese) and Karen in Thailand. Tissue Antigens 86(3): 199-204
Silva, Fábio.França.; Mesquita, E.Rosa.Rêgo.Barros.Pires.Leal.; Patricio, F.José.Brito.; Corrêa, R.da.Graça.Carvalhal.Frazão.; Ferreira, E.César.Macau.Furtado.; Chein, M.Bethânia.da.Costa.; Brito, L.Maria.Oliveira. 2015: HLA alleles association and recurrent spontaneous abortion in a São Luis/Maranhão population, in Brazilian Northeastern region. Revista brasileira de ginecologia e obstetricia: revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 37(8): 347-352
Fernández-Viña, M.A.íb. 2014: HLA allotype expressivity in transplantation. Blood 124(26): 3839-3840
Sousa-Pinto, B.; Correia, C.áu.; Gomes, L.íd.; Gil-Mata, S.; Araújo, L.ís.; Correia, O.; Delgado, L.ís. 2016: HLA and Delayed Drug-Induced Hypersensitivity. International Archives of Allergy and Immunology 170(3): 163-179
Hussain, S.K.; Makgoeng, S.B.; Everly, M.J.; Goodman, M.T.; Martínez-Maza, O.; Morton, L.M.; Clarke, C.A.; Lynch, C.F.; Snyder, J.; Israni, A.; Kasiske, B.L.; Engels, E.A. 2016: HLA and Risk of Diffuse Large B cell Lymphoma After Solid Organ Transplantation. Transplantation 100(11): 2453-2460
Van der Woude, D.; Catrina, A.I. 2015: HLA and anti-citrullinated protein antibodies: Building blocks in RA. Best Practice and Research. Clinical Rheumatology 29(6): 692-705
Azizi, G.; Namaki, S.; Mirshafiey, A.; Hamid, K.M. 2015: HLA antigens and anti-sperm antibody production in Iranian vasectomized men. Journal of Biomedical Research 29(1): 87-90
Rasmussen, T.; Yap, S.Eng.; Stray-Pedersen, B.; Akselsen, H.E.; McKinney, P.A.; Rønningen, K.S. 2014: HLA associated type 1 diabetes risk in children of Pakistani migrants to Norway. Medical hypotheses 83(6): 664-667
Meuleman, T.; Lashley, L.E.L.O.; Dekkers, O.M.; van Lith, J.M.M.; Claas, F.H.J.; Bloemenkamp, K.W.M. 2015: HLA associations and HLA sharing in recurrent miscarriage: A systematic review and meta-analysis. Human Immunology 76(5): 362-373
Pandit, L.; Malli, C.; Singhal, B.; Wason, J.; Malik, O.; Sawcer, S.; Ban, M.; D'Cunha, A.; Mustafa, S. 2016: HLA associations in South Asian multiple sclerosis. Multiple Sclerosis 22(1): 19-24
Zhao, D.; Liao, H.; Zhang, X.; Liu, Y.; Zhang, H.; Huang, C.; Sun, L.; Yan, H. 2014: HLA class i alleles and haplotypes in Chinese patients with primary biliary cirrhosis. Zhonghua Gan Zang Bing Za Zhi 22(12): 904-909
Hirohashi, Y.; Torigoe, T.; Mariya, T.; Kochin, V.; Saito, T.; Sato, N. 2015: HLA class I as a predictor of clinical prognosis and CTL infiltration as a predictor of chemosensitivity in ovarian cancer. Oncoimmunology 4(5): E1005507
Jones, K.; Wockner, L.; Thornton, A.; Gottlieb, D.; Ritchie, D.S.; Seymour, J.F.; Kumarasinghe, G.; Gandhi, M.K. 2015: HLA class I associations with EBV+ post-transplant lymphoproliferative disorder. Transplant Immunology 32(2): 126-130
Zimmer, J.; Ollert, M. 2015: HLA class i deficiency as an additional cause of bronchiectasis. Respirology 20(7): 1145
Sottile, R.; Pangigadde, P.N.; Tan, T.; Anichini, A.; Sabbatino, F.; Trecroci, F.; Favoino, E.; Orgiano, L.; Roberts, J.; Ferrone, S.; Kärre, K.; Colucci, F.; Carbone, E. 2016: HLA class i downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors. European Journal of Immunology 46(2): 409-419
Buhler, Séphane.; Nunes, Jé.Manuel.; Sanchez-Mazas, A. 2016: HLA class I molecular variation and peptide-binding properties suggest a model of joint divergent asymmetric selection. Immunogenetics 68(6-7): 401-416
Ashouri, E.; Norman, P.J.; Guethlein, L.A.; Han, A.S.; Nemat-Gorgani, N.; Norberg, S.J.; Ghaderi, A.; Parham, P. 2016: HLA class i variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands. Hla 88(3): 87-99
Gheorghe, L.; Rugină, S.; Dumitru, I.M.; Franciuc, I.; Martinescu, A.; Balaş, I. 2015: HLA class Ii alleles in Romanian patients with chronic hepatitis C. Germs 5(2): 44-49
Juárez-Martín, A.I.; González-Sobrino, B.Z.; Olvera, Án.E.C.; Falfán-Valencia, R.és. 2014: HLA class Ii alleles in the Otomi population of the Mezquital Valley: a genetic approach to the history of interethnic migrations in the Mexican Central Plateau. Human Biology 86(3): 167-184
Mariaselvam, C.M.; Fortier, C.; Charron, D.; Krishnamoorthy, R.; Tamouza, R.; Negi, V.S. 2016: HLA class Ii alleles influence rheumatoid arthritis susceptibility and autoantibody status in South Indian Tamil population. Hla 88(5): 253-258
Baldwin, K.M.; Ehrenberg, P.K.; Geretz, A.; Prentice, H.A.; Nitayaphan, S.; Rerks-Ngarm, S.; Kaewkungwal, J.; Pitisuttithum, P.; O'Connell, R.J.; Kim, J.H.; Thomas, R. 2015: HLA class Ii diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial. Tissue Antigens 85(2): 117-126
Prentice, H.A.; Tomaras, G.D.; Geraghty, D.E.; Apps, R.; Fong, Y.; Ehrenberg, P.K.; Rolland, M.; Kijak, G.H.; Krebs, S.J.; Nelson, W.; DeCamp, A.; Shen, X.; Yates, N.L.; Zolla-Pazner, S.; Nitayaphan, S.; Rerks-Ngarm, S.; Kaewkungwal, J.; Pitisuttithum, P.; Ferrari, G.; McElrath, M.J.; Montefiori, D.C.; Bailer, R.T.; Koup, R.A.; O'Connell, R.J.; Robb, M.L.; Michael, N.L.; Gilbert, P.B.; Kim, J.H.; Thomas, R. 2015: HLA class Ii genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition. Science Translational Medicine 7(296): 296ra112
Pappas, D.; Hollenbach, J.; Coleman, A.L.; Gorin, M.B.; Yu, F.; Williams, K.; Noble, J.; Tranah, G.J. 2015: HLA class Ii genotypes are not associated with age related macular degeneration in a case-control, population-based study. Human Immunology 76(2-3): 142-145
Rangel-Gamboa, L.ía.; Vega-Memije, M.ía.E.; Acuña-Alonzo, V.íc.; Granados-Arriola, J. 2016: HLA class Ii in Mexican patients with pemphigus vulgaris: shared epitope for autoimmunity. Gaceta Medica de Mexico 152(5): 587-591
Thiagarajan, P. 2015: HLA class Ii meets β2-glycoprotein i. Blood 125(18): 2741
Kiani, J.; Hajilooi, M.; Furst, D.; Rezaei, H.; Shahryari-Hesami, S.; Kowsarifard, S.; Zamani, A.; Solgi, G. 2015: HLA class Ii susceptibility pattern for type 1 diabetes (T1D) in an Iranian population. International Journal of Immunogenetics 42(4): 279-286
Kamoun, M.; Phelan, D.; Noreen, H.; Marcus, N.; Klingman, L.; Gebel, H.M. 2017: HLA compatibility assessment and management of highly sensitized patients under the new kidney allocation system (KAS): A 2016 status report from twelve HLA laboratories across the U.S. Human Immunology 78(1): 19-23
Tambur, A.R.; Claas, F.H.J. 2015: HLA epitopes as viewed by antibodies: what is it all about?. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 15(5): 1148-1154
Kim, K.-H.; Jung, H.-Y.; Choi, J.-Y.; Cho, J.-H.; Park, S.-H.; Kim, Y.-L.; Kim, H.-K.; Huh, S.; Won, D.-I.; Kim, C.-D. 2015: HLA gene dosage effect on renal allograft survival. Transplantation Proceedings 47(3): 635-639
Mazdeh, M.; Taheri, M.; Sayad, A.; Bahram, S.; Omrani, M.D.; Movafagh, A.; Inoko, H.; Akbari, M.T.; Noroozi, R.; Hajilooi, M.; Solgi, G. 2016: HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis. Pharmacogenomics 17(5): 489-498
Inotai, D.; Szilvasi, A.; Benko, S.; Boros-Major, A.; Illes, Z.; Bors, A.; Kiss, K.P.; Rajczy, K.; Gelle-Hossó, A.; Buhler, S.; Nunes, J.M.; Sanchez-Mazas, A.; Tordai, A. 2015: HLA genetic diversity in Hungarians and Hungarian Gypsies: complementary differentiation patterns and demographic signals revealed by HLA-A, -B and -DRB1 in Central Europe. Tissue Antigens 86(2): 115-121
Profaizer, T.; Lázár-Molnár, E.; Close, D.W.; Delgado, J.C.; Kumánovics, A. 2016: HLA genotyping in the clinical laboratory: comparison of next-generation sequencing methods. Hla 88(1-2): 14-24
Nakamae, H.; Koh, H.; Katayama, T.; Nishimoto, M.; Hayashi, Y.; Nakashima, Y.; Nakane, T.; Nakamae, M.; Hirose, A.; Hino, M. 2015: HLA haploidentical peripheral blood stem cell transplantation using reduced dose of posttransplantation cyclophosphamide for poor-prognosis or refractory leukemia and myelodysplastic syndrome. Experimental Hematology 43(11): 921-929.E1
Cecka, J.M.; Reed, E.F.; Zachary, A.A. 2015: HLA high-resolution typing for sensitized patients: a solution in search of a problem?. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 15(4): 855-856
Nunes, K.; Zheng, X.; Torres, M.; Moraes, M.E.; Piovezan, B.Z.; Pontes, G.N.; Kimura, L.; Carnavalli, J.E.P.; Mingroni Netto, R.C.; Meyer, D. 2016: HLA imputation in an admixed population: An assessment of the 1000 Genomes data as a training set. Human Immunology 77(3): 307-312
Kowalewski, D.J.; Schuster, H.; Backert, L.; Berlin, C.; Kahn, S.; Kanz, L.; Salih, H.R.; Rammensee, H.-G.; Stevanovic, S.; Stickel, J.S. 2015: HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL). Proceedings of the National Academy of Sciences of the United States of America 112(2): E166-E175
Peper, J.Kerstin.; Bösmüller, H-Christian.; Schuster, H.; Gückel, B.; Hörzer, H.; Roehle, K.; Schäfer, R.; Wagner, P.; Rammensee, H-Georg.; Stevanović, S.; Fend, F.; Staebler, A. 2016: HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy. Oncoimmunology 5(5): E1065369
Maiers, M.; Halagan, M.; Joshi, S.; Ballal, H.S.; Jagannatthan, L.; Damodar, S.; Srinivasan, P.; Narayan, S.; Khattry, N.; Malhotra, P.; Minz, R.W.; Shah, S.A.; Rajagopal, R.; Cereb, N.; Yang, S.Y.; Parekh, S.; Mammen, J.; Daniels, D.; Weisdorf, D. 2014: HLA match likelihoods for Indian patients seeking unrelated donor transplantation grafts: a population-based study. LANCET. Haematology 1(2): E57-E63
Fleischhauer, K.; Beelen, D.W. 2016: HLA mismatching as a strategy to reduce relapse after alternative donor transplantation. Seminars in Hematology 53(2): 57-64
Petersdorf, E.W. 2015: HLA mismatching in transplantation. Blood 125(7): 1058-1059
Sullivan, P.M.; Warner, P.; Kemna, M.S.; Albers, E.L.; Law, S.P.; Weiss, N.S.; Law, Y.M. 2015: HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 34(7): 950-957
Szender, J.B.; Eng, K.H.; Matsuzaki, J.; Miliotto, A.; Gnjatic, S.; Tsuji, T.; Odunsi, K. 2016: HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer. Gynecologic Oncology 142(1): 158-162
Dos Santos Francisco, R.; Buhler, Séphane.; Nunes, Jé.Manuel.; Bitarello, Bárbara.Domingues.; França, G.Starvaggi.; Meyer, D.; Sanchez-Mazas, A. 2015: HLA supertype variation across populations: new insights into the role of natural selection in the evolution of HLA-A and HLA-B polymorphisms. Immunogenetics 67(11-12): 651-663
Kutty, J.; Hussey, S.; Broderick, A.M.; Quinn, S.; Bourke, B. 2015: HLA testing for coeliac disease in Ireland?. Irish Medical Journal 108(5): 133
Hutchinson, J.A. 2015: HLA typing. Transplantation 99(1): 6-7
Erlich, H.A. 2015: HLA typing using next generation sequencing: An overview. Human Immunology 76(12): 887-890
Mellet, J.; Gray, C.M.; Pepper, M.S. 2015: HLA typing: Conventional techniques v. next-generation sequencing. South African Medical Journal 106(1): 88-91
Thorvaldson, L.; Remberger, M.; Winiarski, J.; Omazic, B.; Fischler, B.ör.; Sundin, M. 2016: HLA, GVHD, and parenteral nutrition are risk factors for hepatic complications in pediatric HSCT. Pediatric Transplantation 20(1): 96-104
Lu, Y.; Wu, T.; Cao, X.; Zhao, Y.; Liu, D.; Sun, R.; Xiong, M.; Wei, Z.; Zhang, J.; Zhou, J.; Lu, D. 2016: HLA- haploidentical donor hematopoietic transplantation for severe aplastic anemia achieved comparable outcomes with HLA- unrelated donor transplantation. Zhonghua Xue Ye Xue Za Zhi 37(1): 35-38
Balas, A.; García-Sánchez, F.; Vicario, J.L. 2015: HLA-A allele dropout in sequence-specific oligonucleotide probe typing due to intronic polymorphism in the novel A*31:01:02:02 allele. Tissue Antigens 86(1): 56-57
Li, S.M.; Guo, H.; Yang, H.J.; Lv, M.Q.; Zhou, D.X. 2015: HLA-A gene polymorphisms contribute to osteoporosis susceptibility in postmenopausal Han Chinese women. Genetics and Molecular Research: Gmr 14(3): 10322-10330
Matthews, P.C.; Carlson, J.M.; Beloukas, A.; Malik, A.; Jooste, P.; Ogwu, A.; Shapiro, R.; Riddell, L.; Chen, F.; Luzzi, G.; Jesuthasan, G.; Jeffery, K.; Jojic, N.; Ndung'u, T.; Carrington, M.; Goulder, P.J.R.; Geretti, A.M.; Klenerman, P. 2016: HLA-A is a Predictor of Hepatitis B e Antigen Status in HIV-Positive African Adults. Journal of Infectious Diseases 213(8): 1248-1252
Zhang, W.; He, Y.; Wang, W.; Han, Z.; He, J.; Chen, N.; Dong, L.; Tao, S.; He, J.; Zhu, F.; Lv, H. 2015: HLA-A locus allelic dropout in Sanger sequence-based typing due to the single nucleotide polymorphism of exon 1. International Journal of Immunogenetics 42(6): 457-460
Yan, S.; Chen, S.-A.; Zhang, W.; Yang, F.; Yang, Y.; Zhu, Q.; Zhu, H.; Sun, X.; Jiang, M.; Su, Y.; Zhang, L.; Xing, Q.; Luo, X. 2016: HLA-A*02 alleles are associated with tetanus antitoxin-induced exanthematous drug eruptions in Chinese patients. Pharmacogenetics and Genomics 26(12): 538-546
Wang, R.-Z.; Zhang, D.-G.; Wu, R.; Hu, Y.-H.; Peng, Y.-C.; Chang, C.; Dong, T.; Wang, X.-Y. 2016: HLA-A*02-B*46 haplotype: an adverse prognostic factor in Han patients with nasopharyngeal carcinoma. Journal of Huazhong University of Science and Technology. Medical Sciences 36(5): 700-704
Fricke-Galindo, I.; Martínez-Juárez, I.E.; Monroy-Jaramillo, N.; Jung-Cook, H.; Falfán-Valencia, R.és.; Ortega-Vázquez, A.; Alonso-Vilatela, M.ía.E.; López-López, M. 2014: HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients. Pharmacogenomics 15(15): 1881-1891
Yang, K.L.; Ng, J.; Lazaro, A.; Hung, J.H.; Lin, P.Y. 2015: HLA-A*02:06:21, a novel variant of HLA-A*02:06, discovered in a Taiwanese bone marrow hematopoietic stem cell donor. Tissue Antigens (): -
Pei, Y.F.; Huang, H.N.; Li, H.C.; Shen, W.D. 2016: HLA-A*02:513, a novel HLA-A*02 allele. Hla 87(5): 382-383
Yang, K.L.; Lee, S.K.; Hung, J.H.; Lin, P.Y. 2015: HLA-A*02:541, a novel variant of HLA-A*02, discovered in a Taiwanese unrelated hematopoietic stem cell donor. Tissue Antigens 85(4): 290-291
Lin, C.Y.; Chang, C.L. 2016: HLA-A*11:134, a novel HLA-A*11 variant, identified by sequence-based typing in a Taiwanese individual. Hla 88(4): 195-196
Yang, K.L.; Hung, J.H.; Lin, P.Y. 2016: HLA-A*11:231, a novel variant of HLA-A*11, found in a Taiwanese hematopoietic stem cell donor. Hla 87(3): 170-171
Yang, K.L.; Hung, J.H.; Lin, P.Y. 2016: HLA-A*11:235Q, a novel HLA-A*11 variant, detected in a Taiwanese individual. Hla 87(6): 456-458
Sidahmed, A.M.Elhassan.; Anderson, J.; Stamm, L.; Khan, F.; Berka, N. 2016: HLA-A*23:01:19, a novel variant of HLA-A*23:01, discovered in a West African stem cell transplantation patient. Hla 88(3): 120-121
Demeester, S.; Balke, E.M.; Van der Auwera, B.J.; Gillard, P.; Hilbrands, R.; Lee, D.; Van de Velde, U.; Ling, Z.; Roep, B.O.; Pipeleers, D.G.; Gorus, F.K.; Keymeulen, B. 2016: HLA-A*24 Carrier Status and Autoantibody Surges Posttransplantation Associate with Poor Functional Outcome in Recipients of an Islet Allograft. Diabetes Care 39(6): 1060-1064
Zhu, Y.-Y.; Qiang, W.; Shen, G.; Zou, J.; Liu, G.-J. 2016: HLA-A*24:02:96, a novel variant of HLA-A*24:02:01:01, identified in a Chinese individual by sequence-based typing. Hla 87(3): 171-172
Yang, K.L.; Lee, S.K.; Hung, J.H.; Lin, P.Y. 2015: HLA-A*24:287, a novel variant of HLA-A*24:02:01:01, discovered in a Taiwanese hematopoietic stem cell donor. Tissue Antigens 85(1): 68-69
Yang, K.L.; Hung, J.H.; Lin, P.Y. 2016: HLA-A*24:333, a novel HLA-A*24 variant, discovered in a Taiwanese individual. Hla 87(6): 458-459
Yang, K.L.; Hung, J.H.; Lin, P.Y. 2016: HLA-A*24:334, a novel variant of HLA-A*24, discovered in a Taiwanese individual. Hla 87(5): 390-391
Sayad, A.; Akbari, M.T.; Mehdizadeh, M.; Taheri, M.; Hajifathali, A. 2014: HLA-A*26 and susceptility of iranian patients with non-Hodgkin lymphoma. Iranian Journal of Immunology: Iji 11(4): 269-274
Balas, A.; Sánchez-Gordo, F.; Gomez-Zumaquero, J.M.; Vicario, J.L. 2017: HLA-A*30:99 shows a new amino acid position 156 within HLA-A*30 subtypes. Hla 89(1): 53-54
Zhang, J.; Zhao, L.; Wang, B.; Gao, J.; Wang, L.; Li, L.; Cui, B.; Hu, M.; Hong, J.; Gu, W.; Wang, W.; Ning, G. 2016: HLA-A*33-DR3 and A*33-DR9 haplotypes enhance the risk of type 1 diabetes in Han Chinese. Journal of Diabetes Investigation 7(4): 514-521
Mercado, E.S.; Espino, F.E.; Perez, M.L.M.; Bilar, J.M.; Bajaro, J.D.P.; Huy, N.T.; Baello, B.Q.; Kikuchi, M.; Hirayama, K. 2015: HLA-A*33:01 as protective allele for severe dengue in a population of Filipino children. Plos one 10(2): E0115619
Yang, K.L.; Hung, J.H.; Lin, P.Y. 2016: HLA-A*33:03:31, a novel variant of HLA-A*33:03, discovered in a Taiwanese individual. Hla 87(6): 459-460
Kim, K.M.; Han, O.J.; Kang, M.S.; Huh, J.Y. 2016: HLA-A*33:102, a novel allele identified by sequence-based typing in cord blood from a Korean woman. Hla 87(5): 391-392
Ulrich, S.; Posch, U.; Helmberg, W.; Schlenke, P. 2016: HLA-A*68:02:11, a new HLA-A*68 allele identified during family HLA typing. Hla 88(4): 197-198
He, Y.; Zhang, W.; Chen, N.; Wang, W.; He, J.; Han, Z.; Tao, S.; Dong, L.; He, J.; Zhu, F.; Lv, H. 2016: HLA-A, -B and -DRB1 allele and haplotype frequencies of 8333 Chinese Han from the Zhejiang province, China. International Journal of Immunogenetics 43(2): 86-95
Kwok, J.; Guo, M.; Yang, W.; Lee, C.K.; Chan, N.K.; Ho, J.; Tang, W.H.; Chan, Y.S.; Middleton, D.; Lu, L.W.; Chan, G.C.F. 2016: HLA-A, -B and -DRB1 genotyping and haplotype frequencies of 3892 cord blood units in the Hong Kong Chinese Cord Blood Registry. Human Immunology 77(12): 1109-1110
Bettencourt, B.F.; Santos, M.R.; Pereira, J.; Amaro, B.; Fialho, R.; Meneses, R.; Couto, A.R.; Bruges Armas, J.ác. 2016: HLA-A, -B, -C, -DQA1, -DQB1, -DRB1, -E, -F and -G genotyping of 130 individuals from Terceira Island, Azores, Portugal. Human Immunology 77(6): 445-446
Rudolph, E.N.; Dunn, T.B.; Mauer, D.; Noreen, H.; Sutherland, D.E.R.; Kandaswamy, R.; Finger, E.B. 2016: HLA-A, -B, -C, -DR, and -DQ Matching in Pancreas Transplantation: Effect on Graft Rejection and Survival. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 16(8): 2401-2412
Sulcebe, G.; Shyti, E. 2016: HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in a population of 432 healthy unrelated individuals from Albania. Human Immunology 77(8): 620-621
Tan, L.-K.; Mohd-Farid, B.; Salsabil, S.; Heselynn, H.; Wahinuddin, S.; Lau, I.-S.; Gun, S.-C.; Nor-Suhaila, S.; Eashwary, M.; Mohd-Shahrir, M.S.; Ainon, M.-M.; Azmillah, R.; Muhaini, O.; Shahnaz, M.; Too, C.-L. 2016: HLA-A, -B, -C, -DRB1 and -DQB1 alleles and haplotypes in 951 Southeast Asia Malays from Peninsular Malaysia. Human Immunology 77(10): 818-819
Kwok, J.; Guo, M.; Yang, W.; Lee, C.K.; Ho, J.; Tang, W.H.; Chan, Y.S.; Middleton, D.; Lu, L.W.; Chan, G.C.F. 2016: HLA-A, -B, -C, and -DRB1 genotyping and haplotype frequencies for a Hong Kong Chinese population of 7595 individuals. Human Immunology 77(12): 1111-1112
Fionnuala, W.; Derek, M. 2015: HLA-A, -B, -C, and -DRB1 genotyping of 1000 Northern Irish individuals from Belfast, Northern Ireland in the United Kingdom. Human Immunology 76(6): 395-396
Schäfer, C.; Sauter, J.ür.; Riethmüller, T.; Kashi, Z.M.; Schmidt, A.H.; Barriga, F.J. 2016: HLA-A, -B, -DRB1 allele and haplotype frequencies of 920 cord blood units from Central Chile. Human Immunology 77(8): 622-623
Ravazzi-Gauch, C.; Bajay, M.M.; Caldas, H.C.; Abbud-Filho, M. 2016: HLA-A, -B, and -DRB1 allele and haplotype diversity in a cohort of Brazilian renal transplant candidates. Human Immunology 77(6): 464-469
Buhler, S.; Nunes, J.M.; Sanchez-Mazas, A.; Richard, L. 2015: HLA-A, B and DRB1 genetic heterogeneity in Quebec. International Journal of Immunogenetics 42(2): 69-77
Park, H.; Lee, Y.-J.; Song, E.Y.; Park, M.H. 2016: HLA-A, HLA-B and HLA-DRB1 allele and haplotype frequencies of 10 918 Koreans from bone marrow donor registry in Korea. International Journal of Immunogenetics 43(5): 287-296
Shao, L.N.; Zhang, S.T.; Yu, W.J.; Zhou, S.H.; Duan, Y.; Pan, L.Z.; Wang, N.; Hu, Y. 2016: HLA-A, HLA-B, HLA-DRB1 allele and haplotype frequencies of 14,529 Chinese Han bone marrow donors living in Dalian, China. International Journal of Immunogenetics 43(2): 79-85
Saito, P.íc.K.; Yamakawa, R.H.; Noguti, E.N.; Bedendo, G.B.; Júnior, W.V.ís.d.S.; Yamada, S.ér.S.; Borelli, S.D. 2016: HLA-A, HLA-B, and HLA-DRB1 Allele and Haplotype Frequencies in Renal Transplant Candidates in a Population in Southern Brazil. Journal of Clinical Laboratory Analysis 30(3): 258-265
Testi, M.; Battarra, M.; Lucarelli, G.; Isgro, A.; Morrone, A.; Akinyanju, O.; Wakama, T.; Nunes, J.M.; Andreani, M.; Sanchez-Mazas, A. 2015: HLA-A-B-C-DRB1-DQB1 phased haplotypes in 124 Nigerian families indicate extreme HLA diversity and low linkage disequilibrium in Central-West Africa. Tissue Antigens 86(4): 285-292
Srivastava, R.; Khan, A.A.; Spencer, D.; Vahed, H.; Lopes, P.P.; Thai, N.T.U.; Wang, C.; Pham, T.T.; Huang, J.; Scarfone, V.M.; Nesburn, A.B.; Wechsler, S.L.; BenMohamed, L. 2015: HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic mice against ocular herpes. Journal of Immunology 194(5): 2232-2248
Wang, Z-Xuan.; Wang, H-Fu.; Tan, L.; Sun, F-Rong.; Tan, M-Shan.; Tan, C-Chen.; Jiang, T.; Tan, L.; Yu, J-Tai. 2017: HLA-A2 Alleles Mediate Alzheimer's Disease by Altering Hippocampal Volume. Molecular Neurobiology 54(4): 2469-2476
Hahn, A.B.; Bravo-Egana, V.; Jackstadt, J.L.; Conti, D.J.; Duquesnoy, R.J. 2015: HLA-A2 reactive antibodies in a patient who types as HLA-A2: the importance of high resolution typing and epitope-based antibody analysis. Transplant Immunology 32(3): 141-143
El-Beeli, M.; Al-Mahrooqi, S.H.; Youssef, R.M.; Zadjali, F.; Balkhair, A.; Al-Balushi, M.S.; Said, E.A.; Hasson, S.S.; Al-Jabri, A.A. 2016: HLA-A68 and HLA-B15 alleles correlate with poor immune response among AIDS patients on combined antiretroviral therapy. Human Immunology 77(6): 490-497
Sukasem, C.; Jantararoungtong, T.; Kuntawong, P.; Puangpetch, A.; Koomdee, N.; Satapornpong, P.; Supapsophon, P.; Klaewsongkram, J.; Rerkpattanapipat, T. 2016: HLA-B (*) 58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand. Frontiers in Pharmacology 7: 186
Puangpetch, A.; Koomdee, N.; Chamnanphol, M.; Jantararoungtong, T.; Santon, S.; Prommas, S.; Hongkaew, Y.; Sukasem, C. 2014: HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivity. Frontiers in Genetics 5: 478
He, Y.; Wang, W.; Han, Z.; He, J.; Chen, N.; Dong, L.; Tao, S.; Zhang, W.; He, J.; Zhu, F.; Lv, H. 2016: HLA-B allele dropout in PCR sequence-specific oligonucleotide probe typing due to intronic polymorphism in the novel B*58:01:01:02 allele. International Journal of Immunogenetics 43(3): 180-183
Xiong, H.; Huang, J.; Rong, X.; Zhang, M.; Huang, K.; Xu, R.; Wang, M.; Li, C.; Liao, Q.; Xia, W.; Luo, G.; Ye, X.; Lu, L.; Fu, Y.; Guo, T.; Nelson, K. 2015: HLA-B alleles B*15:01 and B*15:02: opposite association with hepatitis C virus infection in Chinese voluntary blood donors. Intervirology 58(2): 80-87
Vanni, I.; Ugolotti, E.; Larghero, P.; Biassoni, R. 2015: HLA-B and HLA-C Supratyping by Pyrosequencing®. Methods in Molecular Biology 1315: 133-151
Raghavan, M.; Geng, J. 2015: HLA-B polymorphisms and intracellular assembly modes. Molecular Immunology 68(2 Part A): 89-93
Yang, K.L.; Lin, P.Y. 2017: HLA-B*13:95, a novel variant of HLA-B*13, discovered in a Taiwanese blood donor. Hla 89(1): 54-55
Nguyen, D.V.; Chu, H.C.; Nguyen, D.V.; Phan, M.H.; Craig, T.; Baumgart, K.; van Nunen, S. 2015: HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese. Asia Pacific Allergy 5(2): 68-77
Rampim, G.F.; Araújo, A.S.; Mourão, T.B.; Furuyama, T.N.; Gerbase-DeLima, M. 2016: HLA-B*15:04:04, a novel HLA allele identified during proficiency testing in Brazil. Hla 88(4): 200-201
Yang, K.L.; Lee, S.K.; Hung, J.H.; Lin, P.Y. 2015: HLA-B*15:327, a novel variant of HLA-B*15, discovered in a Taiwanese unrelated hematopoietic stem cell donor. Tissue Antigens 86(1): 60-61
Yang, K.L.; Lin, P.Y. 2016: HLA-B*15:388, a novel variant of HLA-B*15, discovered in a Taiwanese individual. Hla 88(4): 204-205
Li, X-F.; Li, G-J.; Zhang, X.; Li, J-P. 2015: HLA-B*35:168, a novel HLA allele identified in a Chinese platelet donor. Tissue Antigens (): -
Cheung, C.-L.; Sing, C.-W.; Tang, C.S.M.; Cheng, V.K.F.; Pirmohamed, M.; Choi, C.-H.; Hung, C.-S.; Lau, E.Y.-F.; Lee, K.F.; Mak, M.W.-H.; Leung, J.Y.Y.; Wong, T.-W.; Ho, A.Y.Y.; Chan, K.-W.; Hung, V.; Tam, V.; Siu, S.-C.; Pang, H.-K.; Wat, W.Z.-M.; Lee, H.H.-Y.; Chung, C.-T.; Hue, R.S.-M.; Sham, P.-C.; Cheung, B.M.Y.; Wong, I.C.K.; Tan, K.C.B.; Kung, A. W.C. 2016: HLA-B*38:02:01 predicts carbimazole/methimazole-induced agranulocytosis. Clinical Pharmacology and Therapeutics 99(5): 555-561
Fusco, C.; Azzarone, R.; Penta, R.; Canossi, A.; Di Iulio, B.; Toriello, M.; Auriemma, L.; Pagano, M.; Poggi, V.; Papola, F. 2015: HLA-B*38:55Q: a new alternatively expressed allele identified in a three-generation Italian family. International Journal of Immunogenetics 42(4): 294-296
Díaz-Peña, R.; Vidal-Castiñeira, J.R.ón.; López-Vázquez, A.; López-Larrea, C. 2016: HLA-B*40:01 Is Associated with Ankylosing Spondylitis in HLA-B27-positive Populations. Journal of Rheumatology 43(6): 1255-1256
Yang, K.L.; Hung, J.H.; Lin, P.Y. 2016: HLA-B*40:01:44, a novel variant of HLA-B*40:01, discovered in a Taiwanese hematopoietic stem cell donor. Hla 87(3): 179-180
Moon, J.; Kim, T.-J.; Lim, J.-A.; Sunwoo, J.-S.; Byun, J.-I.; Lee, S.-T.; Jung, K.-H.; Park, K.-I.; Jung, K.-Y.; Jeon, D.; Yu, K.-S.; Jang, I.-J.; Chu, K.; Lee, S.K. 2016: HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption. Epilepsia 57(11): 1879-1886
Li, X.-F.; Zhang, X.; Lin, F.-Q.; Zhang, K.-L.; Li, J.-P. 2016: HLA-B*40:167, a novel allele, identified in a Chinese individual. Hla 87(5): 392-394
Yang, K.L.; Hung, J.H.; Lin, P.Y. 2016: HLA-B*40:306, a novel variant of HLA-B*40, discovered in a Taiwanese bone marrow hematopoietic stem cell donor. Hla 87(1): 53-54
Yang, K.L.; Hung, J.H.; Lin, P.Y. 2016: HLA-B*40:326, a novel variant of HLA-B*40, discovered in a Taiwanese blood donor. Hla 87(5): 394-395
Yang, K.L.; Hung, J.H.; Lin, P.Y. 2016: HLA-B*40:327, a novel HLA-B*40 variant, discovered in a Taiwanese blood donor. Hla 87(5): 395-397
Yang, K.L.; Chen, S.-P.; Lin, P.Y. 2016: HLA-B*40:329, a novel HLA-B*40 variant, identified in a Taiwanese individual. Hla 88(1-2): 49-50
Paakkanen, R.; Haaramo, A.; Kolho, K-Leena.; Ruuska, T.; Lokki, M-Liisa. 2016: HLA-B*44 May Be a Marker for Orofacial Granulomatosis. Journal of pediatric gastroenterology and nutrition 63(5): e121-e122
Wang, J.; Ji, X.; Ou, G.J.; Su, P.C.; Liu, Z. 2016: HLA-B*46:40:02, a novel HLA-B*46 allele identified in a Chinese individual by sequence-based typing. Hla 87(6): 462-464
Yang, K.L.; Lee, S.K.; Hung, J.H.; Lin, P.Y. 2015: HLA-B*46:60, a novel variant of HLA-B*46:01:01, detected in a Taiwanese unrelated hematopoietic stem cell donor by sequence-based typing. Tissue Antigens 85(2): 145-146
Yang, K.L.; Hung, J.H.; Lin, P.Y. 2016: HLA-B*46:65, a novel HLA-B*46 variant, detected in a Taiwanese unrelated bone marrow stem cell donor. Hla 87(5): 397-398
Ruiz-Iruela, C.; Padullés-Zamora, Núria.; Podzamczer-Palter, D.; Alonso-Pastor, A.; Candás-Estébanez, B.; Alía-Ramos, P.; Padró-Miquel, A. 2016: HLA-B*57: 01 genotyping in the prevention of hypersensitivity to abacavir: 5 years of experience. Pharmacogenetics and genomics 26(8): 390-396
Xu, C.-F.; Johnson, T.; Wang, X.; Carpenter, C.; Graves, A.P.; Warren, L.; Xue, Z.; King, K.S.; Fraser, D.J.; Stinnett, S.; Briley, L.P.; Mitrica, I.; Spraggs, C.F.; Nelson, M.R.; Tada, H.; du Bois, A.; Powles, T.; Kaplowitz, N.; Pandite, L.N. 2016: HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 22(6): 1371-1377
Mugwagwa, A.N.; Fischer, R.; Zailan, I. 2016: HLA-B*5801: a genetic susceptibility to allopurinol-induced DRESS. Medical Journal of Australia 204(4): 159-160
Cheng, L.; Xiong, Y.; Qin, C.Z.; Zhang, W.; Chen, X.P.; Li, J.; Zhou, H.H. 2015: HLA-B*58:01 is strongly associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese patients: a multicentre retrospective case-control clinical study. British Journal of Dermatology 173(2): 555-558
Ji, X.; Wang, J.; Ou, G.J.; Wang, C.Y.; Liu, Z. 2015: HLA-B*58:63, a novel allele identified by sequence-based typing in a Chinese bone marrow voluntary donor. Tissue Antigens 85(1): 73-75
Hong, S.S.; Han, O.J.; Kang, M.S.; Huh, J.Y. 2015: HLA-B*59:09, a novel allele identified by sequence-based typing in a cord blood donated by a Korean woman. Tissue Antigens 86(2): 146-147
Wakefield, D.; Yates, W.; Amjadi, S.; McCluskey, P. 2016: HLA-B27 Anterior Uveitis: Immunology and Immunopathology. Ocular Immunology and Inflammation 24(4): 450-459
Kidnapillai, S.; Sirisena, N.D.; Dissanayake, V.H. 2016: HLA-B27 allele frequency in Sri Lankan patients with spondyloarthritides. Ceylon Medical Journal 61(2): 71-73
Queiro, R.én.; Morante, I.; Cabezas, I.án.; Acasuso, B.én. 2016: HLA-B27 and psoriatic disease: a modern view of an old relationship. Rheumatology 55(2): 221-229
Nessa, A.; Tabassum, S.; Sultana, S. 2014: HLA-B27 antigen frequency among suspected Spondyloarthropathy patients attaining a tertiary level hospital of Bangladesh. Bangladesh Medical Research Council Bulletin 40(3): 102-106
Skalska, U.; Kozakiewicz, A.; Maśliński, W.ło.; Jurkowska, M. 2015: HLA-B27 detection - comparison of genetic sequence-based method and flow cytometry assay. Reumatologia 53(2): 74-78
Srivastava, R.; Agnihotry, S.; Aggarwal, R.; Bajpai, P.; Aggarwal, A. 2015: HLA-B27 subtypes in enthesitis-related arthritis category of juvenile idiopathic arthritis and ankylosing spondylitis in northern India. Clinical and Experimental Rheumatology 33(6): 931-935
Marroquin Belaunzaran, O.; Kleber, S.; Schauer, S.; Hausmann, M.; Nicholls, F.; Van den Broek, M.; Payeli, S.; Ciurea, A.; Milling, S.; Stenner, F.; Shaw, J.; Kollnberger, S.; Bowness, P.; Petrausch, U.; Renner, C. 2015: HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats. Plos one 10(6): E0130811
Horie, Y.; Meguro, A.; Ohta, T.; Lee, E.Bong.; Namba, K.; Mizuuchi, K.; Iwata, D.; Mizuki, N.; Ota, M.; Inoko, H.; Ishida, S.; Ohno, S.; Kitaichi, N. 2017: HLA-B51 Carriers are Susceptible to Ocular Symptoms of Behçet Disease and the Association between the Two Becomes Stronger towards the East along the Silk Road: A Literature Survey. Ocular Immunology and Inflammation 25(1): 37-40
Karino, K.; Kono, M. 2016: HLA-B52-positive Aortitis with Antineutrophil Cytoplasmic Antibody-associated Vasculitis. Internal Medicine 55(23): 3545
Barker, E.; Evans, D.T. 2016: HLA-C Downmodulation by HIV-1 Vpu. Cell Host and Microbe 19(5): 570-571
Vince, N.; Li, H.; Ramsuran, V.; Naranbhai, V.; Duh, F.-M.; Fairfax, B.P.; Saleh, B.; Knight, J.C.; Anderson, S.K.; Carrington, M. 2016: HLA-C Level Is Regulated by a Polymorphic Oct1 Binding Site in the HLA-C Promoter Region. American Journal of Human Genetics 99(6): 1353-1358
Stelma, F.; Jansen, L.; Sinnige, M.J.; van Dort, K.A.; Takkenberg, R.B.; Janssen, H.L.A.; Reesink, H.W.; Kootstra, N.A. 2016: HLA-C and KIR combined genotype as new response marker for HBeAg-positive chronic hepatitis B patients treated with interferon-based combination therapy. Journal of Viral Hepatitis 23(8): 652-659
Cardili, R.N.; Deghaide, N.S.; Mendes-Junior, C.T.; Donadi, E.A.; Souza, C.S. 2016: HLA-C and TNF gene polymorphisms are associated with psoriasis in Brazilian patients. International Journal of Dermatology 55(1): E16-E22
Meuleman, T.; van Beelen, E.; Kaaja, R.J.; van Lith, J.M.M.; Claas, F.H.J.; Bloemenkamp, K.W.M. 2016: HLA-C antibodies in women with recurrent miscarriage suggests that antibody mediated rejection is one of the mechanisms leading to recurrent miscarriage. Journal of Reproductive Immunology 116: 28-34
Sips, M.; Liu, Q.; Draghi, M.; Ghebremichael, M.; Berger, C.T.; Suscovich, T.J.; Sun, Y.; Walker, B.D.; Carrington, M.; Altfeld, M.; Brouckaert, P.; De Jager, P.L.; Alter, G. 2016: HLA-C levels impact natural killer cell subset distribution and function. Human Immunology 77(12): 1147-1153
Jung, E.S.; Cheon, J.H.; Lee, J.H.; Park, S.J.; Jang, H.W.; Chung, S.H.; Park, M.H.; Kim, T.-G.; Oh, H.-B.; Yang, S.-K.; Park, S.H.; Han, J.Y.; Hong, S.P.; Kim, T.I.; Kim, W.H.; Lee, M.G. 2016: HLA-C*01 is a Risk Factor for Crohn's Disease. Inflammatory Bowel Diseases 22(4): 796-806
Talamonti, M.; Galluzzo, M.; Chimenti, S.; Costanzo, A. 2016: HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-up. Journal of the American Academy of Dermatology 74(2): 374-375
Li, K.; Huang, C.Chris.; Randazzo, B.; Li, S.; Szapary, P.; Curran, M.; Campbell, K.; Brodmerkel, C. 2016: HLA-C*06:02 Allele and Response to IL-12/23 Inhibition: Results from the Ustekinumab Phase 3 Psoriasis Program. Journal of Investigative Dermatology 136(12): 2364-2371
Shepherd, B.L.; Ferrand, R.; Rowland-Jones, S.; Yindom, L.-M. 2016: HLA-C*06:04:02 a novel HLA-C allele isolated from donors of Southern African descent. Hla 87(5): 402-403
Han, Z.-D.; He, J.; Wang, W.; Zhu, F.-M.; Lv, H.-J. 2015: HLA-C*06:103, a novel allele was identified in a Chinese patient awaiting hematopoietic stem cell transplantation. Tissue Antigens 85(6): 510-511
Testi, M.; Andreani, M.; Galluccio, T.; Guagnano, A.; Paladini, E. 2015: HLA-C*07:02:60, a variant of HLA-C*07 found in an unrelated volunteer stem cell donor. Tissue Antigens 85(1): 77-78
Yang, K.L.; Hung, J.H.; Lin, P.Y. 2016: HLA-C*07:486, a novel HLA-C*07 variant, detected in a Taiwanese individual. Hla 87(5): 404-405
Shepherd, B.L.; Bandason, T.; Ferrand, R.; Rowland-Jones, S.; Yindom, L.-M. 2016: HLA-C*16:01:01:02, a recently isolated HLA class i allele from Southern Africa. Hla 87(6): 470-471
Galluzzo, M.; Andreani, M.; Testi, M.; Chimenti, S.; Talamonti, M. 2016: HLA-C*18:01: a Rare Allele in the European Caucasian Population Coinciding with Difficult-to-Treat Plaque Psoriasis. Molecular Diagnosis and Therapy 20(3): 227-230
Dabiri, S.; Ghadimi, F.; Firouzifar, M.; Yazdani, N.; Mohammad-Amoli, M.; Vakili, V.; Mahvi, Z. 2016: HLA-Cw Allele Frequency in Definite Meniere's Disease Compared to Probable Meniere's Disease and Healthy Controls in an Iranian Sample. Iranian Journal of Otorhinolaryngology 28(87): 262-266
Caldarola, G.; Sgambato, A.; Fanali, C.; Moretta, G.; Farina, M.; Lucchetti, D.; Peris, K.; De Simone, C. 2016: HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patients. Pharmacogenetics and Genomics 26(9): 423-427
Thorleifsdottir, R.H.; Sigurdardottir, S.L.; Sigurgeirsson, B.; Olafsson, J.H.; Petersen, H.; Sigurdsson, M.I.; Gudjonsson, J.E.; Johnston, A.; Valdimarsson, H. 2016: HLA-Cw6 homozygosity in plaque psoriasis is associated with streptococcal throat infections and pronounced improvement after tonsillectomy: a prospective case series. Journal of the American Academy of Dermatology 75(5): 889-896
Álvaro-Benito, M.; Wieczorek, M.; Sticht, J.; Kipar, C.; Freund, C. 2015: HLA-DMA polymorphisms differentially affect MHC class Ii peptide loading. Journal of Immunology 194(2): 803-816
Arnaiz-Villena, A.; Palacio-Grüber, J.; Muñiz, E.; Rey, D.; Recio, M.J.; Campos, C.; Martinez-Quiles, N.; Martin-Villa, J.M.; Martinez-Laso, J. 2016: HLA-DMB in Amerindians: Specific linkage of DMB*01:03:01/DRB1 alleles. Human Immunology 77(5): 389-394
Jia, M.; Han, J.; Hang, D.; Jiang, J.; Wang, M.; Wei, B.; Dai, J.; Zhang, K.; Guo, L.; Qi, J.; Ma, H.; Shi, J.; Ren, J.; Hu, Z.; Dai, M.; Li, N. 2016: HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(6): 8019-8025
Ollila, H.M.; Ravel, J.-M.; Han, F.; Faraco, J.; Lin, L.; Zheng, X.; Plazzi, G.; Dauvilliers, Y.; Pizza, F.; Hong, S.-C.; Jennum, P.; Knudsen, S.; Kornum, B.R.; Dong, X.S.; Yan, H.; Hong, H.; Coquillard, C.; Mahlios, J.; Jolanki, O.; Einen, M.; Arnulf, I.; Lavault, S.; Högl, B.; Frauscher, B.; Crowe, C.; Partinen, M.; Huang, Y.S.; Bourgin, P.; Vaarala, O.; Désautels, A.; Montplaisir, J.; Mack, S.J.; Mindrinos, M.; Fernandez-Vina, M.; Mignot, E. 2015: HLA-DPB1 and HLA class i confer risk of and protection from narcolepsy. American Journal of Human Genetics 96(1): 136-146
Hilhorst, M.; Arndt, F.; Joseph Kemna, M.; Wieczorek, S.; Donner, Y.; Wilde, B.; Thomas Epplen, Jörg.; van Paassen, P.; Cohen Tervaert, J.Willem. 2016: HLA-DPB1 as a Risk Factor for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Cohort Study. Arthritis and Rheumatology 68(7): 1721-1730
Wu, Z.; Wu, Q.; Xu, J.; Chen, S.; Sun, F.; Li, P.; Bai, Y.; Zheng, W.; Chen, H.; Zhang, F.; Li, Y. 2017: HLA-DPB1 variant rs3117242 is associated with anti-neutrophil cytoplasmic antibody-associated vasculitides in a Han Chinese population. International Journal of Rheumatic Diseases 20(8): 1009-1015
Leiro-Fernández, V.; Valverde, D.; Vázquez-Gallardo, R.; Constenla-Caramés, L.ía.; Del Campo-Pérez, V.íc.; Fernández-Villar, A. 2016: HLA-DQ B1*0201 and A1*0102 Alleles Are not Responsible for Antituberculosis Drug-Induced Hepatotoxicity Risk in Spanish Population. Frontiers in Medicine 3: 34
Lim, W.H.; Chapman, J.R.; Coates, P.T.; Lewis, J.R.; Russ, G.R.; Watson, N.; Holdsworth, R.; Wong, G. 2016: HLA-DQ Mismatches and Rejection in Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology: Cjasn 11(5): 875-883
Sarabu, N.; Hricik, D.E. 2016: HLA-DQ Mismatching: Mounting Evidence for a Role in Kidney Transplant Rejection. Clinical Journal of the American Society of Nephrology: Cjasn 11(5): 759-760
Tafti, M. 2015: HLA-DQ allele competition in narcolepsy: where is the evidence?. Sleep 38(1): 153-154
Ogese, M.O.; Saide, K.; Faulkner, L.; Whitaker, P.; Peckham, D.; Alfirevic, A.; Baker, D.M.; Sette, A.; Pirmohamed, M.; Park, B.K.; Naisbitt, D.J. 2015: HLA-DQ allele-restricted activation of nitroso sulfamethoxazole-specific CD4-positive T lymphocytes from patients with cystic fibrosis. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 45(8): 1305-1316
Tambur, A.R. 2016: HLA-DQ antibodies: are they real? Are they relevant? Why so many?. Current Opinion in Organ Transplantation 21(4): 441-446
Ochi, Y.; Hashimoto, S.; Kawabe, N.; Murao, M.; Nakano, T.; Kan, T.; Nakaoka, K.; Ohki, M.; Kurashita, T.; Takamura, T.; Nomura, S.; Nishikawa, T.; Fukui, A.; Osakabe, K.; Ichino, N.; Yoshioka, K. 2017: HLA-DQ gene polymorphisms are associated with hepatocellular carcinoma and hepatitis B surface antigen in chronic hepatitis B virus infection. Hepatology Research: the Official Journal of the Japan Society of Hepatology 47(8): 755-766
Mejía-León, M.E.; Ruiz-Dyck, K.M.; Calderón de la Barca, A.M. 2015: HLA-DQ genetic risk gradient for type 1 diabetes and celiac disease in northwestern Mexico. Revista de Gastroenterologia de Mexico 80(2): 135-143
Stoupa, A.; Dorchy, H. 2016: HLA-DQ genotypes - but not immune markers - differ by ethnicity in patients with childhood onset type 1 diabetes residing in Belgium. Pediatric Diabetes 17(5): 342-350
Pisapia, L.; Camarca, A.; Picascia, S.; Bassi, V.; Barba, P.; Del Pozzo, G.; Gianfrani, C. 2016: HLA-DQ2.5 genes associated with celiac disease risk are preferentially expressed with respect to non-predisposing HLA genes: Implication for anti-gluten T cell response. Journal of Autoimmunity 70: 63-72
Lv, N.; Wang, Z.; Dang, A.; Zhu, X.; Liu, Y.; Zheng, D.; Liu, G. 2015: HLA-DQA1, DQB1 and DRB1 alleles associated with Takayasu arteritis in the Chinese Han population. Human Immunology 76(4): 241-244
Shimokawa, P.Tadashi.; Targa, Lília.Spaleta.; Yamamoto, L.; Rodrigues, J.Cristian.; Kanunfre, K.Aparecida.; Okay, T.Suely. 2016: HLA-DQA1/B1 alleles as putative susceptibility markers in congenital toxoplasmosis. Virulence 7(4): 456-464
Moon, S.-H.; Jeong, K.-H.; Kim, S.-K.; Chung, J.-H.; Shin, M.K.; Lee, M.-H. 2016: HLA-DQB1 gene polymorphisms and non-segmental vitiligo: a case-control study in the Korean population. Journal of Dermatological Science 82(1): 48-50
Zhou, D.; Jin, S.-Z.; Zou, H.-Y. 2017: HLA-DQB1*03:01:34, a novel allele, which has arisen by silent mutation in codon 87. Hla 89(1): 62-64
Gao, S.-Q.; Tao, H.; Wang, D.-M.; Li, Z. 2015: HLA-DQB1*05:10, a variant of HLA-DQB1*05:01, detected in a Chinese individual by cloning and sequencing. Tissue Antigens 86(4): 304-305
Sapir-Pichhadze, R.; Tinckam, K.; Quach, K.; Logan, A.G.; Laupacis, A.; John, R.; Beyene, J.; Kim, S.J. 2015: HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 15(1): 137-148
Mendoza, A.S.; Qing, X.; Dungo, M.; Lasky, J.; Panosyan, E.; Cai, J. 2016: HLA-DR antigen-positive acute promyelocytic leukemia. Experimental and Molecular Pathology 101(2): 197-200
Vester, H.; Dargatz, P.; Huber-Wagner, S.; Biberthaler, P.; van Griensven, M. 2015: HLA-DR expression on monocytes is decreased in polytraumatized patients. European Journal of Medical Research 20: 84
Blazekovic, F.; Odukoya, D.; Butler, S.N.; Mauro, J.A.; Ramsamooj, M.; Puleo, E.; Szekeres, K.; Dana, D.; Kumar, S.; Ragupathi, G.; Blanck, G. 2016: HLA-DR peptide occupancy can be regulated with a wide variety of small molecules. Human Vaccines and Immunotherapeutics 12(3): 593-598
Krogman, A.; Tilahun, A.; David, C.S.; Chowdhary, V.R.; Alexander, M.P.; Rajagopalan, G. 2017: HLA-DR polymorphisms influence in vivo responses to staphylococcal toxic shock syndrome toxin-1 in a transgenic mouse model. Hla 89(1): 20-28
Pow Sang, L.; Surls, J.; Mendoza, M.; Casares, S.; Brumeanu, T. 2015: HLA-DR*0401 expression in the NOD mice prevents the development of autoimmune diabetes by multiple alterations in the T-cell compartment. Cellular Immunology 298(1-2): 54-65
Wen, J.; Xie, K.; Zhang, M.; Chen, J.; Zhang, J.; Cheng, D.; Li, X.; Ji, S.; Liu, Z. 2016: HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy. Medicine 95(37): E4809
Chan, D.V.; Flynn, J.; Ziegler, R.; Wong, H.K. 2015: HLA-DR1 in familial frontal fibrosing alopecia. Journal of the American Academy of Dermatology 73(1): E39
Jin, B.; Wu, B.W.; Wen, Z.C.; Shi, H.M.; Zhu, J. 2016: HLA-DR3 antigen in the resistance to idiopathic dilated cardiomyopathy. Brazilian Journal of Medical and Biological Research 49(4): E5131
Esmaeilzadeh, H.; Nabavi, M.; Amirzargar, A.A.; Aryan, Z.; Arshi, S.; Bemanian, M.H.; Fallahpour, M.; Mortazavi, N.; Rezaei, N. 2015: HLA-DRB and HLA-DQ genetic variability in patients with aspirin-exacerbated respiratory disease. American Journal of Rhinology and Allergy 29(3): E63-E69
Najafi, S.; Mohammadzadeh, M.; Zare Bidoki, A.; Meighani, G.; Aslani, S.; Mahmoudi, M.; Rezaei, N. 2016: HLA-DRB and HLA-DQB Allele and Haplotype Frequencies in Iranian Patients with Recurrent Aphthous Stomatitis. Iranian Journal of Allergy Asthma and Immunology 15(4): 289-295
Yaldizli, Özgür.; Sethi, V.; Pardini, M.; Tur, C.; Mok, K.Y.; Muhlert, N.; Liu, Z.; Samson, R.S.; Wheeler-Kingshott, C.A.M.; Yousry, T.A.; Houlden, H.; Hardy, J.; Miller, D.H.; Chard, D.T. 2016: HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis. Multiple Sclerosis and Related Disorders 7: 47-52
Weiskopf, D.; Angelo, M.A.; Grifoni, A.; O'Rourke, P.H.; Sidney, J.; Paul, S.; De Silva, A.D.; Phillips, E.; Mallal, S.; Premawansa, S.; Premawansa, G.; Wijewickrama, A.; Peters, B.; Sette, A. 2016: HLA-DRB1 Alleles Are Associated with Different Magnitudes of Dengue Virus-Specific CD4+ T-Cell Responses. Journal of Infectious Diseases 214(7): 1117-1124
Ling, S.F.; Viatte, S.; Lunt, M.; Van Sijl, A.M.; Silva-Fernandez, L.; Symmons, D.P.M.; Young, A.; Macgregor, A.J.; Barton, A. 2016: HLA-DRB1 Amino Acid Positions 11/13, 71, and 74 Are Associated With Inflammation Level, Disease Activity, and the Health Assessment Questionnaire Score in Patients With Inflammatory Polyarthritis. Arthritis and Rheumatology 68(11): 2618-2628
Yao, K.; Yang, S.; Shen, J.; Zhang, R.; Li, L. 2017: HLA-DRB1 allele polymorphism and nasopharyngeal carcinoma risk: a meta-analysis. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 274(1): 297-303
Ohnuki, Y.; Suzuki, S.; Shiina, T.; Uruha, A.; Watanabe, Y.; Suzuki, S.; Izumi, S.; Nakahara, J.; Hamanaka, K.; Takayama, K.; Suzuki, N.; Nishino, I. 2016: HLA-DRB1 alleles in immune-mediated necrotizing myopathy. Neurology 87(18): 1954-1955
Baharlou, R.; Faghihi-Kashani, A.; Faraji, F.; Najafi-Samei, M.; Setareh, M.; Zamani, F.; Tajik, N. 2016: HLA-DRB1 alleles of susceptibility and protection in Iranians with autoimmune hepatitis. Human Immunology 77(4): 330-335
Pithukpakorn, M.; Roothumnong, E.; Angkasekwinai, N.; Suktitipat, B.; Assawamakin, A.; Luangwedchakarn, V.; Umrod, P.; Thongnoppakhun, W.; Foongladda, S.; Suputtamongkol, Y. 2015: HLA-DRB1 and HLA-DQB1 Are Associated with Adult-Onset Immunodeficiency with Acquired Anti-Interferon-Gamma Autoantibodies. Plos one 10(5): E0128481
Hu, J.Ming.; Li, L.; Chen, Y.Zhao.; Liu, C.; Cui, X.; Yin, L.; Yang, L.; Zou, H.; Pang, L.; Zhao, J.; Qi, Y.; Cao, Y.; Jiang, J.; Liang, W.; Li, F. 2014: HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC. Epigenetics 9(10): 1366-1373
López-Mejías, R.; Genre, F.; Pérez, Bén.Sevilla.; Castañeda, S.; Ortego-Centeno, N.; Llorca, J.; Ubilla, Bña.; Remuzgo-Martínez, S.; Mijares, Vónica.; Pina, T.; Calvo-Río, V.; Márquez, A.; Sala-Icardo, L.; Miranda-Filloy, Jé.A.; Conde-Jaldón, M.; Ortiz-Fernández, L.; Rubio, E.; León Luque, M.; Blanco-Madrigal, J.M.; Galíndez-Aguirregoikoa, E.; González-Vela, M.Carmen.; Ocejo-Vinyals, J.Gonzalo.; González Escribano, F.; Martín, J.; Blanco, R.; González-Gay, M.A. 2015: HLA-DRB1 association with Henoch-Schonlein purpura. Arthritis and Rheumatology 67(3): 823-827
Samadzadeh, S.; Tabibian, E.; Sabokbar, T.; Shakoori, A.; Dehgolan, S.R.; Armaki, S.A.; Aslanbeigi, B.; Abolfazli, R. 2015: HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patients. Journal of the Neurological Sciences 352(1-2): 37-40
Wang, J.; Zhang, H.; Wang, G-Q.; Quan, Y. 2016: HLA-DRB1 gene polymorphisms and its associations with rheumatoid arthritis in Chinese Han women of Shaanxi province, northwest of China. International Journal of Immunogenetics 43(1): 25-31
Aggarwal, R.; Gupta, A.; Naru, J.; Berka, N.; Nanda, N.; Suri, D.; Singh, S. 2016: HLA-DRB1 in Henoch-Schönlein purpura: a susceptibility study from North India. Human Immunology 77(7): 555-558
Konuma, T.; Kato, S.; Ishii, H.; Takeda, R.; Oiwa-Monna, M.; Tojo, A.; Takahashi, S. 2015: HLA-DRB1 mismatch is associated with a decreased relapse in adult acute myeloid leukemia after single-unit myeloablative cord blood transplantation. Annals of Hematology 94(7): 1233-1235
Liu, W.-X.; Jiang, Y.; Hu, Q.-X.; You, X.-B. 2016: HLA-DRB1 shared epitope allele polymorphisms and rheumatoid arthritis: a systemic review and meta-analysis. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 39(6): E182-E203
Konda Mohan, V.; Ganesan, N.; Gopalakrishnan, R.; Venkatesan, V. 2017: HLA-DRB1 shared epitope alleles in patients with rheumatoid arthritis: relation to autoantibodies and disease severity in a south Indian population. International Journal of Rheumatic Diseases 20(10): 1492-1498
Arango, M.ía.-T.; Perricone, C.; Kivity, S.; Cipriano, E.; Ceccarelli, F.; Valesini, G.; Shoenfeld, Y. 2017: HLA-DRB1 the notorious gene in the mosaic of autoimmunity. Immunologic Research 65(1): 82-98
Ražanskaitė-Virbickienė, D.ė; Danytė, E.; Žalinkevičius, R. 2016: HLA-DRB1*03 as a risk factor for microalbuminuria in same duration of type 1 diabetes: a case control study. Bmc Nephrology 17: 38
Zhao, Y.; Zhao, Y.; Li, J.; Zhang, Y.; Zhang, L. 2016: HLA-DRB1*08:03:02 and HLA-DQB1*06:01:01 are associated with house dust mite-sensitive allergic rhinitis in Chinese subjects. International Forum of Allergy and Rhinology 6(8): 854-861
Ombrello, M.J.; Remmers, E.F.; Tachmazidou, I.; Grom, A.; Foell, D.; Haas, J.-P.; Martini, A.; Gattorno, M.; Özen, S.; Prahalad, S.; Zeft, A.S.; Bohnsack, J.F.; Mellins, E.D.; Ilowite, N.T.; Russo, R.; Len, C.; Hilario, M.O.E.; Oliveira, S.; Yeung, R.S.M.; Rosenberg, A.; Wedderburn, L.R.; Anton, J.; Schwarz, T.; Hinks, A.; Bilginer, Y.; Park, J.; Cobb, J.; Satorius, C.L.; Han, B.; Baskin, E.; Signa, S.; Duerr, R.H.; Achkar, J.P.; Kamboh, M.I.; Kaufman, K.M.; Kottyan, L.C.; Pinto, D.; Scherer, S.W.; Alarcón-Riquelme, M.E.; Docampo, E.; Estivill, X.; Gül, A.; de Bakker, P.I.W.; Raychaudhuri, S.; Langefeld, C.D.; Thompson, S.; Zeggini, E.; Thomson, W.; Kastner, D.L.; Woo, P.; Achkar, J.P.; Alarcón-Riquelme, M.E.; Allen, R.; Anton, J.; Bask 2015: HLA-DRB1*11 and variants of the MHC class Ii locus are strong risk factors for systemic juvenile idiopathic arthritis. Proceedings of the National Academy of Sciences of the United States of America 112(52): 15970-15975
Lin, F-Q.; Li, X-F.; Zhang, X.; Zhang, K-L.; Li, J-P. 2015: HLA-DRB1*11:106, a variant of HLA-DRB1*11, discovered in a Chinese bone marrow donor. Tissue Antigens 85(1): 79-80
Kanai, T.; Uzawa, A.; Kawaguchi, N.; Sakamaki, T.; Yoshiyama, Y.; Himuro, K.; Oda, F.; Kuwabara, S. 2016: HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patients. Journal of the Neurological Sciences 363: 116-118
Toro, J.; Cuellar-Giraldo, D.; Díaz-Cruz, C.; Burbano, L.-E.; Guío, C.-M.; Reyes, S.úl.; Cortes, F.án.; Cárdenas-Robledo, S.ón.; Narváez, D.M.; Cárdenas, W.; Porras, A.; Lattig, M.ía.-C.; Groot de Restrepo, H. 2016: HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population. Neurology (R) Neuroimmunology and Neuroinflammation 3(1): E192
Yang, K.L.; Hung, J.H.; Lin, P.Y. 2015: HLA-DRB1*14:84 may have been derived from HLA-DRB1*14:05 and HLA-DRB1*04:58 via a genetic recombination event. Tissue Antigens 86(4): 309-310
Pugliese, A.; Boulware, D.; Yu, L.; Babu, S.; Steck, A.K.; Becker, D.; Rodriguez, H.; DiMeglio, L.; Evans-Molina, C.; Harrison, L.C.; Schatz, D.; Palmer, J.P.; Greenbaum, C.; Eisenbarth, G.S.; Sosenko, J.M. 2016: HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives from Type 1 Diabetes Throughout the Stages of Disease Progression. Diabetes 65(4): 1109-1119
Nicoletti, P.; Werk, A.N.; Sawle, A.; Shen, Y.; Urban, T.J.; Coulthard, S.A.; Bjornsson, E.S.; Cascorbi, I.; Floratos, A.; Stammschulte, T.; Gundert-Remy, U.; Nelson, M.R.; Aithal, G.P.; Daly, A.K.; Andrade, R.J.; Bessone, F.; Bjornsson, E.; Cascorbi, I.; Daly, A.K.; Dillon, J.F.; Day, C.P.; Hallberg, P.; Hernández, N.; Ibanez, L.; Kullak-Ublick, G.A.; Laitinen, T.; Larrey, D.; Lucena, M. I.; Maitland-van der Zee, A.; Martin, J.H.; Menzies, D.; Molokhia, M.; Pirmohamed, M.; Qin, S.; Wadelius, M. 2016: HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury. Pharmacogenetics and Genomics 26(5): 218-224
Yang, K.L.; Hung, J.H.; Lin, P.Y. 2016: HLA-DRB1*16:39, a novel HLA-DRB1*16 variant, discovered in a Taiwanese bone marrow hematopoietic stem cell donor. Hla 88(3): 124-125
Zajacova, M.; Kotrbova-Kozak, A.; Cerna, M. 2016: HLA-DRB1, -DQA1 and -DQB1 genotyping of 180 Czech individuals from the Czech Republic pop 3. Human Immunology 77(4): 365-366
Reynolds, R.J.; Ahmed, A.F.; Danila, M.I.; Hughes, L.B.; Gregersen, P.K.; Raychaudhuri, S.; Plenge, R.M.; Bridges, S.Louis. 2014: HLA-DRB1-associated rheumatoid arthritis risk at multiple levels in African Americans: hierarchical classification systems, amino acid positions, and residues. Arthritis and Rheumatology 66(12): 3274-3282
Bunupuradah, T.; Hansudewechakul, R.; Kosalaraksa, P.; Ngampiyaskul, C.; Kanjanavanit, S.; Wongsawat, J.; Luesomboon, W.; Sophonphan, J.; Puthanakit, T.; Ruxrungtham, K.; Shearer, W.T.; Ananworanich, J.; Phanuphak, P.; Cooper, D.A.; Kaldor, J.; Vun, M.C.; Vonthanak, S.; Ruxrungtham, K.; Giaquinto, C.; Cotton, M.; Lolekha, R.; Sirisanthana, V.; Chokephaibulkit, K.; Suntarattiwong, P.; Volberding, P.; Bangdiwala, S.; Lim, K.; Samuel, N.M.; Schoenfeld, D.; Sohn, A.; Solomon, S.; Suwangool, P.; Wang, R.; Zhang, F.; Zoloth, L.; Dixon, D.O.; Fox, L.; Ojumu, A.O.; Bupp, J.E.; Ussery, M.; Wetherall, N.T.; Brouwers, P.; Mofenson, L.M.; Law, M.; Shearer, W.T.; Valcour, V.; Paul, R.; Pattanapanyasat, K.; Sakulploy, N.; McNicholl, J.M.; Snowden, W.; Th 2015: HLA-DRB1454 and predictors of new-onset asthma in HIV-infected Thai children. Clinical Immunology 157(1): 26-29
Benedek, G.; Meza-Romero, R.; Jordan, K.; Keenlyside, L.; Offner, H.; Vandenbark, A.A. 2015: HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection. Journal of Neuroinflammation 12: 123
Wagner, B.; da Silva Nardi, F.; Schramm, S.; Kraemer, T.; Celik, A.A.; Dürig, J.; Horn, P.A.; Dührsen, U.; Nückel, H.; Rebmann, V. 2017: HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia. Cancer 123(5): 814-823
Castelli, E.C.; Mendes-Junior, C.T.; Sabbagh, A.; Porto, I.O.P.; Garcia, Aé.; Ramalho, J.; Lima, Tálitta.H.A.; Massaro, J.D.; Dias, Fício.C.; Collares, C.V.A.; Jamonneau, V.; Bucheton, B.; Camara, M.; Donadi, E.A. 2015: HLA-E coding and 3' untranslated region variability determined by next-generation sequencing in two West-African population samples. Human Immunology 76(12): 945-953
Seliger, B.; Jasinski-Bergner, S.; Quandt, D.; Stoehr, C.; Bukur, J.; Wach, S.; Legal, W.; Taubert, H.; Wullich, B.; Hartmann, A. 2016: HLA-E expression and its clinical relevance in human renal cell carcinoma. Oncotarget 7(41): 67360-67372
Zhou, Y.; Wu, Z.; Tang, Y.; Jia, T. 2015: HLA-E gene polymorphisms and plasma soluble HLA-E levels and their relationship with genetic susceptibility to breast cancer. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 31(4): 524-527
Mossallam, G.I.; Fattah, R.A.; El-Haddad, A.; Mahmoud, H.K. 2015: HLA-E polymorphism and clinical outcome after allogeneic hematopoietic stem cell transplantation in Egyptian patients. Human Immunology 76(2-3): 161-165
Zidi, I.; Laaribi, A.B.; Bortolotti, D.; Belhadj, M.; Mehri, A.; Yahia, H.B.; Babay, W.; Chaouch, H.; Zidi, N.; Letaief, A.; Yacoub, S.; Boukadida, J.; Di Luca, D.; Hannachi, N.; Rizzo, R. 2016: HLA-E polymorphism and soluble HLA-E plasma levels in chronic hepatitis B patients. Hla 87(3): 153-159
Lauterbach, N.; Wieten, L.; Popeijus, H.E.; Voorter, C.E.M.; Tilanus, M.G.J. 2015: HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire. Human Immunology 76(8): 578-586
Di Cristofaro, J.; Pelardy, M.; Loundou, A.; Basire, A.ès.; Gomez, C.; Chiaroni, J.; Thomas, P.; Reynaud-Gaubert, M.; Picard, C. 2016: HLA-E(⁎)01:03 Allele in Lung Transplant Recipients Correlates with Higher Chronic Lung Allograft Dysfunction Occurrence. Journal of Immunology Research 2016: 1910852
Kraemer, T.; Celik, A.A.; Huyton, T.; Kunze-Schumacher, H.; Blasczyk, R.; Bade-Döding, C. 2015: HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome. Stem Cells International 2015: 346714
Burian, A.; Wang, K.L.; Finton, K.A.K.; Lee, N.; Ishitani, A.; Strong, R.K.; Geraghty, D.E. 2016: HLA-F and MHC-i Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1. Plos one 11(9): E0163297
Lima, T.ál.H.A.; Buttura, R.V.; Donadi, E.A.ôn.; Veiga-Castelli, L.C.; Mendes-Junior, C.T.; Castelli, E.C. 2016: HLA-F coding and regulatory segments variability determined by massively parallel sequencing procedures in a Brazilian population sample. Human Immunology 77(10): 841-853
Sakly, K.; Maatouk, M.; Hammami, S.; Harzallah, O.; Sakly, W.; Feki, S.; Mirshahi, M.; Ghedira, I.; Sakly, N. 2016: HLA-G 14 bp insertion/deletion polymorphism and its association with sHLA-G levels in Behçet's disease Tunisian patients. Human Immunology 77(1): 90-95
Genre, J.; Reginaldo, F.P.S.; Andrade, J.M.d.L.; Lima, F.P.; da Camara, A.V.C.; Donadi, E.A.; Crispim, J.C. 2016: HLA-G 14-bp Ins/Ins Genotype in Patients Harbouring Helicobacter pylori Infection: a Potential Risk Factor?. Scandinavian Journal of Immunology 83(1): 52-57
Gerasimou, P.; Skordis, N.; Picolos, M.; Spyridonidis, A.; Costeas, P. 2016: HLA-G 14-bp polymorphism affects the age of onset in Type i Diabetes Mellitus. International Journal of Immunogenetics 43(3): 135-142
de Figueiredo-Feitosa, N.Lobo.; Martelli Palomino, G.; Cilião Alves, D.Cristina.; Mendes Junior, C.Teixeira.; Donadi, E.Antonio.; Maciel, Léa.Maria.Zanini. 2017: HLA-G 3' untranslated region polymorphic sites associated with increased HLA-G production are more frequent in patients exhibiting differentiated thyroid tumours. Clinical Endocrinology 86(4): 597-605
Cilião Alves, D.Cristina.; Haddad, R.; Rocha-Júnior, Mício.Cristiano.; de Deus Wagatsuma, Vínia.Mara.; Martelli-Palomino, G.; Marques, A.Aparecida.; Takayanagui, O.Massaiti.; Covas, D.Tadeu.; Kashima, S.; Donadi, E.Antônio. 2016: HLA-G 3'-untranslated region polymorphisms are associated with HTLV-1 infection, proviral load and HTLV-associated myelopathy/tropical spastic paraparesis development. Journal of General Virology 97(10): 2742-2752
Garziera, M.; Bidoli, E.; Cecchin, E.; Mini, E.; Nobili, S.; Lonardi, S.; Buonadonna, A.; Errante, D.; Pella, N.; D'Andrea, M.; De Marchi, F.; De Paoli, A.; Zanusso, C.; De Mattia, E.; Tassi, R.; Toffoli, G. 2015: HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-IIi CRC Patients in Fluoropyrimidine-Based Treatment. Plos one 10(12): E0144000
Rizzo, R.; Bortolotti, D.; Bolzani, S.; Fainardi, E. 2014: HLA-G Molecules in Autoimmune Diseases and Infections. Frontiers in Immunology 5: 592
Gregori, S.; Amodio, G.; Quattrone, F.; Panina-Bordignon, P. 2015: HLA-G Orchestrates the Early Interaction of Human Trophoblasts with the Maternal Niche. Frontiers in Immunology 6: 128
Vianna, P.; Mondadori, A.G.; Bauer, M.és.E.; Dornfeld, D.; Chies, J.é A.B. 2016: HLA-G and CD8+ regulatory T cells in the inflammatory environment of pre-eclampsia. Reproduction 152(6): 741-751
Jesionek-Kupnicka, D.; Bojo, M.; Prochorec-Sobieszek, M.; Szumera-Ciećkiewicz, A.; Jabłońska, J.; Kalinka-Warzocha, E.; Kordek, R.ła.; Młynarski, W.; Robak, T.; Warzocha, K.; Lech-Maranda, E. 2016: HLA-G and MHC Class Ii Protein Expression in Diffuse Large B-Cell Lymphoma. Archivum Immunologiae et Therapiae Experimentalis 64(3): 225-240
Swets, M.; König, M.H.; Zaalberg, A.; Dekker-Ensink, N.G.; Gelderblom, H.; van de Velde, C.J.H.; van den Elsen, P.J.; Kuppen, P.J.K. 2016: HLA-G and classical HLA class i expression in primary colorectal cancer and associated liver metastases. Human Immunology 77(9): 773-779
Catamo, E.; Zupin, L.; Segat, L.; Celsi, F.; Crovella, S. 2015: HLA-G and susceptibility to develop celiac disease. Human Immunology 76(1): 36-41
Shi, B. 2014: HLA-G and transplantation immuology tolerance. Zhonghua Yi Xue Za Zhi 94(42): 3281-3283
Lin, A.; Yan, W.-H. 2016: HLA-G as an Inhibitor of Immune Responses. Methods in Molecular Biology 1371: 3-9
Wang, W.Yi.; Tian, W.; Liu, X.Xiang.; Li, L.Xin. 2016: HLA-G coding region and 3'untranslated region (3'UTR) in two Chinese Han populations. Immunology Letters 176: 65-71
Rizzo, R.; Bergamini, G.; Bortolotti, D.; Leal, T.; D'Orazio, C.; Pintani, E.; Melchiorri, L.; Zavatti, E.; Assael, B.M.; Sorio, C.; Melotti, P. 2016: HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients. Future Microbiology 11(3): 363-373
Caocci, G.; Greco, M.; Fanni, D.; Senes, G.; Littera, R.; Lai, S.; Risso, P.; Carcassi, C.; Faa, G.; La Nasa, G. 2016: HLA-G expression and role in advanced-stage classical Hodgkin lymphoma. European Journal of Histochemistry: Ejh 60(2): 2606
Lin, A.; Yan, W.-H. 2015: Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy. Molecular Medicine 21(1): 782-791
Mori, A.; Nishi, H.; Sasaki, T.; Nagamitsu, Y.; Kawaguchi, R.; Okamoto, A.; Kuroda, M.; Isaka, K. 2016: HLA-G expression is regulated by miR-365 in trophoblasts under hypoxic conditions. Placenta 45: 37-41
Amodio, G.; Comi, M.; Tomasoni, D.; Gianolini, M.E.; Rizzo, R.; LeMaoult, J.ël.; Roncarolo, M.-G.; Gregori, S. 2015: HLA-G expression levels influence the tolerogenic activity of human DC-10. Haematologica 100(4): 548-557
Coelho, A.V.C.; Moura, R.R.; Crovella, S.; Celsi, F. 2016: HLA-G genetic variants and hepatocellular carcinoma: a meta-analysis. Genetics and Molecular Research: Gmr 15(3)
Zhou, L.; Niu, Z.-Y.; Liang, Z.-Y.; Zhou, W.-X.; You, L.; Wang, M.-Y.; Yao, L.-T.; Liao, Q.; Zhao, Y.-P. 2015: HLA-G impairs host immune response and predicts poor prognosis in pancreatic cancer. American Journal of Translational Research 7(10): 2036-2044
Costa, C.H.; Gelmini, G.F.; Nardi, F.S.; Roxo, V.ér.M.M.S.; Schuffner, A.; da Graça Bicalho, M. 2016: HLA-G profile of infertile couples who underwent assisted reproduction treatment. Human Immunology 77(12): 1179-1186
Köstlin, N.; Ostermeir, A.-L.; Spring, B.är.; Schwarz, J.; Marmé, A.; Walter, C.B.; Poets, C.F.; Gille, C. 2017: HLA-G promotes myeloid-derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4. European Journal of Immunology 47(2): 374-384
Di Cristofaro, J.; Reynaud-Gaubert, M.; Carlini, F.; Roubertoux, P.; Loundou, A.; Basire, A.; Frassati, C.; Thomas, P.; Gomez, C.; Picard, C. 2015: HLA-G*01:04∼UTR3 Recipient Correlates with Lower Survival and Higher Frequency of Chronic Rejection After Lung Transplantation. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 15(9): 2413-2420
Viganò, S.; Negrón, J.J.; Tse, S.; Chowdhury, F.Z.; Lichterfeld, M.; Yu, X.G. 2017: HLA-G+ HIV-1-specific CD8+ T cells are associated with HIV-1 immune control. Aids 31(2): 207-212
Eguchi, H.; Maeda, A.; Lo, P.C.; Matsuura, R.; Esquivel, E.L.; Asada, M.; Sakai, R.; Nakahata, K.; Yamamichi, T.; Umeda, S.; Deguchi, K.; Ueno, T.; Okuyama, H.; Miyagawa, S. 2016: HLA-G1, but not HLA-G3, Suppresses Human Monocyte/Macrophage-mediated Swine Endothelial Cell Lysis. Transplantation Proceedings 48(4): 1285-1287
Abediankenari, S.; Farzad, F.; Rahmani, Z.; Hashemi-Soteh, M.B. 2015: HLA-G5 and G7 Isoforms in Pregnant Women. Iranian Journal of Allergy Asthma and Immunology 14(2): 217-221
Carosella, E.D.; Rouas-Freiss, N.; Tronik-Le Roux, D.; Moreau, P.; LeMaoult, J. 2015: HLA-G: An Immune Checkpoint Molecule. Advances in Immunology 127: 33-144
Carosella, E.D. 2014: HLA-G: from feto-maternal tolerance to organ acceptance. Bulletin del'Academie Nationale de Medecine 198(4-5): 801
Sugita, J.; Kawashima, N.; Fujisaki, T.; Kakihana, K.; Ota, S.; Matsuo, K.; Miyamoto, T.; Akashi, K.; Taniguchi, S.; Harada, M.; Teshima, T. 2015: HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 21(9): 1646-1652
Rostaing, L.P.E.; Malvezzi, P. 2016: HLA-Incompatible Kidney Transplantation--Worth the Risk?. New England Journal of Medicine 374(10): 982-984
Nariai, N.; Kojima, K.; Saito, S.; Mimori, T.; Sato, Y.; Kawai, Y.; Yamaguchi-Kabata, Y.; Yasuda, J.; Nagasaki, M. 2015: HLA-VBSeq: accurate HLA typing at full resolution from whole-genome sequencing data. Bmc Genomics 16(Suppl 2): S7
Cornejo Castro, E.M.; Carr, D.F.; Jorgensen, A.L.; Alfirevic, A.; Pirmohamed, M. 2015: HLA-allelotype associations with nevirapine-induced hypersensitivity reactions and hepatotoxicity: a systematic review of the literature and meta-analysis. Pharmacogenetics and Genomics 25(4): 186-198
Nerstheimer, S.; Tauscher, P.; Petek, E.; Schappacher-Tilp, G. 2015: HLA-frequencies of Austrian umbilical cord blood samples. Human Immunology 76(11): 863-867
Barone, J.C.; Saito, K.; Beutner, K.; Campo, M.; Dong, W.; Goswami, C.P.; Johnson, E.S.; Wang, Z.-X.; Hsu, S. 2015: HLA-genotyping of clinical specimens using Ion Torrent-based NGS. Human Immunology 76(12): 903-909
Hirosawa, M.; Higashi, T.; Iwashige, A.; Yamaguchi, T.; Tsukada, J. 2017: HLA-haploidentical hematopoietic stem cell transplantation with low-dose thymoglobulin GVHD prophylaxis for an adult T cell leukemia/lymphoma patient treated with pretransplant mogamulizumab. Annals of Hematology 96(2): 327-328
Fujimoto, K.; Sugita, J.; Teshima, T. 2016: HLA-haploidentical hematopoietic stem cell transplantation: current status and future perspectives. Japanese Journal of Clinical Hematology 57(3): 288-297
Boran, M.; Boran, M.; Boran, E. 2014: HLA-identical sibling renal transplantation: influence of donor and recipient gender mismatch on long-term outcomes. Transplantation Proceedings 46(10): 3423-3425
Benajiba, L.; Salvado, C.; Dalle, J.-H.; Jubert, C.; Galambrun, C.; Soulier, J.; Socié, G.; Peffault de Latour, R. 2015: HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabine. Blood 125(2): 417-418
Kako, S.; Akahoshi, Y.; Harada, N.; Nakano, H.; Kameda, K.; Ugai, T.; Yamasaki, R.; Wada, H.; Ishihara, Y.; Kawamura, K.; Sakamoto, K.; Sato, M.; Ashizawa, M.; Terasako-Saito, K.; Kimura, S-Ichi.; Kikuchi, M.; Nakasone, H.; Yamazaki, R.; Kanda, J.; Kanda, Y. 2017: HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin). Hematology 22(3): 129-135
Piaia, M.; Bub, C.B.; Succi, G.d.M.; Torres, M.; Costa, T.H.; Pinheiro, F.C.; Napimoga, M.H. 2017: HLA-typing analysis following allogeneic bone grafting for sinus lifting. Cell and Tissue Banking 18(1): 75-81
Dierickx, D.; Sprangers, B.; Van Besien, K. 2016: HLA: revisiting an old suspect in the complex pathogenesis of posttransplant lymphoproliferative disorders. Leukemia and Lymphoma 57(10): 2241-2242
Du, T.; Yang, L.; Luo, H.; Zhou, P.; Mei, H.; Xuan, J.; Xing, Q.; Ning, B.; Mendrick, D.L.; Shi, L. 2015: HLADR: a database system for enhancing the discovery of biomarkers for predicting human leukocyte antigen-mediated idiosyncratic adverse drug reactions. Biomarkers in Medicine 9(11): 1079-1093
Huang, Y.; Yang, J.; Ying, D.; Zhang, Y.; Shotelersuk, V.; Hirankarn, N.; Sham, P.Chung.; Lau, Y.Lung.; Yang, W. 2015: HLAreporter: a tool for HLA typing from next generation sequencing data. Genome Medicine 7(1): 25
Wang, S.; Guo, L.; Liu, D.; Liu, W.; Wu, Y. 2016: HLAsupE: an integrated database of HLA supertype-specific epitopes to aid in the development of vaccines with broad coverage of the human population. Bmc Immunology 17(1): 17
Sparks, J.Alan.; Kwon, T.; Renna, L.; Liao, F.; Brandizzi, F.; Blancaflor, E.B. 2016: HLB1 Is a Tetratricopeptide Repeat Domain-Containing Protein That Operates at the Intersection of the Exocytic and Endocytic Pathways at the TGN/EE in Arabidopsis. Plant Cell 28(3): 746-769
Li, X.; Xue, W.; Liu, Y.; Li, W.; Fan, D.; Zhu, C.; Wang, Y. 2016: HLC/pullulan and pullulan hydrogels: their microstructure, engineering process and biocompatibility. Materials Science and Engineering. C Materials for Biological Applications 58: 1046-1057
Chen, S.; Wang, Y.; Ni, C.; Meng, G.; Sheng, X. 2016: HLF/miR-132/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells. Biomedicine and PharmacoTherapy 83: 898-904
Meeths, M.; Bryceson, Y.T. 2016: HLH susceptibility: genetic lesions add up. Blood 127(17): 2051-2052
Chen, H-Da.; Kao, C-Yuan.; Liu, B-Yu.; Huang, S-Whei.; Kuo, C-Ju.; Ruan, J-Wei.; Lin, Y-Hung.; Huang, C-Rung.; Chen, Y-Hung.; Wang, H-Dar.; Aroian, R.V.; Chen, C-Shi. 2017: HLH-30/TFEB-mediated autophagy functions in a cell-autonomous manner for epithelium intrinsic cellular defense against bacterial pore-forming toxin in C. elegans. Autophagy 13(2): 371-385
Kile, A.C.; Chavez, D.A.; Bacal, J.; Eldirany, S.; Korzhnev, D.M.; Bezsonova, I.; Eichman, B.F.; Cimprich, K.A. 2015: HLTF's Ancient HIRAN Domain Binds 3' DNA Ends to Drive Replication Fork Reversal. Molecular Cell 58(6): 1090-1100
Mukherjee, S.; Bhattacharyya, C.; Chandra, N. 2016: HLaffy: estimating peptide affinities for Class-1 HLA molecules by learning position-specific pair potentials. Bioinformatics 32(15): 2297-2305
Köhler, S.C.; Wiese, M. 2015: HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2). Journal of Medicinal Chemistry 58(9): 3910-3921
Park, J.K.; Byun, J.-Y.; Park, J.A.; Kim, Y.-Y.; Lee, Y.J.; Oh, J.I.; Jang, S.Y.; Kim, Y.H.; Song, Y.W.; Son, J.; Suh, K.H.; Lee, Y.-M.; Lee, E.B. 2016: HM71224, a novel Bruton's tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis. Arthritis Research and Therapy 18: 91
Sautron, E.; Mayerhofer, H.; Giustini, C.; Pro, Dèle.; Crouzy, S.; Ravaud, Séphanie.; Pebay-Peyroula, E.; Rolland, N.; Catty, P.; Seigneurin-Berny, Dé. 2015: HMA6 and HMA8 are two chloroplast Cu+-ATPases with different enzymatic properties. Bioscience Reports (): -
Hoffman, J.R.; Gepner, Y.; Stout, J.R.; Hoffman, M.W.; Ben-Dov, D.; Funk, S.; Daimont, I.; Jajtner, A.J.; Townsend, J.R.; Shelef, I.; Avital, G.; Chen, Y.; Frankel, H.; Ostfeld, I. 2016: HMB Supplementation may Affect Cytokine and Inflammatory Response during High Intensity Military Training: 631 Board #3 June 1, 1: 00 PM - 3: 00 PM. Medicine and Science in Sports and Exercise 48(5 Suppl 1): 164-164
Lin, C-Yu.; Tsai, C-Chih.; Kau, H-Chuan.; Yu, W-Kuang.; Kao, S-Ching.; Liu, C.Jui-Ling. 2016: HMB-45 negative angiomyolipoma of the orbit: a case report and review of the literature. Bmc Ophthalmology 16: 8
Kapoor, A.; Beniwal, S.; Singhal, M.Kumar.; Kumar, N.; Kumar, V.; Kumar, H.Singh. 2015: HMB-45 negative multifocal malignant perivascular epithelioid cell tumor of the soft tissue responding to sirolimus: First case report from India. Journal of Cancer Research and Therapeutics 11(4): 1036
Chen, D.; Wang, H.; Aweya, J.Juventus.; Chen, Y.; Chen, M.; Wu, X.; Chen, X.; Lu, J.; Chen, R.; Liu, M. 2016: HMBA Enhances Prostratin-Induced Activation of Latent HIV-1 via Suppressing the Expression of Negative Feedback Regulator A20/TNFAIP3 in NF-κB Signaling. Biomed Research International 2016: 5173205
Kilcollins, A.M.; Li, J.; Hsiao, C.-H.C.; Wiemer, A.J. 2016: HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake to Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by Vγ9Vδ2 T Lymphocyte Effectors. Journal of Immunology 197(2): 419-428
Li, C.-F.; Tsai, H.-H.; Ko, C.-Y.; Pan, Y.-C.; Yen, C.-J.; Lai, H.-Y.; Yuh, C.-H.; Wu, W.-C.; Wang, J.-M. 2015: HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells. Molecular Cancer Therapeutics 14(11): 2623-2633
Costoya, A.; Ballarin, F.M.; Llovo, J.; Concheiro, A.; Abraham, G.A.; Alvarez-Lorenzo, C. 2016: HMDSO-plasma coated electrospun fibers of poly(cyclodextrin)s for antifungal dressings. International Journal of Pharmaceutics 513(1-2): 518-527
Lin, G.; Zhang, N. 2016: HMF-GUT2016 and GITAU2016 Invitation. Translational Andrology and Urology 5(1): 164-165
Rodrigues, C.ás.J.é d.O. 2015: HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Sao Paulo Medical Journal 133(6): 541-542
Lewicki, M.; Ng, I.; Schneider, A.G. 2015: HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass. Cochrane Database of Systematic Reviews 2015(3): Cd010480
Jasińska-Stroschein, M.; Owczarek, J.; Surowiecka, A.; Kącikowska, J.; Orszulak-Michalak, D. 2015: HMG-COA reductase inhibitors: An opportunity for the improvement of imatinib safety. An experimental study in rat pulmonary hypertension. Pharmacological Reports: Pr 67(1): 32-37
Kilic, E.; Reitmeir, R.; Kilic, Ülkan.; Caglayan, A.Burak.; Beker, M.Caglar.; Kelestemur, T.; Ethemoglu, M.Sinem.; Ozturk, G.; Hermann, D.M. 2014: HMG-CoA Reductase Inhibition Promotes Neurological Recovery, Peri-Lesional Tissue Remodeling, and Contralesional Pyramidal Tract Plasticity after Focal Cerebral Ischemia. Frontiers in Cellular Neuroscience 8: 422
Roy, A.; Jana, M.; Kundu, M.; Corbett, G.T.; Rangaswamy, S.B.; Mishra, R.K.; Luan, C-Hao.; Gonzalez, F.J.; Pahan, K. 2015: HMG-CoA Reductase Inhibitors Bind to PPARα to Upregulate Neurotrophin Expression in the Brain and Improve Memory in Mice. Cell metabolism 22(2): 253-265
Oliveira, E.Filipe.; Santos-Martins, D.; Ribeiro, Aónio.Meireles.; Brás, Nércia.Fernandes.; Cerqueira, N.Sousa.; Sousa, Sérgio.Filipe.; Ramos, M.João.; Fernandes, P.Alexandrino. 2016: HMG-CoA Reductase inhibitors: an updated review of patents of novel compounds and formulations (2011-2015). Expert opinion on therapeutic patents 26(11): 1257-1272
Seker, F.B.; Kilic, U.; Caglayan, B.; Ethemoglu, M.S.; Caglayan, A.B.; Ekimci, N.; Demirci, S.; Dogan, A.; Oztezcan, S.; Sahin, F.; Yilmaz, B.; Kilic, E. 2015: HMG-CoA reductase inhibitor rosuvastatin improves abnormal brain electrical activity via mechanisms involving eNOS. Neuroscience 284: 349-359
Baskaran, G.; Salvamani, S.; Ahmad, S.A.; Shaharuddin, N.A.; Pattiram, P.D.; Shukor, M.Y. 2015: HMG-CoA reductase inhibitory activity and phytocomponent investigation of Basella alba leaf extract as a treatment for hypercholesterolemia. Drug Design Development and Therapy 9: 509-517
Wang, F.; Xiang, H.; Fischer, G.; Liu, Z.; Dupont, M.J.; Hogan, Q.H.; Yu, H. 2016: HMG-CoA synthase isoenzymes 1 and 2 localize to satellite glial cells in dorsal root ganglia and are differentially regulated by peripheral nerve injury. Brain Research 1652: 62-70
Andreozzi, M.; Quintavalle, C.; Benz, D.; Quagliata, L.; Matter, M.; Calabrese, D.; Tosti, N.; Ruiz, C.; Trapani, F.; Tornillo, L.; Fusco, A.; Heim, M.H.; Ng, C.K.; Pallante, P.; Terracciano, L.M.; Piscuoglio, S. 2016: HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models. Neoplasia 18(12): 724-731
Williams, M.D.; Zhang, X.; Belton, A.S.; Xian, L.; Huso, T.; Park, J-Jin.; Siems, W.F.; Gang, D.R.; Resar, L.M.S.; Reeves, R.; Hill, H.H. 2015: HMGA1 drives metabolic reprogramming of intestinal epithelium during hyperproliferation, polyposis, and colorectal carcinogenesis. Journal of Proteome Research 14(3): 1420-1431
Han, X.; Cao, Y.; Wang, K.; Zhu, G. 2016: HMGA1 facilitates tumor progression through regulating Wnt/β-catenin pathway in endometrial cancer. Biomedicine and PharmacoTherapy 82: 312-318
De Rosa, S.; Chiefari, E.; Salerno, N.; Ventura, V.; D'Ascoli, G.L.; Arcidiacono, B.; Ambrosio, G.; Bilotta, F.L.; Torella, D.; Foti, D.; Indolfi, C.; Brunetti, A. 2017: HMGA1 is a novel candidate gene for myocardial infarction susceptibility. International Journal of Cardiology 227: 331-334
Sepe, R.; Piscuoglio, S.; Quintavalle, C.; Perrina, V.; Quagliata, L.; Formisano, U.; Terracciano, L.M.; Fusco, A.; Pallante, P. 2016: HMGA1 overexpression is associated with a particular subset of human breast carcinomas. Journal of Clinical Pathology 69(2): 117-121
Colamaio, M.; Tosti, N.; Puca, F.; Mari, A.; Gattordo, R.; Kuzay, Yçın.; Federico, A.; Pepe, A.; Sarnataro, D.; Ragozzino, E.; Raia, M.; Hirata, H.; Gemei, M.; Mimori, K.; Del Vecchio, L.; Battista, S.; Fusco, A. 2016: HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells. Expert Opinion on Therapeutic Targets 20(10): 1169-1179
Esposito, F.; De Martino, M.; D'Angelo, D.; Mussnich, P.; Raverot, G.; Jaffrain-Rea, M-Lise.; Fraggetta, F.; Trouillas, J.; Fusco, A. 2015: HMGA1-pseudogene expression is induced in human pituitary tumors. Cell Cycle 14(9): 1471-1475
Esposito, F.; De Martino, M.; Forzati, F.; Fusco, A. 2014: HMGA1-pseudogene overexpression contributes to cancer progression. Cell Cycle 13(23): 3636-3639
De Martino, M.; Forzati, F.; Arra, C.; Fusco, A.; Esposito, F. 2016: HMGA1-pseudogenes and cancer. Oncotarget 7(19): 28724-28735
Jun, K.-H.; Jung, J.-H.; Choi, H.-J.; Shin, E.-Y.; Chin, H.-M. 2015: HMGA1/HMGA2 protein expression and prognostic implications in gastric cancer. International Journal of Surgery 24(Part A): 39-44
De Vasconcellos, J.F.; Lee, Y.T.; Byrnes, C.; Tumburu, L.; Rabel, A.; Miller, J.L. 2016: HMGA2 Moderately Increases Fetal Hemoglobin Expression in Human Adult Erythroblasts. Plos one 11(11): E0166928
Wu, Z.; Eguchi-Ishimae, M.; Yagi, C.; Iwabuki, H.; Gao, W.; Tauchi, H.; Inukai, T.; Sugita, K.; Ishii, E.; Eguchi, M. 2015: HMGA2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia. British Journal of Haematology 171(5): 818-829
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2016: HMGA2 expression and response to anthracycline-based preoperative chemotherapy in patients with operable breast cancer. Journal of Clinical Oncology 26(15_Suppl): 22035-22035
Kloth, L.; Gottlieb, A.; Helmke, B.; Wosniok, W.; Löning, T.; Burchardt, K.ät.; Belge, G.; Günther, K.; Bullerdiek, J.ör. 2015: HMGA2 expression distinguishes between different types of postpubertal testicular germ cell tumour. Journal of Pathology. Clinical Research 1(4): 239-251
Agostini, A.; Panagopoulos, I.; Andersen, H.K.; Johannesen, L.E.; Davidson, B.; Tropé, C.G.ör.; Heim, S.; Micci, F. 2015: HMGA2 expression pattern and TERT mutations in tumors of the vulva. Oncology Reports 33(6): 2675-2680
Xia, Y.-Y.; Yin, L.; Tian, H.; Guo, W.-J.; Jiang, N.; Jiang, X.-S.; Wu, J.; Chen, M.; Wu, J.-Z.; He, X. 2015: HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma. Oncotargets and Therapy 8: 169-176
Zhang, H.; Tang, Z.; Deng, C.; He, Y.; Wu, F.; Liu, O.; Hu, C. 2017: HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma. Oral Diseases 23(2): 255-264
Boo, L.M.; Zhou, B.; Louie, S.G.; Yen, Y.; Ann, D.K. 2016: HMGA2 mediates topoisomerase II inhibitors cytotoxicity in breast cancer cells. Journal of Clinical Oncology 23(16_Suppl): 2110-2110
Palumbo, A.; Da Costa, N.M.; Esposito, F.; De Martino, M.; D'Angelo, D.; de Sousa, V.P.L.; Martins, I.; Nasciutti, L.E.; Fusco, A.; Ribeiro Pinto, L.F. 2016: HMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma. Oncotarget 7(18): 25872-25884
Xi, Y.; Shen, W.; Ma, L.; Zhao, M.; Zheng, J.; Bu, S.; Hino, S.; Nakao, M. 2016: HMGA2 promotes adipogenesis by activating C/EBPβ-mediated expression of PPARγ. Biochemical and biophysical research communications 472(4): 617-623
Li, W.; Wang, Z.; Zha, L.; Kong, D.; Liao, G.; Li, H. 2017: HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer. Oncology Reports 37(1): 185-192
Zhong, X.; Liu, X.; Li, Y.; Cheng, M.; Wang, W.; Tian, K.; Mu, L.; Zeng, T.; Liu, Y.; Jiang, X.; Yu, L.; Gao, L.; Zhou, Y. 2016: HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells. Oncotarget 7(28): 44365-44380
Zhao, H.; Zhang, J.; Yu, J. 2015: HMGB-1 as a Potential Target for the Treatment of Diabetic Retinopathy. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 21: 3062-3067
Du, H.; Li, J.; Yu, H.; Lian, J.; Zhang, Y.; Zhang, Y.; Bai, X.; Wang, P. 2015: HMGB-1 as a novel predictor of disease severity and prognosis in patients with hemorrhagic fever with renal syndrome. Mediators of Inflammation 2015: 696248
Das, N.; Dewan, V.; Grace, P.M.; Gunn, R.J.; Tamura, R.; Tzarum, N.; Watkins, L.R.; Wilson, I.A.; Yin, H. 2016: HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia. Cell Reports 17(4): 1128-1140
Kwak, M.S.; Lim, M.; Lee, Y.J.; Lee, H.S.; Kim, Y.H.; Youn, J.H.; Choi, J.E.; Shin, J.-S. 2015: HMGB1 Binds to Lipoteichoic Acid and Enhances TNF-α and IL-6 Production through HMGB1-Mediated Transfer of Lipoteichoic Acid to CD14 and TLR2. Journal of Innate Immunity 7(4): 405-416
Chen, Y.; Huang, X-Jing.; Yu, N.; Xie, Y.; Zhang, K.; Wen, F.; Liu, H.; Di, Q. 2015: HMGB1 Contributes to the Expression of P-Glycoprotein in Mouse Epileptic Brain through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products. Plos one 10(10): E0140918
Zheng, H.; Chen, J.-N.; Yu, X.; Jiang, P.; Yuan, L.; Shen, H.-S.; Zhao, L.-H.; Chen, P.-F.; Yang, M. 2016: HMGB1 Enhances Drug Resistance and Promotes in Vivo Tumor Growth of Lung Cancer Cells. Dna and Cell Biology 35(10): 622-627
Cheng, M.; Liu, H.; Zhang, D.; Liu, Y.; Wang, C.; Liu, F.; Chen, J. 2015: HMGB1 Enhances the AGE-Induced Expression of CTGF and TGF-β via RAGE-Dependent Signaling in Renal Tubular Epithelial Cells. American Journal of Nephrology 41(3): 257-266
Chen, Q.; Bei, J-Jie.; Liu, C.; Feng, S-Bin.; Zhao, W-Bo.; Zhou, Z.; Yu, Z-Ping.; Du, X-Jun.; Hu, H-Yuan. 2016: HMGB1 Induces Secretion of Matrix Vesicles by Macrophages to Enhance Ectopic Mineralization. Plos one 11(5): E0156686
Plazyo, O.; Romero, R.; Unkel, R.; Balancio, A.; Mial, T.N.; Xu, Y.; Dong, Z.; Hassan, S.S.; Gomez-Lopez, N. 2016: HMGB1 Induces an Inflammatory Response in the Chorioamniotic Membranes that Is Partially Mediated by the Inflammasome. Biology of Reproduction 95(6): 130
Mazur-Bialy, A.I.; Pocheć, E. 2016: HMGB1 Inhibition During Zymosan-Induced Inflammation: the Potential Therapeutic Action of Riboflavin. Archivum Immunologiae et Therapiae Experimentalis 64(2): 171-176
Foglio, E.; Puddighinu, G.; Germani, A.; Russo, M.A.; Limana, F. 2017: HMGB1 Inhibits Apoptosis Following Mi and Induces Autophagy via mTORC1 Inhibition. Journal of Cellular Physiology 232(5): 1135-1143
Montanini, L.; Cirillo, F.; Smerieri, A.; Pisi, G.; Giardino, I.; d'Apolito, M.; Spaggiari, C.; Bernasconi, S.; Amarri, S.; Street, M.E. 2016: HMGB1 Is Increased by CFTR Loss of Function, Is Lowered by Insulin, and Increases in Vivo at Onset of CFRD. Journal of Clinical Endocrinology and Metabolism 101(3): 1274-1281
Saïdi, H.él.; Bras, M.èn.; Formaglio, P.; Melki, M.-T.ér.ès.; Charbit, B.; Herbeuval, J.-P.; Gougeon, M.-L. 2016: HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells. Plos Pathogens 12(2): E1005407
Resman Rus, K.; Fajs, L.; Korva, M.ša.; Avšič-Županc, T. 2016: HMGB1 Is a Potential Biomarker for Severe Viral Hemorrhagic Fevers. Plos Neglected Tropical Diseases 10(6): E0004804
Sokół, B.; Woźniak, A.; Jankowski, R.; Jurga, S.; Wąsik, N.; Shahid, H.; Grześkowiak, B. 2015: HMGB1 Level in Cerebrospinal Fluid as a Marker of Treatment Outcome in Patients with Acute Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 24(8): 1897-1904
Shu, X.; Peng, Q.; Lu, X.; Wang, G. 2016: HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease. Plos one 11(8): E0161436
Zhou, Y.; Li, Y.; Mu, T. 2015: HMGB1 Neutralizing Antibody Attenuates Cardiac Injury and Apoptosis Induced by Hemorrhagic Shock/Resuscitation in Rats. Biological and Pharmaceutical Bulletin 38(8): 1150-1160
Martinotti, S.; Patrone, M.; Manfredi, M.; Gosetti, F.; Pedrazzi, M.; Marengo, E.; Ranzato, E. 2016: HMGB1 Osteo-Modulatory Action on Osteosarcoma SaOS-2 Cell Line: An Integrated Study from Biochemical and -Omics Approaches. Journal of Cellular Biochemistry 117(11): 2559-2569
Yu, R.; Yang, D.; Lei, S.; Wang, X.; Meng, X.; Xue, B.; Zhu, H. 2015: HMGB1 Promotes Hepatitis C Virus Replication by Interaction with Stem-Loop 4 in the Viral 5' Untranslated Region. Journal of Virology 90(5): 2332-2344
Tancharoen, S.; Gando, S.; Binita, S.; Nagasato, T.; Kikuchi, K.; Nawa, Y.; Dararat, P.; Yamamoto, M.; Narkpinit, S.; Maruyama, I. 2016: HMGB1 Promotes Intraoral Palatal Wound Healing through RAGE-Dependent Mechanisms. International Journal of Molecular Sciences 17(11)
Qi, L.; Sun, X.; Li, F.-E.; Zhu, B.-S.; Braun, F.K.; Liu, Z.-Q.; Tang, J.-L.; Wu, C.; Xu, F.; Wang, H.-H.; Velasquez, L.A.; Zhao, K.; Lei, F.-R.; Zhang, J.-G.; Shen, Y.-T.; Zou, J.-X.; Meng, H.-M.; An, G.-L.; Yang, L.; Zhang, X.-D. 2015: HMGB1 Promotes Mitochondrial Dysfunction-Triggered Striatal Neurodegeneration via Autophagy and Apoptosis Activation. Plos one 10(11): E0142901
Lu, M.; Yu, S.; Xu, W.; Gao, B.; Xiong, S. 2015: HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response. Journal of Immunology Research 2015: 946748
Hu, N.; Kong, L.; Qian, A.; Meng, Q.; Li, C.; Yu, X.; Chen, H.; Du, X.; Li, X. 2015: HMGB1 Silencing Potentiates the Anti-inflammatory Effects of Sodium Ferulate in ox-LDL-Stimulated Vascular Smooth Muscle Cells. Cell Biochemistry and Biophysics 72(1): 297-304
Zhang, J.; Klufas, D.; Manalo, K.; Adjepong, K.; Davidson, J.O.; Wassink, G.; Bennet, L.; Gunn, A.J.; Stopa, E.G.; Liu, K.; Nishibori, M.; Stonestreet, B.S. 2016: HMGB1 Translocation After Ischemia in the Ovine Fetal Brain. Journal of Neuropathology and Experimental Neurology 75(6): 527-538
Zheng, S.; Pan, Y.; Wang, C.; Liu, Y.; Shi, M.; Ding, G. 2016: HMGB1 Turns Renal Tubular Epithelial Cells into Inflammatory Promoters by Interacting with TLR4 During Sepsis. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 36(1): 9-19
Napolitano, A.; Antoine, D.J.; Pellegrini, L.; Baumann, F.; Pagano, I.; Pastorino, S.; Goparaju, C.M.; Prokrym, K.; Canino, C.; Pass, H.I.; Carbone, M.; Yang, H. 2016: HMGB1 and its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 22(12): 3087-3096
Muth, I.E.; Zschüntzsch, J.; Kleinschnitz, K.; Wrede, A.; Gerhardt, E.; Balcarek, P.; Schreiber-Katz, O.; Zierz, S.; Dalakas, M.C.; Voll, R.E.; Schmidt, J. 2015: HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis. Experimental Neurology 271: 189-197
Huebener, P.; Hernandez, C.; Schwabe, R.F. 2015: HMGB1 and injury amplification. Oncotarget 6(27): 23048-23049
Festoff, B.W.; Sajja, R.K.; van Dreden, P.; Cucullo, L. 2016: HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease. Journal of Neuroinflammation 13(1): 194
Singh, V.; Roth, S.; Veltkamp, R.; Liesz, A. 2016: HMGB1 as a Key Mediator of Immune Mechanisms in Ischemic Stroke. Antioxidants and Redox Signaling 24(12): 635-651
Venereau, E.; De Leo, F.; Mezzapelle, R.; Careccia, G.; Musco, G.; Bianchi, M.E. 2016: HMGB1 as biomarker and drug target. Pharmacological Research 111: 534-544
Gdynia, G. 2016: HMGB1 as metabolic weapon in the arsenal of natural killer cells. Der Pathologe 37(Suppl 2): 169-172
Liang, Y.; Hou, C.; Kong, J.; Wen, H.; Zheng, X.; Wu, L.; Huang, H.; Chen, Y. 2015: HMGB1 binding to receptor for advanced glycation end products enhances inflammatory responses of human bronchial epithelial cells by activating p38 MAPK and ERK1/2. Molecular and Cellular Biochemistry 405(1-2): 63-71
Ahrens, I.; Chen, Y.-C.; Topcic, D.; Bode, M.; Haenel, D.; Hagemeyer, C.E.; Seeba, H.; Duerschmied, D.; Bassler, N.; Jandeleit-Dahm, K.A.; Sweet, M.J.; Agrotis, A.; Bobik, A.; Peter, K. 2015: HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi. Thrombosis and Haemostasis 114(5): 994-1003
Zhou, Y.; Oskolkov, N.; Shcherbina, L.; Ratti, J.; Kock, K.-H.; Su, J.; Martin, B.; Oskolkova, M.Z.; Göransson, O.; Bacon, J.; Li, W.; Bucciarelli, S.; Cilio, C.; Brazma, A.; Thatcher, B.; Rung, J.; Wierup, N.; Renström, E.; Groop, L.; Hansson, O. 2016: HMGB1 binds to the rs7903146 locus in TCF7L2 in human pancreatic islets. Molecular and Cellular Endocrinology 430: 138-145
Ming, B.; Gao, M.; Zou, H.; Chen, H.; Sun, Y.; Xiao, Y.; Lai, L.; Xiong, P.; Xu, Y.; Tan, Z.; Wang, J.; Chen, G.; Gong, F.; Xia, J.; Zheng, F. 2016: HMGB1 blockade differentially impacts pulmonary inflammation and defense responses in poly(I:C)/LPS-exposed heart transplant mice. Molecular Immunology 76: 80-89
Rojas, A.; Delgado-López, F.; Perez-Castro, R.ón.; Gonzalez, I.; Romero, J.; Rojas, I.; Araya, P.; Añazco, C.; Morales, E.; Llanos, J. 2016: HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(3): 3321-3329
He, L.; Sun, F.; Wang, Y.; Zhu, J.; Fang, J.; Zhang, S.; Yu, Q.; Gong, Q.; Ren, B.; Xiang, X.; Chen, Z.; Ning, Q.; Hu, J.; Yang, P.; Wang, C.-Y. 2016: HMGB1 exacerbates bronchiolitis obliterans syndrome via RAGE/NF-κB/HPSE signaling to enhance latent TGF-β release from ECM. American Journal of Translational Research 8(5): 1971-1984
Chen, X.; Li, L.; Khan, M.N.; Shi, L.; Wang, Z.; Zheng, F.; Gong, F.; Fang, M. 2016: HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production. Innate Immunity 22(8): 696-705
Cseri, K.; Vincze, J.án.; Cseri, J.; Fodor, J.án.; Csernátony, Z.án.; Csernoch, L.ás.ó; Dankó, K. 2015: HMGB1 expression and muscle regeneration in idiopathic inflammatory myopathies and degenerative joint diseases. Journal of Muscle Research and Cell Motility 36(3): 255-262
Budman, D.R.; Barginear, M.F.; Goyal, A.; Chavan, S.; Yang, L.; Callabro, A.; Bradley, T.P.; Tracey, K.J. 2016: HMGB1 expression in hormonally independent breast carcinoma. Journal of Clinical Oncology 26(15_Suppl): 14655-14655
Sun, Y.; Chen, H.; Dai, J.; Zou, H.; Gao, M.; Wu, H.; Ming, B.; Lai, L.; Xiao, Y.; Xiong, P.; Xu, Y.; Gong, F.; Zheng, F. 2015: HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 280: 29-35
Singh, B.; Biswas, I.; Bhagat, S.; Surya Kumari, S.; Khan, G.A. 2016: HMGB1 facilitates hypoxia-induced vWF upregulation through TLR2-MYD88-SP1 pathway. European Journal of Immunology 46(10): 2388-2400
Ito, H.; Fujita, K.; Tagawa, K.; Chen, X.; Homma, H.; Sasabe, T.; Shimizu, J.; Shimizu, S.; Tamura, T.; Muramatsu, S.-i.; Okazawa, H. 2015: HMGB1 facilitates repair of mitochondrial DNA damage and extends the lifespan of mutant ataxin-1 knock-in mice. Embo Molecular Medicine 7(1): 78-101
Supic, G.; Kozomara, R.; Zeljic, K.; Stanimirovic, D.; Magic, M.; Surbatovic, M.; Jovic, N.; Magic, Z. 2015: HMGB1 genetic polymorphisms in oral squamous cell carcinoma and oral lichen planus patients. Oral Diseases 21(4): 536-543
Zhu, Z.; Hu, X. 2017: HMGB1 induced endothelial permeability promotes myocardial fibrosis in diabetic cardiomyopathy. International Journal of Cardiology 227: 875
Zhang, H.; Liu, Z.; Liu, S. 2016: HMGB1 induced inflammatory effect is blocked by CRISPLD2 via MiR155 in hepatic fibrogenesis. Molecular Immunology 69: 1-6
Park, S.Y.; Lee, S.W.; Kim, H.Y.; Lee, W.S.; Hong, K.W.; Kim, C.D. 2015: HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1α activation. European Journal of Immunology 45(4): 1216-1227
Ouyang, F.; Huang, H.; Zhang, M.; Chen, M.; Huang, H.; Huang, F.; Zhou, S. 2016: HMGB1 induces apoptosis and EMT in association with increased autophagy following H/R injury in cardiomyocytes. International Journal of Molecular Medicine 37(3): 679-689
Zhu, J.; Luo, J.; Li, Y.; Jia, M.; Wang, Y.; Huang, Y.; Ke, S. 2016: HMGB1 induces human non-small cell lung cancer cell motility by activating integrin αvβ3/FAK through TLR4/NF-κB signaling pathway. Biochemical and Biophysical Research Communications 480(4): 522-527
Mukherjee, A.; Vasquez, K.M. 2016: HMGB1 interacts with XPA to facilitate the processing of DNA interstrand crosslinks in human cells. Nucleic Acids Research 44(3): 1151-1160
Chen, Y.; Qiao, F.; Zhao, Y.; Wang, Y.; Liu, G. 2015: HMGB1 is activated in type 2 diabetes mellitus patients and in mesangial cells in response to high glucose. International Journal of Clinical and Experimental Pathology 8(6): 6683-6691
Zeng, C.; Zhu, Z.; Liu, Q. 2016: HMGB1 is responsible for Amitriptyline-mediated cardiac protection from ischemic-reperfusion injury. International Journal of Cardiology 222: 1071
Shimizu, T.; Yamakuchi, M.; Biswas, K.K.; Aryal, B.; Yamada, S.; Hashiguchi, T.; Maruyama, I. 2016: HMGB1 is secreted by 3T3-L1 adipocytes through JNK signaling and the secretion is partially inhibited by adiponectin. Obesity 24(9): 1913-1921
Wang, Z.; Wang, X.; Li, J.; Yang, C.; Xing, Z.; Chen, R.; Xu, F. 2016: HMGB1 knockdown effectively inhibits the progression of rectal cancer by suppressing HMGB1 expression and promoting apoptosis of rectal cancer cells. Molecular Medicine Reports 14(1): 1026-1032
Chen, Y.; Zhang, J.; Wang, X.; Wu, Y.; Zhu, L.; Lu, L.; Shen, Q.; Qin, Y. 2016: HMGB1 level in cerebrospinal fluid as a complimentary biomarker for the diagnosis of tuberculous meningitis. Springerplus 5(1): 1775
Cuppari, C.; Manti, S.; Salpietro, A.; Valenti, S.; Capizzi, A.; Arrigo, T.; Salpietro, C.; Leonardi, S. 2016: HMGB1 levels in children with atopic eczema/dermatitis syndrome (AEDS). Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 27(1): 99-102
Lei, C.; Zhang, S.; Cao, T.; Tao, W.; Liu, M.; Wu, B. 2015: HMGB1 may act via RAGE to promote angiogenesis in the later phase after intracerebral hemorrhage. Neuroscience 295: 39-47
Valdés-Ferrer, S.I.; Papoin, J.; Dancho, M.E.; Olofsson, P.S.; Li, J.; Lipton, J.M.; Avancena, P.; Yang, H.; Zou, Y.-R.; Chavan, S.S.; Volpe, B.T.; Gardenghi, S.; Rivella, S.; Diamond, B.; Andersson, U.; Steinberg, B.M.; Blanc, L.; Tracey, K.J. 2016: HMGB1 Mediates Anemia of Inflammation in Murine Sepsis Survivors. Molecular Medicine 21(1): 951-958
Su, Z.; Wang, T.; Zhu, H.; Zhang, P.; Han, R.; Liu, Y.; Ni, P.; Shen, H.; Xu, W.; Xu, H. 2015: HMGB1 modulates Lewis cell autophagy and promotes cell survival via RAGE-HMGB1-Erk1/2 positive feedback during nutrient depletion. Immunobiology 220(5): 539-544
Wu, T.; Zhang, W.; Yang, G.; Li, H.; Chen, Q.; Song, R.; Zhao, L. 2016: HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review. Oncotarget 7(31): 50417-50427
Xu, Y.; Chen, Z.; Zhang, G.; Xi, Y.; Sun, R.; Chai, F.; Wang, X.; Guo, J.; Tian, L. 2015: HMGB1 overexpression correlates with poor prognosis in early-stage squamous cervical cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(11): 9039-9047
Chen, Y.; Lin, C.; Liu, Y.; Jiang, Y. 2016: HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(4): 4399-4408
Bredeson, S.; Papaconstantinou, J.; Deford, J.H.; Kechichian, T.; Syed, T.A.; Saade, G.R.; Menon, R. 2014: HMGB1 promotes a p38MAPK associated non-infectious inflammatory response pathway in human fetal membranes. Plos one 9(12): E113799
Lin, F.; Xue, D.; Xie, T.; Pan, Z. 2016: HMGB1 promotes cellular chemokine synthesis and potentiates mesenchymal stromal cell migration via Rap1 activation. Molecular Medicine Reports 14(2): 1283-1289
Chi, W.; Chen, H.; Li, F.; Zhu, Y.; Yin, W.; Zhuo, Y. 2015: HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucoma. Journal of Neuroinflammation 12: 137
Fu, J.; Lin, S.-H.; Wang, C.-J.; Li, S.-Y.; Feng, X.-Y.; Liu, Q.; Xu, F. 2016: HMGB1 regulates IL-33 expression in acute respiratory distress syndrome. International Immunopharmacology 38: 267-274
Jiang, G.; Wang, Y.; Yun, J.; Hajrasouliha, A.R.; Zhao, Y.; Sun, D.; Kaplan, H.J.; Shao, H. 2015: HMGB1 release triggered by the interaction of live retinal cells and uveitogenic T cells is Fas/FasL activation-dependent. Journal of Neuroinflammation 12: 179
Demoulin, S.ép.; Herfs, M.; Somja, J.; Roncarati, P.; Delvenne, P.; Hubert, P. 2015: HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells. International Journal of Cancer 137(2): 345-358
Ni, P.; Zhang, Y.; Liu, Y.; Lin, X.; Su, X.; Lu, H.; Shen, H.; Xu, W.; Xu, H.; Su, Z. 2015: HMGB1 silence could promote MCF-7 cell apoptosis and inhibit invasion and metastasis. International Journal of Clinical and Experimental Pathology 8(12): 15940-15946
Gupta, K. 2014: HMGB1 takes a "Toll" in sickle cell disease. Blood 124(26): 3837-3838
Cheng, Y.; Wang, D.; Wang, B.; Li, H.; Xiong, J.; Xu, S.; Chen, Q.; Tao, K.; Yang, X.; Zhu, Y.; He, S. 2017: HMGB1 translocation and release mediate cigarette smoke-induced pulmonary inflammation in mice through a TLR4/MyD88-dependent signaling pathway. Molecular Biology of the Cell 28(1): 201-209
Kong, Q.; Xu, L.-H.; Xu, W.; Fang, J.-P.; Xu, H.-G. 2015: HMGB1 translocation is involved in the transformation of autophagy complexes and promotes chemoresistance in leukaemia. International Journal of Oncology 47(1): 161-170
Tesarova, P.; Kalousova, M.; Zima, T.; Tesar, V. 2016: HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targets. Biomedical Papers of the Medical Faculty of the University Palacky Olomouc Czechoslovakia 160(1): 1-10
Cai, J.; Yuan, H.; Wang, Q.; Yang, H.; Al-Abed, Y.; Hua, Z.; Wang, J.; Chen, D.; Wu, J.; Lu, B.; Pribis, J.P.; Jiang, W.; Yang, K.; Hackam, D.J.; Tracey, K.J.; Billiar, T.R.; Chen, A.F. 2015: HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4. Arteriosclerosis Thrombosis and Vascular Biology 35(12): 2579-2593
Mardente, S.; Mari, E.; Massimi, I.; Fico, F.; Faggioni, A.; Pulcinelli, F.; Antonaci, A.; Zicari, A. 2015: HMGB1-Induced Cross Talk between PTEN and mi Rs 221/222 in Thyroid Cancer. Biomed Research International 2015: 512027
Lin, H.; Shen, L.; Zhang, X.; Xie, J.; Hao, H.; Zhang, Y.; Chen, Z.; Yamamoto, H.; Liao, W.; Bin, J.; Cao, S.; Huang, X.; Liao, Y. 2016: HMGB1-RAGE Axis Makes No Contribution to Cardiac Remodeling Induced by Pressure-Overload. Plos one 11(6): E0158514
Zhu, L.; Zhang, Z.; Zhang, L.; Shi, Y.; Qi, J.; Chang, A.; Gao, J.; Feng, Y.; Yang, X. 2015: HMGB1-RAGE signaling pathway in severe preeclampsia. Placenta 36(10): 1148-1152
Shimizu, S.; Kouzaki, H.; Kato, T.; Tojima, I.; Shimizu, T. 2016: HMGB1-TLR4 signaling contributes to the secretion of interleukin 6 and interleukin 8 by nasal epithelial cells. American Journal of Rhinology and Allergy 30(3): 167-172
Zhang, J.; Xia, J.; Zhang, Y.; Xiao, F.; Wang, J.; Gao, H.; Liu, Y.; Rong, S.; Yao, Y.; Xu, G.; Li, J. 2016: HMGB1-TLR4 signaling participates in renal ischemia reperfusion injury and could be attenuated by dexamethasone-mediated inhibition of the ERK/NF-κB pathway. American Journal of Translational Research 8(10): 4054-4067
Kim, I.-D.; Luo, L.; Lee, H.-b.; Lee, H.-K.; Lee, J.-K. 2015: HMGB1-binding heptamer suppresses the synergistic effect of HMGB1 and LPS by interacting directly with HMGB1. Neuroscience Letters 593: 40-44
Liu, Y.; Song, L. 2015: HMGB1-induced autophagy in Schwann cells promotes neuroblastoma proliferation. International Journal of Clinical and Experimental Pathology 8(1): 504-510
Liu, W.; Zhang, Z.; Zhang, Y.; Chen, X.; Guo, S.; Lei, Y.; Xu, Y.; Ji, C.; Bi, Z.; Wang, K. 2015: HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway. Cancer Biology and Therapy 16(4): 511-517
Lui, G.; Wong, C.K.; Ip, M.; Chu, Y.J.; Yung, I.M.H.; Cheung, C.S.K.; Zheng, L.; Lam, J.S.Y.; Wong, K.T.; Sin, W.W.Y.; Choi, K.W.; Lee, N. 2016: HMGB1/RAGE Signaling and Pro-Inflammatory Cytokine Responses in Non-HIV Adults with Active Pulmonary Tuberculosis. Plos one 11(7): E0159132
Jhun, J.; Lee, S.; Kim, H.; Her, Y.-M.; Byun, J.K.; Kim, E.-K.; Lee, S.K.; Cho, M.-L.; Choi, J.Y. 2015: HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients. Journal of Translational Medicine 13: 310
Shao, Y.; Sha, M.; Chen, L.; Li, D.; Lu, J.; Xia, S. 2016: HMGB1/TLR4 signaling induces an inflammatory response following high-pressure renal pelvic perfusion in a porcine model. American Journal of Physiology. Renal Physiology 311(5): F915-F925
Zhou, Q.; Zhu, Z.; Hu, X.; Shu, C. 2016: HMGB1: a critical mediator for oxidized-low density lipoproteins induced atherosclerosis. International Journal of Cardiology 202: 956-957
Fan, Z.; Yang, J.; Yang, J.; Yang, C.; Guo, X. 2016: HMGB1: a promising therapeutic approach for atherosclerosis. International Journal of Cardiology 202: 507-508
Cerwenka, A.; Kopitz, Jürgen.; Schirmacher, P.; Roth, W.; Gdynia, G. 2016: HMGB1: The metabolic weapon in the arsenal of NK cells. Molecular and Cellular Oncology 3(4): E1175538
Yang, X.; Wang, H.; Zhang, M.; Liu, J.; Lv, B.; Chen, F. 2015: HMGB1: a novel protein that induced platelets active and aggregation via Toll-like receptor-4, NF-κB and cGMP dependent mechanisms. Diagnostic Pathology 10: 134
Ding, J.-W.; Zheng, X.-X.; Zhou, T.; Tong, X.-H.; Luo, C.-Y.; Wang, X.-A. 2016: HMGB1Modulates the Treg/Th17 Ratio in Atherosclerotic Patients. Journal of Atherosclerosis and Thrombosis 23(6): 737-745
Guerrero, A.; Gil, J.ús. 2016: HMGB2 holds the key to the senescence-associated secretory phenotype. Journal of Cell Biology 215(3): 297-299
Aird, K.M.; Iwasaki, O.; Kossenkov, A.V.; Tanizawa, H.; Fatkhutdinov, N.; Bitler, B.G.; Le, L.; Alicea, G.; Yang, T.-L.; Johnson, F.B.; Noma, K.-I.; Zhang, R. 2016: HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene loci. Journal of Cell Biology 215(3): 325-334
Zhou, X.; Li, M.; Huang, H.; Chen, K.; Yuan, Z.; Zhang, Y.; Nie, Y.; Chen, H.; Zhang, X.; Chen, L.; Chen, Y.; Mo, D. 2016: HMGB2 regulates satellite-cell-mediated skeletal muscle regeneration through IGF2BP2. Journal of Cell Science 129(22): 4305-4316
Tsujikawa, K.; Hara, K.; Muro, Y.; Nakanishi, H.; Niwa, Y.; Koike, M.; Noda, S.; Riku, Y.; Sahashi, K.; Atsuta, N.; Ito, M.; Shimoyama, Y.; Akiyama, M.; Katsuno, M. 2016: HMGCR antibody-associated myopathy as a paraneoplastic manifestation of esophageal carcinoma. Neurology 87(8): 841-843
Chushi, L.; Wei, W.; Kangkang, X.; Yongzeng, F.; Ning, X.; Xiaolei, C. 2016: HMGCR is up-regulated in gastric cancer and promotes the growth and migration of the cancer cells. Gene 587(1): 42-47
Qiu, Z.; Yuan, W.; Chen, T.; Zhou, C.; Liu, C.; Huang, Y.; Han, D.; Huang, Q. 2016: HMGCR positively regulated the growth and migration of glioblastoma cells. Gene 576(1 Part 1): 22-27
Cuevas, A.; Fernández, C.és.; Ferrada, L.; Zambrano, T.ás.; Rosales, A.; Saavedra, N.ás.; Salazar, L.A. 2016: HMGCR rs17671591 SNP Determines Lower Plasma LDL-C after Atorvastatin Therapy in Chilean Individuals. Basic and Clinical Pharmacology and Toxicology 118(4): 292-297
Kennedy, N.; Keating, P.; O'Donnell, J. 2016: HMGCR-associated myositis: a New Zealand case series and estimate of incidence. Internal Medicine Journal 46(5): 622-625
Chen, S-Wen.; Chou, C-Ting.; Chang, C-Chi.; Li, Y-Ju.; Chen, S-Ta.; Lin, I-Ching.; Kok, S-Heng.; Cheng, S-Jung.; Lee, J-Jaer.; Wu, T-Sheng.; Kuo, M-Liang.; Lin, B-Ren. 2017: HMGCS2 enhances invasion and metastasis via direct interaction with PPARα to activate Src signaling in colorectal cancer and oral cancer. Oncotarget 8(14): 22460-22476
Mansoori, B.; Mohammadi, A.; Shirjang, S.; Baradaran, B. 2016: HMGI-C suppressing induces P53/caspase9 axis to regulate apoptosis in breast adenocarcinoma cells. Cell Cycle 15(19): 2585-2592
Zhang, S.; Zhu, I.; Deng, T.; Furusawa, T.; Rochman, M.; Vacchio, M.S.; Bosselut, R.; Yamane, A.; Casellas, R.; Landsman, D.; Bustin, M. 2016: HMGN proteins modulate chromatin regulatory sites and gene expression during activation of naïve B cells. Nucleic Acids Research 44(15): 7144-7158
He, J.; Liu, C.; Wang, B.; Li, N.; Zuo, G.; Gao, D. 2015: HMGN5 blockade by siRNA enhances apoptosis, suppresses invasion and increases chemosensitivity to temozolomide in meningiomas. International Journal of Oncology 47(4): 1503-1511
Martínez de Paz, A.; Ausió, J. 2016: HMGNs: the enhancer charmers. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 38(3): 226-231
Yu, X.; Sun, S. 2016: HMM-DM: identifying differentially methylated regions using a hidden Markov model. Statistical Applications in Genetics and Molecular Biology 15(1): 69-81
Sun, S.; Yu, X. 2016: HMM-Fisher: identifying differential methylation using a hidden Markov model and Fisher's exact test. Statistical Applications in Genetics and Molecular Biology 15(1): 55-67
Lai, X.; Ning, F.; Xia, X.; Wang, D.; Tang, L.; Hu, J.; Wu, J.; Liu, J.; Li, X. 2015: HMME combined with green light-emitting diode irradiation results in efficient apoptosis on human tongue squamous cell carcinoma. Lasers in Medical Science 30(7): 1941-1948
Finn, R.D.; Clements, J.; Arndt, W.; Miller, B.L.; Wheeler, T.J.; Schreiber, F.; Bateman, A.; Eddy, S.R. 2015: HMMER web server: 2015 update. Nucleic Acids Research 43(W1): W30-W38
Liu, W.; Ma, J.; Cheng, Y.; Zhang, H.; Luo, W.; Zhang, H. 2016: HMMR antisense RNA 1, a novel long noncoding RNA, regulates the progression of basal-like breast cancer cells. Breast Cancer 8: 223-229
Liu, M.; Watson, L.T.; Zhang, L. 2015: HMMvar-func: a new method for predicting the functional outcome of genetic variants. Bmc Bioinformatics 16: 351
Yang, D.; Peng, Y.; Ouzhuluobu; Bianbazhuoma; Cui, C.; Bianba; Wang, L.; Xiang, K.; He, Y.; Zhang, H.; Zhang, X.; Liu, J.; Shi, H.; Pan, Y.; Duojizhuoma; Dejiquzong; Cirenyangji; Baimakangzhuo; Gonggalanzi; Liu, S.; Gengdeng; Wu, T.; Chen, H.; Qi, X.; Su, B. 2016: HMOX2 Functions as a Modifier Gene for High-Altitude Adaptation in Tibetans. Human Mutation 37(2): 216-223
Monahan, T. 1986: HMOs: Directing the Future of Sports Medicine?. Physician and Sportsmedicine 14(3): 254-261
Bateman, C. 2015: HMPG secures top-drawer CEO. South African Medical Journal 105(2): 82